<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1001233086
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR JPI 500 mg vial
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Sterile, lyophilized, white powder
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        193.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Hikma Farmaceutica" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Hikma Farmaceutica
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J05AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Acyclovir JPI contains a medicine called acyclovir.</p><p>This belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses.</p><p>Acyclovir JPI can be used to:</p><ul><li>Treat chickenpox</li><li>Treat severe cases of genital herpes</li><li>Treat and stop cold sores and genital herpes in people whose immune systems work less well, which means their bodies are less able to fight infections</li><li>Treat serious virus infections in children up to 3 months of age. This can rarely be caused by the virus responsible for cold sore infection and genital herpes.</li><li>Treat inflammation of the brain. This can rarely be caused by the virus responsible for cold sore infection and genital herpes.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>You should not be given Acyclovir JPI:</strong></p><ul><li>&nbsp;If you are allergic to acyclovir or valacyclovir or any of the other ingredients of this medicine (listed in section 6).</li></ul><p>Do not take Acyclovir JPI if the above applies to you. If you are not sure, talk to your doctor or pharmacist before having Acyclovir JPI.</p><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor or pharmacist before having Acyclovir JPI if:</p><ul><li>You have kidney problems</li><li>You are over 65 years of age.</li></ul><p>If you are not sure if the above apply to you, talk to your doctor or pharmacist before taking Acyclovir JPI.</p><p>It is important that you drink plenty of water while taking Acyclovir JPI.</p><p><strong>Other medicines and Acyclovir JPI</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines.</p><p>In particular, tell your doctor or pharmacist if you are taking any of the following medicines:</p><ul><li>&nbsp;Probenecid, used to treat gout</li><li>Cimetidine, used to treat stomach ulcers</li><li>&nbsp;Tacrolimus, ciclosporin or mycophenolate mofetil, used to stop your body rejecting transplanted organs.</li></ul><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Acyclovir JPI contains sodium </strong></p><p>Acyclovir JPI contains sodium. Each vial of Acyclovir JPI 250 mg and 500 mg Powder for Solution for Infusion contains 42.6 mg or 85.2 mg sodium; respectively. This is equivalent to 2.13% or 4.26%; respectively, of the recommended maximum daily dietary intake of sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How your medicine is given </strong></p><p>You will never be expected to give yourself this medicine. It will always be given to you by a person who is trained to do so.</p><p>Before the medicine is given to you it will be diluted.</p><p>Acyclovir JPI will be given to you as a continuous infusion into your vein. This is where the drug is slowly given to you over a period of time.</p><p>The dose you will be given, the frequency and the duration of the dose will depend on:</p><ul><li>The type of infection you have</li><li>Your weight</li><li>&nbsp;Your age.</li></ul><p><strong>Your doctor may adjust the dose of Acyclovir JPI if: </strong></p><ul><li>You have kidney problems. If you have kidney problems, it is important you receive plenty of fluids while you are being treated with Acyclovir JPI.</li></ul><p>Talk to your doctor before having Acyclovir JPI if any of the above apply.</p><p><strong>If you are given too much Acyclovir JPI</strong></p><p>If you think you have been given too much Acyclovir JPI, talk to your doctor or nurse straight away.</p><p><em>If you have been given too much Acyclovir JPI you may:</em></p><ul><li>Feel confused or agitated</li><li>Have hallucinations (seeing or hearing things that aren&rsquo;t there)</li><li>&nbsp;Have fits</li><li>&nbsp;Become unconscious (coma).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong><em>The following side effects may happen with this medicine:</em></strong></p><p><strong>Allergic reactions</strong> (may affect up to 1 in 10,000 people)</p><p>If you have an allergic reaction, stop taking acyclovir and see a doctor straight away. The signs may include:</p><ul><li>Rash, itching or hives on your skin</li><li>Swelling of your face, lips, tongue or other parts of your body</li><li>&nbsp;Shortness of breath, wheezing or trouble breathing</li><li>Unexplained fever (high temperature) and feeling faint, especially when standing up.</li></ul><p><strong><em>Other side effects include:</em></strong></p><p><strong>Common</strong> (may affect up to 1 in 10 people)</p><ul><li>Feeling or being sick</li><li>Itchy, hive-like rash</li><li>Skin reaction after exposure to light (photosensitivity)</li><li>Itching</li><li>Swelling, redness and tenderness at the site of injection</li><li>Increase in the liver enzymes.</li></ul><p><strong>Uncommon</strong> (may affect up to 1 in 100 people)</p><ul><li>Reduced numbers of red blood cells (anaemia)</li><li>Reduced numbers of white blood cells (leukopenia)</li><li>Reduced numbers of blood platelets (cells that help the blood to clot) (thrombocytopenia).</li></ul><p><strong>Very rare</strong> (may affect up to 1 in 10,000 people)</p><ul><li>Headache or feeling dizzy</li><li>Diarrhoea or stomach pains</li><li>Feeling tired</li><li>Fever</li><li>Effects on some blood urine tests</li><li>Feeling weak</li><li>Feeling agitated or confused</li><li>Shaking or tremors</li><li>Hallucinations (seeing or hearing things that aren&rsquo;t there)</li><li>Fits</li><li>Feeling unusually sleepy or drowsy</li><li>Unsteadiness when walking and lack of coordination</li><li>Difficulty speaking</li><li>Inability to think or judge clearly</li><li>Unconsciousness (coma)</li><li>Paralysis of part or all of your body</li><li>Disturbances of behaviour, speech and eye movements</li><li>Stiff neck and sensitivity to light</li><li>Inflammation of the liver (hepatitis)</li><li>Yellowing of your skin and whites of your eyes (jaundice)</li><li>Kidney problems where you pass little or no urine</li><li>Pain in your lower back, the kidney area of your back or just above your hip (renal pain).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not store above 30&deg;C.</p><p>Store in the original package.</p><p>Prepare immediately before use.</p><p>When reconstituted and/or diluted, the solutions are stable for up to 12 hours at room temperature (15 to 25&deg;C).</p><p>Discard unused solution.</p><p>Do not use this medicine after the expiry date which is stated on the package after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice any visible signs of deterioration.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is acyclovir.</p><p>Each vial of Acyclovir JPI 250 mg Powder for Solution for Infusion<strong> </strong>contains 250 mg acyclovir.</p><p>Each vial of Acyclovir JPI 500 mg Powder for Solution for Infusion<strong> </strong>contains 500 mg acyclovir.</p><p>The other ingredient is sodium hydroxide.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Acyclovir JPI 250 mg Powder for Solution for Infusion is a white powder having characteristic appearance of products prepared by freeze drying in 10 ml type I clear tubular glass vials with grey lyo-rubber stoppers and aluminum caps. 
After reconstitution, it’s a clear solution with no visible solid residues. 

Acyclovir JPI 500 mg Powder for Solution for Infusion is a white powder having characteristic appearance of products prepared by freeze drying in 20 ml type I clear tubular glass vials with grey lyo-rubber stoppers and aluminum caps. 
After reconstitution, it’s a clear solution with no visible solid residues.

Pack size: 5 Vials. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong></p><p>Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. Box 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: SAPV@hikma.com</p><p><strong>Manufacturer</strong></p><p>Hikma Farmaceutica (Portugal), S.A.</p><p>Estrada do Rio Da M&oacute;,</p><p>n.&deg;8, 8A e 8B, Ferven&ccedil;a</p><p>2705-906 Terrugem</p><p>Sintra, Portugal</p><p>Tel: + (351-2) 19608410</p><p>Fax: + (351-2) 19615102</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 12/2021; version number SA2.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي أسيكلوڤير JPI على دواء يُسمى أسيكلوڤير.</p><p dir="RTL">ينتمي هذا الدواء إلى مجموعة من الأدوية تسمى مضادات الفيروسات. حيث يعمل على قتل الفيروسات أو إيقاف نموها.</p><p dir="RTL">يمكن استخدام أسيكلوڤير JPI فيما يلي:</p><ul dir="rtl"><li>&nbsp;علاج جدري الماء.</li><li>&nbsp;علاج الحالات الحادة من الهربس التناسلي.</li><li>&nbsp;علاج وإيقاف قرح الزكام والهربس التناسلي لدى الأشخاص الذين يعانون من قصور في عمل الجهاز المناعي، مما يعني أن أجسادهم أقل قدرة على مقاومة العدوى.</li><li>&nbsp;علاج عدوى الفيروسات الخطيرة لدى الأطفال حتى 3 أشهر. قد يتسبب الفيروس المسؤول عن عدوى قرح الزكام والهربس التناسلي بهذه العدوى في حالات نادرة.</li><li>علاج التهاب الدماغ. قد يتسبب الفيروس المسؤول عن عدوى قرح الزكام والهربس التناسلي بهذه العدوى في حالات نادرة.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا يجب إعطائك أسيكلوڤير </strong><strong>JPI</strong><strong>:</strong></p><ul dir="rtl"><li>&nbsp;إذا كنت تعاني من حساسية للأسيكلوڤير أو فالأسيكلوڤير أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم 6).</li></ul><p dir="RTL">لا تستخدم أسيكلوڤير JPI في حالة تعرضك لما ورد أعلاه. إذا لم تكن متأكداً، تحدث مع طبيبك أو الصيدلي قبل تلقي أسيكلوڤير JPI.</p><p dir="RTL"><strong>الاحتياطات والتحذيرات </strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي قبل استخدام أسيكلوڤير JPI إذا:</p><ul dir="rtl"><li>كنت تعاني من مشاكل في الكلى</li><li>تجاوز عمرك 65 سنة.</li></ul><p dir="RTL">إذا لم تكن متأكداً من انطباق ما ورد أعلاه عليك، فتحدث مع طبيبك أو الصيدلي قبل أخذ أسيكلوڤير JPI.</p><p dir="RTL">من المهم شرب كمية وفيرة من الماء عند أخذ أسيكلوڤير JPI.</p><p><strong>&nbsp;الأدوية الأخرى وأسيكلوڤير JPI</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، تناولت مؤخراً، أو قد تتناول أية أدوية أخرى. ويشمل ذلك الأدوية التي حصلت عليها بدون وصفة طبية، بما في ذلك الأدوية العشبية.</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أيًّا من الأدوية التالية، على وجه الخصوص:</p><ul dir="rtl"><li>بروبينيسيد، الذي يُستخدم لعلاج النقرس</li><li>سيميتيدين، الذي يُستخدم لعلاج قرح المعدة</li><li>تاكروليمس، سيكلوسبورين أو ميكوفينوليت موفيتيل، الذي يُستخدم لوقف رفض جسدك للأعضاء المزروعة.</li></ul><p dir="RTL"><strong>الحمل والرضاعة </strong></p><p dir="RTL">يرجى طلب النصيحة من طبيبك أو الصيدلي قبل أخذ هذا الدواء إذا كنت حاملاً أو مرضع، تعتقدين بأنك حاملاً أو تخططين لذلك.</p><p dir="RTL"><strong>يحتوي أسيكلوڤير </strong><strong>JPI</strong><strong> </strong><strong>على الصوديوم </strong></p><p dir="RTL">يحتوي أسيكلوڤير JPI على الصوديوم. تحتوي كل زجاجة من أسيكلوڤير JPI 250 ملغم و500 ملغم مسحوق للحل للتسريب على 42.6 ملغم أو 85.2 ملغم صوديوم؛ على التوالي. هذا يكافئ 2.13% أو 4.26%؛ على التوالي، من الحد الأقصى الموصى به من الحصة الغذائية اليومية من الصوديوم للبالغين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>طريقة إعطاء الدواء</strong></p><p dir="RTL">ليس من المتوقع على الإطلاق أن تعطي هذا الدواء لنفسك. حيث سيتم إعطاؤه لك من قبل شخص مدرب على القيام بذلك.</p><p dir="RTL">سيتم تخفيف هذا الدواء قبل إعطائك إياه.</p><p dir="RTL">سيتم إعطاؤك أسيكلوڤير JPI بالتسريب المستمر في الوريد. حيث سيتم إعطاؤك هذا الدواء ببطء على مدى فترة زمنية.</p><p dir="RTL">تعتمد الجرعة التي سيتم إعطاؤك إياها، ومعدل تكرارها ومدتها على ما يلي:</p><ul dir="rtl"><li>نوع العدوى التي أصابتك</li><li>وزنك</li><li>عمرك.</li></ul><p dir="RTL"><strong>قد يعدّل طبيبك جرعة أسيكلوڤير </strong><strong>JPI</strong><strong> إذا:</strong></p><ul dir="rtl"><li>كنت تعاني من مشاكل في الكلى. من المهم أن تتناول كميات وفيرة من السوائل أثناء علاجك بأسيكلوڤير JPI، إذا كنت تعاني من مشاكل في الكلى.</li></ul><p dir="RTL">تحدث مع طبيبك قبل أخذ أسيكلوڤير JPI في حالة وجود أي مما ورد أعلاه.</p><p dir="RTL"><strong>إذا أُعطيت أسيكلوڤير </strong><strong>JPI</strong><strong> أكثر من اللازم</strong></p><p dir="RTL">تحدث مع طبيبك أو الممرض على الفور، إذا كنت تعتقد بأنك قد أُعطيت جرعة زائدة من أسيكلوڤير JPI.</p><p dir="RTL"><em>إذا تم اعطاؤك أسيكلوڤير </em><em>JPI</em><em> أكثر من اللازم</em><em> قد:</em></p><ul dir="rtl"><li>تشعر بالاضطراب أو الاهتياج</li><li>تعاني من الهلوسات (رؤية أو سماع أشياء غير موجودة)</li><li>&nbsp;تعاني من النوبات</li><li>تغيب عن الوعي (الغيبوبة).</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبيةً، إلا أنه ليس بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء.</p><p dir="RTL"><strong><em>قد تحدث الآثار الجانبية التالية عند تناول هذا الدواء:</em></strong></p><p dir="RTL"><strong>ردود فعل تحسسية</strong> (قد تؤثر في ما يصل إلى شخص واحد من كل 10000 شخص)</p><p dir="RTL">إذا كنت تعاني من رد فعل تحسسي، فتوقف عن أخذ أسيكلوڤير وتوجه إلى الطبيب على الفور. قد تشمل العلامات:</p><ul dir="rtl"><li>طفح جلدي، حكة أو شرى على جلدك</li><li>تورم الوجه، الشفتين، اللسان أو أعضاء أخرى في جسدك</li><li>ضيق النفس، صفير أو صعوبة في التنفس</li><li>حمى مجهولة السبب (ارتفاع درجة الحرارة) والشعور بالإغماء، خاصةً عند الوقوف.</li></ul><p dir="RTL"><strong><em>تشمل الآثار الجانبية الأخرى:</em></strong></p><p dir="RTL"><strong>شائعة</strong> (قد تؤثر في ما يصل إلى شخص واحد من كل 10 أشخاص)</p><ul dir="rtl"><li>الغثيان أو القيء</li><li>حكة، طفح جلدي مشابه للشرى</li><li>رد فعل تحسسي جلدي بعد التعرض للضوء (حساسية للضوء)</li><li>حكة</li><li>تورم، احمرار وإيلام في موضع الحقن</li><li>زيادة في انزيمات الكبد.</li></ul><p dir="RTL"><strong>غير شائعة</strong> (قد تؤثر في ما يصل إلى شخص واحد من كل 100 شخص)</p><ul dir="rtl"><li>انخفاض عدد خلايا الدم الحمراء (فقر الدم)</li><li>انخفاض عدد خلايا الدم البيضاء (قلة الكريات البيض)</li><li>انخفاض عدد الصفائح الدموية (الخلايا التي تساعد على تجلط الدم) (قلة الصفيحات).</li></ul><p dir="RTL"><strong>نادرة جداً</strong> (قد تؤثر في ما يصل إلى شخص واحد من كل 10000 شخص)</p><ul dir="rtl"><li>صداع أو الشعور بالدوخة</li><li>إسهال أو آلام بالمعدة</li><li>الشعور بالتعب</li><li>حمّى</li><li>التأثير على بعض نتائج اختبارات الدم والبول</li><li>الشعور بالضعف</li><li>الشعور بالاهتياج أو الاضطراب</li><li>ارتعاش أو اختلاجات</li><li>هلوسات (رؤية أو سماع أشياء غير موجودة)</li><li>نوبات</li><li>شعور غير طبيعي بالنعاس أو الخمول</li><li>&nbsp;عدم الاستقرار عند المشي وانعدام التوافق الحركي</li><li>صعوبة في الكلام</li><li>عدم القدرة على التفكير أو الحكم بوضوح</li><li>فقدان الوعي (الغيبوبة)</li><li>شلل جزئي أو كلي في الجسم</li><li>اضطرابات في السلوك، الكلام وحركات العين</li><li>تيبس الرقبة والحساسية للضوء</li><li>التهاب الكبد</li><li>اصفرار البشرة وبياض العينين (اليرقان)</li><li>مشاكل في الكلى بحيث تتبول بكمية قليلة أو لا تتبول</li><li>ألم في أسفل الظهر، منطقة الكلى من ظهرك أو أعلى الفخذ مباشرةً (ألم بالكلى).</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا يحفظ عند درجة حرارة أعلى من 30&deg; مئوية.</p><p dir="RTL">يحفظ داخل العبوة الأصلية.</p><p dir="RTL">قم بتحضیره فوراً قبل الاستخدام.</p><p dir="RTL">عند الحل و/أو التخفيف، تكون المحاليل مستقرة لمدة تصل إلى 12 ساعة عند درجة حرارة الغرفة (15 إلى 25&deg; مئوية).</p><p dir="RTL">تخلص من بقایا المحلول غیر المستخدمة.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية بعد &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات ستساعد في الحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أسيكلوڤير.</p><p dir="RTL">تحتوي كل زجاجة من أسيكلوڤير JPI 250 ملغم مسحوق للحل للتسريب على 250 ملغم أسيكلوڤير.</p><p dir="RTL">تحتوي كل زجاجة من أسيكلوڤير JPI 500 ملغم مسحوق للحل للتسريب على 500 ملغم أسيكلوڤير.</p><p dir="RTL">المادة الأخرى المستخدمة في التركيبة التصنيعية هي هيدروكسيد الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">أسيكلوڤير JPI 250 ملغم مسحوق للحل للتسريب هو مسحوق أبيض له مظهر المستحضرات التي يتم تحضيرها من خلال التجفيف بالتجميد في زجاجات أنبوبية شفافة من النوع رقم واحد بحجم 10 مللتر مزودة بسدادات مطاطية رمادية اللون وأغطية من الألومنيوم.</p><p dir="RTL" style="text-align:right">بعد الحل، هو محلول شفاف لا يحتوي على بقايا صلبة مرئية.</p><p dir="RTL" style="text-align:right">أسيكلوڤير JPI 500 ملغم مسحوق للحل للتسريب هو مسحوق أبيض له مظهر المستحضرات التي يتم تحضيرها من خلال التجفيف بالتجميد في زجاجات أنبوبية شفافة من النوع رقم واحد بحجم 20 مللتر مزودة بسدادات مطاطية رمادية اللون وأغطية من الألومنيوم.</p><p dir="RTL" style="text-align:right">بعد الحل، هو محلول شفاف لا يحتوي على بقايا صلبة مرئية.</p><p dir="RTL" style="text-align:right"><strong>&nbsp;</strong>حجم العبوة: 5 زجاجات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق</strong></p><p dir="RTL">شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية<br />هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: SAPV@hikma.com</p><p dir="RTL"><strong>الشركة المصنعة</strong></p><p dir="RTL">شركة أدوية الحكمة (البرتغال)<br />إسترادا دو ريو دا مو،</p><p dir="RTL">مبنى رقم &deg;8, 8A e 8B، فارفانسا<br />906-2705 تيروجيم</p><p dir="RTL">سنترا، البرتغال<br />هاتف: 19608410 (2-351) +<br />فاكس: 19615102 (2-351) +</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ 2021/12؛ رقم النسخة SA2.0.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acyclovir JPI 500 mg Powder for Solution for Infusion 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains 500 mg acyclovir.

Excipient with known effect: Sodium. 

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for solution for infusion.

White powder having characteristic appearance of products prepared by freeze drying. 
After reconstitution, it’s a clear solution with no visible solid residues. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir JPI is indicated for the treatment of <em>Herpes simplex</em> infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised.</p><p>Acyclovir JPI is indicated for the prophylaxis of <em>Herpes simplex</em> infections in immunocompromised patients.</p><p>Acyclovir JPI is indicated for the treatment of <em>Varicella zoster</em> infections.</p><p>Acyclovir JPI is indicated for the treatment of herpes encephalitis.</p><p>Acyclovir JPI is indicated for the treatment of <em>Herpes simplex</em> infections in the neonate and infant up to 3 months of age.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Route of administration:</strong>&nbsp;</p><p>Slow intravenous infusion over 1 hour.</p><p>A course of treatment with Acyclovir JPI usually lasts 5 days, but this may be adjusted according to the patient&#39;s condition and response to therapy. Treatment for herpes encephalitis usually lasts 10 days. Treatment for neonatal herpes infections usually lasts 14 days for mucocutaneous (skin-eye-mouth) infections and 21 days for disseminated or central nervous system disease.</p><p>The duration of prophylactic administration of Acyclovir JPI is determined by the duration of the period at risk.</p><p><strong>Dosage in adults:</strong></p><p>Patients with&nbsp;<em>Herpes simplex</em>&nbsp;(except herpes encephalitis) or&nbsp;<em>Varicella zoster&nbsp;</em>infections should be given Acyclovir JPI in doses of 5 mg/kg body weight every 8 hours provided renal function is not impaired (see Dosage in renal impairment).</p><p>Immunocompromised patients with&nbsp;<em>Varicella zoster</em>&nbsp;infections or patients with herpes encephalitis should be given Acyclovir JPI in doses of 10 mg/kg body weight every 8 hours provided renal function is not impaired (see Dosage in renal impairment).</p><p>In obese patients dosed with intravenous acyclovir based on using ideal body weight, rather than actual body weight, higher plasma concentrations may be obtained (see 5.2 Pharmacokinetic properties). Consideration should therefore be given to dosage reduction in obese patients and especially in those with renal impairment or the elderly.</p><p><strong>Dosage in infants and children:&nbsp;</strong></p><p>The dose of Acyclovir JPI for infants and children aged between 3 months and 12 years is calculated on the basis of body weight.</p><p>Infants and children 3 months of age or older with herpes simplex infections should be given acyclovir 20 mg / kg body weight IV every eight hours for 21 days for herpes encephalitis, or for 14 days for disease limited to skin and mucous membrane if renal function is not impaired. Infants and children with varicella zoster infections should be given acyclovir 20mg/kg body weight IV every eight hours if renal function is not impaired.</p><p>In immunocompromised children with&nbsp;<em>Varicella zoster</em>&nbsp;infections or children with herpes encephalitis, Acyclovir JPI should be given in doses of 500 mg per square metre body surface area every 8 hours, if renal function is not impaired.</p><p>The recommended regimen for infants treated for known or suspected neonatal herpes is acyclovir 20 mg/kg body weight IV every 8 hours for 21 days for disseminated and CNS disease, or for 14 days for disease limited to the skin and mucous membranes.</p><p>Infants and children with impaired renal function require an appropriately modified dose, according to the degree of impairment (see Dosage in renal impairment).</p><p><strong>Dosage in the elderly:</strong></p><p>The possibility of renal impairment in the elderly must be considered and dosage should be adjusted accordingly (see&nbsp;<em>Dosage in renal impairment</em>&nbsp;below).</p><p>Adequate hydration should be maintained.</p><p><strong>Dosage in renal impairment</strong>:</p><p>Caution is advised when administering Acyclovir JPI to patients with impaired renal function. Adequate hydration should be maintained.</p><p>Dosage adjustment for patients with renal impairment is based on creatinine clearance, in units of ml/min for adults and adolescents and in units of ml/min/1.73 m<sup>2</sup>&nbsp;for infants and children less than 13 years of age. The following adjustments in dosage are suggested:&nbsp;</p><p><strong>Recommended dosage adjustments in adults and adolescents:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Creatinine Clearance</strong></p></td><td style="vertical-align:top"><p><strong>Dosage</strong></p></td></tr><tr><td style="vertical-align:top"><p>25 to 50 ml/min</p></td><td style="vertical-align:top"><p>5 or 10 mg/kg body weight given every 12 hours.</p></td></tr><tr><td style="vertical-align:top"><p>10 to 25 ml/min</p></td><td style="vertical-align:top"><p>5 or 10 mg/kg body weight given every 24 hours.</p></td></tr><tr><td style="vertical-align:top"><p>0 (anuric) to 10 ml/min</p></td><td style="vertical-align:top"><p>In patients receiving continuous ambulatory peritoneal dialysis (CAPD) the dose recommended above (5 or 10 mg/kg body weight) should be halved and administered every 24 hours.</p></td></tr><tr><td style="vertical-align:top"><p><em>Patients on haemodialysis</em></p></td><td style="vertical-align:top"><p>5 or 10 mg/kg body weight halved and administered every 24 hours and after dialysis.</p></td></tr></tbody></table><p><strong>Recommended dosage adjustments in infants and children:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Creatinine Clearance</strong></p><p>(ml/min/1.73 m<sup>2</sup>)</p></td><td style="vertical-align:top"><p><strong>Dosage</strong></p></td></tr><tr><td style="vertical-align:top"><p>Normal renal function</p></td><td style="vertical-align:top"><p>20 mg/kg body weight given three times a day.</p></td></tr><tr><td style="vertical-align:top"><p>25 to 50</p></td><td style="vertical-align:top"><p>20 mg/kg body weight given twice a day.</p></td></tr><tr><td style="vertical-align:top"><p>10 to 25</p></td><td style="vertical-align:top"><p>10 mg/kg body weight given twice a day.</p></td></tr><tr><td style="vertical-align:top"><p>0 (anuric) to 10</p></td><td style="vertical-align:top"><p>In patients receiving continuous ambulatory peritoneal dialysis (CAPD) 5 mg/kg body weight given twice a day.</p></td></tr><tr><td style="vertical-align:top"><p>Patients on haemodialysis</p></td><td style="vertical-align:top"><p>In patients receiving haemodialysis: 5 mg/kg body weight given twice a day after dialysis</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to acyclovir or valacyclovir, or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adequate hydration should be maintained in patients given IV or high oral doses of acyclovir.</p><p>Intravenous doses should be given by infusion over one hour to avoid precipitation of acyclovir in the kidney; rapid or bolus injection should be avoided.</p><p>The risk of renal impairment is increased by use with other nephrotoxic drugs. Care is required if administering IV acyclovir with other nephrotoxic drugs.</p><p><strong>Use in patients with renal impairment and in elderly patients:</strong></p><p>Acyclovir is eliminated by renal clearance, therefore the dose must be adjusted in patients with renal impairment (see section 4.2 Posology and method of administration). Elderly patients are likely to have reduced renal function and therefore the need for dose adjustment must be considered in this group of patients. Both elderly patients and patients with renal impairment are at increased risk of developing neurological side effects and should be closely monitored for evidence of these effects. In the reported cases, these reactions were generally reversible on discontinuation of treatment (see section 4.8 Undesirable effects). Prolonged or repeated courses of acyclovir in severely immune-compromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued acyclovir treatment (see section 5.1).</p><p>In patients receiving Acyclovir JPI at higher doses (e.g. for herpes encephalitis) specific care regarding renal function should be taken, particularly when patients are dehydrated or have any renal impairment.</p><p>Reconstituted Acyclovir JPI has a pH of approximately 11 and should not be administered by mouth. Each vial contains 42.6 mg sodium. To be taken into consideration by patients on a controlled sodium diet.</p><p>Acyclovir JPI contains no antimicrobial preservative. Reconstitution and dilution should therefore be carried out under full aseptic conditions immediately before use and any unused solution discarded. The reconstituted or diluted solutions should not be refrigerated.</p><p><strong>Other warnings and precautions</strong></p><p>The labels shall contain the following statements:</p><p>For intravenous use.</p><p>Keep out of the sight and reach of children.</p><p>Do not store above 30&deg;C.</p><p>Prepare immediately before use.</p><p>Discard unused solution.</p><p><strong>Acyclovir JPI contains sodium </strong></p><p>Acyclovir JPI contains sodium. Each vial contains 85.2 mg sodium. This is equivalent to 4.26% of the WHO recommended maximum daily intake of 2 g sodium for an adult.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir is eliminated primarily unchanged in the urine via active renal tubular secretion. Any drugs administered concurrently that compete with this mechanism may increase acyclovir plasma concentrations. Probenecid and cimetidine increase the AUC of acyclovir by this mechanism and reduce acyclovir renal clearance. However, no dosage adjustment is necessary because of the wide therapeutic index of acyclovir.</p><p>In patients receiving intravenous acyclovir caution is required during concurrent administration with drugs which compete with acyclovir for elimination, because of the potential for increased plasma concentrations of one or both drugs or their metabolites. Increases in plasma AUCs of acyclovir and of the inactive metabolite of mycophenolate mofetil, an immunosuppressant agent used in transplant patients, have been shown when the drugs are coadministered.</p><p>If&nbsp;lithium<strong>&nbsp;</strong>is administered concurrently with high dose acyclovir IV, the lithium serum concentration should be closely monitored because of the risk of lithium toxicity.</p><p>Care is also required (with monitoring for changes in renal function) if administering intravenous acyclovir with drugs which affect other aspects of renal physiology (e.g. cyclosporin, tacrolimus).</p><p>An experimental study on five male subjects indicates that concomitant therapy with acyclovir increases AUC of totally administered&nbsp;theophylline&nbsp;with approximately 50%. It is recommended to measure plasma concentrations during concomitant therapy with acyclovir.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Fertility:</strong></p><p>There is no information on the effect of acyclovir on human female fertility.</p><p>In a study of 20 male patients with normal sperm count, oral acyclovir administered at doses of up to 1g per day for up to six months has been shown to have no clinically significant effect on sperm count, motility or morphology.</p><p>See clinical studies in section 5.2.</p><p><strong>Pregnancy:</strong></p><p>A post-marketing acyclovir pregnancy registry has documented pregnancy outcomes in women exposed to any formulation of acyclovir. The registry findings have not shown an increase in the number of birth defects amongst acyclovir exposed subjects compared to with the general population, and any birth defects showed no uniqueness or consistent pattern to suggest a common cause. Systemic administration of acyclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rabbits, rats or mice. In a non-standard test in rats, foetal abnormalities were observed but only following such high subcutaneous doses that maternal toxicity was produced. The clinical relevance of these findings is uncertain.</p><p>Caution should therefore be exercised by balancing the potential benefits of treatment against any possible hazard. Findings from reproduction toxicology studies are included in Section 5.3.</p><p><strong>Breast-feeding:</strong></p><p>Following oral administration of 200 mg five times a day, acyclovir has been detected in human breast milk at concentrations ranging from 0.6 to 4.1 times the corresponding plasma concentrations. These concentrations would potentially expose nursing infants to acyclovir dosages of up to 0.3 mg/kg body weight/day. Caution is therefore advised if acyclovir is to be administered to a nursing woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir IV for infusion is generally used in an in-patient hospital population and information on ability to drive and operate machinery is not usually relevant. There have been no studies to investigate the effect of acyclovir on driving performance or the ability to operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency categories associated with the adverse events below are estimates. For most events, suitable data for estimating incidence were not available. In addition, adverse events may vary in their incidence depending on the indication.</p><p>The following convention has been used for the classification of undesirable effects in terms of frequency: Very common &ge; 1/10, common &ge; 1/100 and &lt; 1/10, uncommon &ge; 1/1,000 and &lt; 1/100, rare &ge; 1/10,000 and &lt; 1/1,000, very rare &lt; 1/10,000.</p><p><strong>Blood and lymphatic system disorders:</strong></p><p>Uncommon: decreases in haematological indices (anaemia, thrombocytopenia, leukopenia).</p><p><strong>Immune system disorders:</strong></p><p>Very rare: anaphylaxis.</p><p><strong>Psychiatric and nervous system disorders:</strong></p><p>Very rare: headache, dizziness, agitation, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, convulsions, somnolence, encephalopathy, coma.</p><p>The above events are generally reversible and usually reported in patients with renal impairment or with other predisposing factors (see 4.4 Special Warnings and Precautions for Use).</p><p><strong>Vascular disorders:</strong></p><p>Common: phlebitis.</p><p><strong>Respiratory, thoracic and mediastinal disorders:</strong></p><p>Very rare: dyspnoea.</p><p><strong>Gastrointestinal disorders:</strong></p><p>Common: nausea, vomiting.</p><p>Very rare: diarrhoea, abdominal pain.</p><p><strong>Hepato-biliary disorders:</strong></p><p>Common: reversible increases in liver-related enzymes.</p><p>Very rare: reversible increases in bilirubin, jaundice, hepatitis.</p><p><strong>Skin and subcutaneous tissue disorders:</strong></p><p>Common: pruritus, urticaria, rashes (including photosensitivity).</p><p>Very rare: angioedema.</p><p><strong>Renal and urinary disorders:</strong></p><p>Common: increases in blood urea and creatinine.</p><p>Rapid increases in blood urea and creatinine concentrations are believed to be related to the peak plasma concentrations and the state of hydration of the patient. To avoid this effect the drug should not be given as an intravenous bolus injection but by slow infusion over a one-hour period.</p><p>Very rare: renal impairment, acute renal failure and renal pain.</p><p>Adequate hydration should be maintained. Renal impairment usually responds rapidly to rehydration of the patient and/or dosage reduction or withdrawal of the drug. Progression to acute renal failure however, can occur in exceptional cases.</p><p>Renal pain may be associated with renal failure and crystalluria.</p><p><strong>General disorders and administration site conditions:</strong></p><p>Very rare: fatigue, fever, local inflammatory reactions</p><p>Severe local inflammatory reactions sometimes leading to breakdown of the skin have occurred when acyclovir IV has been inadvertently infused into extracellular tissues.</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage of intravenenous acyclovir has resulted in elevations of serum creatinine, blood urea nitrogen and subsequent renal failure. Neurological effects including confusion, hallucinations, agitation, seizures and coma have been described in association with overdosage.</p><p>Patients should be observed closely for signs of toxicity. Haemodialysis significantly enhances the removal of acyclovir from the blood and may, therefore, be considered an option in the management of overdose of this drug.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors</p><p>ATC code: J05AB01.</p><p>Acyclovir is a synthetic purine nucleoside analogue with <em>in vitro</em> and <em>in vivo</em> inhibitory activity against human herpes viruses, including Herpes simplex virus types 1 and 2 and Varicella zoster virus (VZV), Epstein Barr virus (EBV) and Cytomegalovirus (CMV). In cell culture acyclovir has the greatest antiviral activity against HSV-1, followed (in decreasing order of potency) by HSV-2, VZV, EBV and CMV.</p><p>The inhibitory activity of acyclovir for HSV-1, HSV-2, VZV and EBV is highly selective. The enzyme thymidine kinase (TK) of normal, uninfected cells does not use acyclovir effectively as a substrate, hence toxicity to mammalian host cells is low; however, TK encoded by HSV, VZV and EBV converts acyclovir to acyclovir monophosphate, a nucleoside analogue, which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes. Acyclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with resultant chain termination following its incorporation into the viral DNA.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Acyclovir is only partially absorbed from the gut. The average oral bioavailability varies between 10 and 20%. Under fasting conditions, mean peak concentrations (C<sub>max</sub>) of 0.4 microgram/ml are achieved at approximately 1.6 hours after a 200 mg dose administered as oral suspension or capsule. Mean peak plasma concentrations (C<sup>ss</sup><sub>max</sub>) increase to 0.7 microgram/ml (3.1 micromoles) at steady state following doses of 200 mg administered every four hours. A less than proportional increase is observed for C<sup>ss</sup><sub>max</sub> concentrations following doses of 400 mg and 800 mg administered four-hourly, with values reaching 1.2 and 1.8 microgram/ml (5.3 and 8 micromoles), respectively.</p><p><strong>Distribution</strong></p><p>The mean volume of distribution of 26 L indicates that acyclovir is distributed within total body water. Apparent values after oral administration (Vd/F) ranged from 2.3 to 17.8 L/kg. As plasma protein binding is relatively low (9 to 33%), drug interactions involving binding site displacement are not anticipated. Cerebrospinal fluid concentrations are approximately 50% of corresponding plasma concentrations at steady-state.</p><p><strong>Metabolism</strong></p><p>Acyclovir is predominantly excreted unchanged by the kidney. The only significant urinary metabolite is 9-[(carboxymethoxy) methyl]guanine, and accounts for 10-15% of the dose excreted in the urine.</p><p><strong>Elimination</strong></p><p>In adults mean systemic exposure (AUC0-&infin;) to acyclovir ranges between 1.9 and 2.2 microgram*h/ml after a 200 mg dose. At this dose, the mean terminal plasma half-life after oral administration has been shown to vary between 2.8 and 4.1 hours.</p><p>In adults, the terminal plasma half-life of acyclovir after administration of acyclovir IV is about 2.9 hours. Renal clearance of acyclovir (CLr= 14.3 L/h) is substantially greater than creatinine clearance, indicating that tubular secretion, in addition to glomerular filtration, contributes to the renal elimination of the drug. The half-life and total clearance of acyclovir are dependent on renal function. Therefore, dosage adjustment is recommended for renally impaired patients.</p><p>In adults, mean steady state peak plasma concentrations (C<sup>ss</sup><sub>max</sub>) following a one-hour infusion of 2.5 mg/kg, 5 mg/kg and 10 mg/kg were 22.7 micromolar (5.1 microgram/ml), 43.6 micromolar (9.8 microgram/ml) and 92 micromolar (20.7 microgram/ml) respectively. The corresponding trough concentrations (C<sup>ss</sup><sub>min</sub>) 7 hours later were 2.2 micromolar (0.5 microgram/ml), 3.1 micromolar (0.7 microgram/ml) and 10.2 micromolar (2.3 microgram/ml) respectively. In children over 1 year of age similar mean peak (C<sup>ss</sup><sub>max</sub>) and trough (C<sup>ss</sup><sub>min</sub>) concentrations were observed when a dose of 250 mg/m<sup>2</sup> was substituted for 5 mg/kg and a dose of 500 mg/m<sup>2</sup> was substituted for 10 mg/kg.</p><p>In neonates (0 to 3 months of age) treated with doses of 10 mg/kg administered by infusion over a one-hour period every 8 hours the C<sup>ss</sup><sub>max</sub> was found to be 61.2 micromolar (13.8 microgram/ml) and the C<sup>ss</sup><sub>min</sub> to be 10.1 micromolar (2.3 microgram/ml). A separate group of neonates treated with 15 mg/kg every 8 hours showed approximate dose proportional increases, with a C<sub>max</sub> of 83.5 micromolar (18.8 microgram/ml) and C<sub>min</sub> of 14.1 micromolar (3.2 microgram/ml). The terminal plasma half-life in these patients was 3.8 hours.</p><p><strong>Special Patient Populations</strong></p><p><em>Elderly</em></p><p>In the elderly patients with normal renal function total clearance falls with increasing age due to decreases in creatinine clearance. However, the possibility of renal impairment in the elderly must be considered and the dosage should be adjusted accordingly.</p><p><em>Renal impairment</em></p><p>In patients with chronic renal failure the mean terminal half-life was found to be 19.5 hours. The mean acyclovir half-life during haemodialysis was 5.7 hours. Plasma acyclovir concentrations dropped approximately 60% during dialysis.</p><p><em>Weight</em></p><p>In a clinical study in which morbidly obese female patients (n=7) were dosed with intravenous acyclovir based on their actual body weight, plasma concentrations were found to be approximately twice that of normal weight patients (n=5), consistent with the difference in body weight between the two groups.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mutagenicity:</strong></p><p>The results of a wide range of mutagenicity tests<em>&nbsp;in vitro&nbsp;</em>and<em>&nbsp;in vivo</em>&nbsp;indicate that acyclovir is unlikely to pose a genetic risk to man.</p><p><strong>Carcinogenicity:</strong></p><p>Acyclovir was not found to be carcinogenic in long-term studies in the rat and the mouse.</p><p><strong>Teratogenicity:</strong></p><p>Systemic administration of acyclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rabbits, rats or mice.</p><p>In a non-standard test in rats, foetal abnormalities were observed but only following such high subcutaneous doses that maternal toxicity was produced. The clinical relevance of these findings is uncertain.</p><p><strong>Fertility:</strong></p><p>Largely reversible adverse effects on spermatogenesis in association with overall toxicity in rats and dogs have been reported only at doses of acyclovir greatly in excess of those employed therapeutically. Two-generation studies in mice did not reveal any effect of (orally administered) acyclovir on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;&nbsp;&nbsp; Sodium hydroxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The reconstituted concentrate and diluted solution for infusion must not be mixed with other medicinal products except those mentioned in Section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>Store in the original package.</p><p>Prepare immediately before use.</p><p>When reconstituted and/or diluted, the solutions are stable for up to 12 hours at room temperature (15 to 25&deg;C).</p><p>Discard unused solution.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>20 ml type I clear tubular glass vials with grey lyo-rubber stoppers and aluminum caps.</p><p>Pack size: 5 Vials.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Reconstitution:</em></p><p>Acyclovir JPI should be reconstituted using the following volumes of either water for injection or 0.9% sodium chloride intravenous injection to provide a solution containing 25 mg acyclovir per ml:</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Formulation</strong></p></td><td style="vertical-align:top"><p><strong>Volume of fluid for reconstitution</strong></p></td></tr><tr><td style="vertical-align:top"><p>250 mg vials</p></td><td style="vertical-align:top"><p>10 ml</p></td></tr><tr><td style="vertical-align:top"><p>500 mg vials</p></td><td style="vertical-align:top"><p>20 ml</p></td></tr></tbody></table><p>From the calculated dose, determine the appropriate number and strength of vials to be used. To reconstitute each vial, add the recommended volume of infusion fluid and shake gently until the contents of the vial have dissolved completely.</p><p><em>Administration:</em></p><p>The required dose of Acyclovir JPI should be administered by slow intravenous infusion over a one-hour period.</p><p>After reconstitution Acyclovir JPI may be administered by a controlled-rate infusion pump.</p><p>Alternatively, the reconstituted solution may be further diluted to give an acyclovir concentration of not greater than 5 mg/ml (0.5% w/v) for administration by infusion:</p><p>Add the required volume of reconstituted solution to the chosen infusion solution, as recommended below, and shake well to ensure adequate mixing occurs.</p><p>For children and neonates, where it is advisable to keep the volume of infusion fluid to a minimum, it is recommended that dilution is on the basis of 4 ml reconstituted solution (100 mg acyclovir) added to 20 ml of infusion fluid reaching a concentration of 4.2 mg/ml.</p><p>For adults, it is recommended that infusion bags containing 100 ml of infusion fluid are used, even when this would give an acyclovir concentration substantially below 0.5% w/v (reaching a concentration of 2.3 mg/ml for 250 mg vial and 4.2 mg/ml for 500 mg vial). Thus one 100 ml infusion bag may be used for any dose between 250 mg and 500 mg acyclovir (10 and 20 ml of reconstituted solution) but a second bag must be used for doses between 500 mg and 1000 mg.</p><p>When diluted in accordance with the recommended schedules, Acyclovir JPI is known to be compatible with the following infusion fluids and stable for up to 12 hours at room temperature (15 to 25&deg;C):</p><ul><li>(0.45% and 0.9% w/v) Sodium chloride intravenous infusion</li><li>(0.18% w/v) Sodium chloride and (4% w/v) dextrose intravenous infusion</li><li>(0.45% w/v) Sodium chloride and (2.5% w/v) dextrose intravenous infusion</li><li>(0.45% w/v) Sodium chloride and (5% w/v) dextrose intravenous infusion</li><li>Compound sodium lactate intravenous infusion (Hartmann&#39;s solution).</li></ul><p>Acyclovir JPI when diluted in accordance with the above schedule will give an acyclovir concentration not greater than 0.5% w/v.</p><p>Since no antimicrobial preservative is included, reconstitution and dilution must be carried out under full aseptic conditions, immediately before use, and any unused solution discarded.</p><p>Should any visible turbidity or crystallisation appear in the solution before or during infusion, the preparation should be discarded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. Box 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: SAPV@hikma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                20 January 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,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&#x2B;IDxkYzp0aXRsZT4gPHJkZjpBbHQ&#x2B;IDxyZGY6bGkgeG1sOmxhbmc9IngtZGVmYXVsdCI&#x2B;QXByaXZhIDMwIG1nIGJveDwvcmRmOmxpPiA8L3JkZjpBbHQ&#x2B;IDwvZGM6dGl0bGU&#x2B;IDx4bXBNTTpEZXJpdmVkRnJvbSBzdFJlZjppbnN0YW5jZUlEPSJ4bXAuaWlkOjI5MDBhZjU2LWEyODctNDkwMS05YTY5LTNjYzI3MzBmZTVmYyIgc3RSZWY6ZG9jdW1lbnRJRD0iYWRvYmU6ZG9jaWQ6cGhvdG9zaG9wOjJmYTY5OGVlLTg5ZjAtODE0NS1hMTBhLWQ5ZmYzMmFkM2JjOCIgc3RSZWY6b3JpZ2luYWxEb2N1bWVudElEPSJ1dWlkOjhGMUUwRDI3MjdERkREMTFCQjhGRkIwMDFFRUFFNEVDIiBzdFJlZjpyZW5kaXRpb25DbGFzcz0icHJvb2Y6cGRmIi8&#x2B;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&#x2B;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&#x2B;IDxyZGY6bGkgc3RFdnQ6YWN0aW9uPSJkZXJpdmVkIiBzdEV2dDpwYXJhbWV0ZXJzPSJjb252ZXJ0ZWQgZnJvbSBhcHBsaWNhdGlvbi92bmQuYWRvYmUucGhvdG9zaG9wIHRvIGltYWdlL3BuZyIvPiA8cmRmOmxpIHN0RXZ0OmFjdGlvbj0ic2F2ZWQiIHN0RXZ0Omluc3RhbmNlSUQ9InhtcC5paWQ6ZWNmZTZmNzItODhkMC00ZjhjLWI2OTQtOTQ1ODYyZTQxN2IwIiBzdEV2dDp3aGVuPSIyMDIxLTEwLTE0VDEzOjU3OjU5KzAyOjAwIiBzdEV2dDpzb2Z0d2FyZUFnZW50PSJBZG9iZSBQaG90b3Nob3AgMjEuMCAoTWFjaW50b3NoKSIgc3RFdnQ6Y2hhbmdlZD0iLyIvPiA8cmRmOmxpIHN0RXZ0OmFjdGlvbj0ic2F2ZWQiIHN0RXZ0Omluc3RhbmNlSUQ9InhtcC5paWQ6OGQ4YjY5NWYtNmExNy00ZGIwLWE4ZjgtZDVlMjg3Nzc4MDg5IiBzdEV2dDp3aGVuPSIyMDIyLTA1LTI5VDA5OjI2OjI0KzAzOjAwIiBzdEV2dDpzb2Z0d2FyZUFnZW50PSJBZG9iZSBQaG90b3Nob3AgMjMuMyAoTWFjaW50b3NoKSIgc3RFdnQ6Y2hhbmdlZD0iLyIvPiA8cmRmOmxpIHN0RXZ0OmFjdGlvbj0iY29udmVydGVkIiBzdEV2dDpwYXJhbWV0ZXJzPSJmcm9tIGltYWdlL3BuZyB0byBpbWFnZS9qcGVnIi8&#x2B;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&#x2B;IDxyZGY6bGkgc3RFdnQ6YWN0aW9uPSJkZXJpdmVkIiBzdEV2dDpwYXJhbWV0ZXJzPSJjb252ZXJ0ZWQgZnJvbSBpbWFnZS9qcGVnIHRvIGltYWdlL3BuZyIvPiA8cmRmOmxpIHN0RXZ0OmFjdGlvbj0ic2F2ZWQiIHN0RXZ0Omluc3RhbmNlSUQ9InhtcC5paWQ6ZDFiYzRhZjAtZWI1OS00Yzc5LWEwODUtZDY5MWNhNThhZjVkIiBzdEV2dDp3aGVuPSIyMDIyLTA4LTI5VDA4OjQ5KzAzOjAwIiBzdEV2dDpzb2Z0d2FyZUFnZW50PSJBZG9iZSBQaG90b3Nob3AgMjMuMyAoTWFjaW50b3NoKSIgc3RFdnQ6Y2hhbmdlZD0iLyIvPiA8L3JkZjpTZXE&#x2B;IDwveG1wTU06SGlzdG9yeT4gPHhtcFRQZzpNYXhQYWdlU2l6ZSBzdERpbTp3PSIyMC45OTk5ODAiIHN0RGltOmg9IjI5LjcwMDAwOSIgc3REaW06dW5pdD0iQ2VudGltZXRlcnMiLz4gPHhtcFRQZzpGb250cz4gPHJkZjpCYWc&#x2B;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&#x2B;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&#x2B;IDxyZGY6bGk&#x2B;TWFnZW50YTwvcmRmOmxpPiA8cmRmOmxpPlllbGxvdzwvcmRmOmxpPiA8cmRmOmxpPkJsYWNrPC9yZGY6bGk&#x2B;IDxyZGY6bGk&#x2B;UEFOVE9ORSBSZWQgMDMyIEM8L3JkZjpsaT4gPHJkZjpsaT5QQU5UT05FIDIzNDggQzwvcmRmOmxpPiA8cmRmOmxpPlBBTlRPTkUgNzUxNCBDPC9yZGY6bGk&#x2B;IDxyZGY6bGk&#x2B;UEFOVE9ORSAyNzY2IEM8L3JkZjpsaT4gPHJkZjpsaT5QQU5UT05FIDI5MiBDPC9yZGY6bGk&#x2B;IDwvcmRmOlNlcT4gPC94bXBUUGc6UGxhdGVOYW1lcz4gPHhtcFRQZzpTd2F0Y2hHcm91cHM&#x2B;IDxyZGY6U2VxPiA8cmRmOmxpPiA8cmRmOkRlc2NyaXB0aW9uIHhtcEc6Z3JvdXBOYW1lPSJEZWZhdWx0IFN3YXRjaCBHcm91cCIgeG1wRzpncm91cFR5cGU9IjAiPiA8eG1wRzpDb2xvcmFudHM&#x2B;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&#x2B;IDxyZGY6bGkgeG1wRzpzd2F0Y2hOYW1lPSJQQU5UT05FIFJlZCAwMzIgQyIgeG1wRzp0eXBlPSJTUE9UIiB4bXBHOnRpbnQ9IjEwMC4wMDAwMDAiIHhtcEc6bW9kZT0iTEFCIiB4bXBHOkw9IjU1LjI5NDExNyIgeG1wRzpBPSI3MiIgeG1wRzpCPSI0MyIvPiA8L3JkZjpTZXE&#x2B;IDwveG1wRzpDb2xvcmFudHM&#x2B;IDwvcmRmOkRlc2NyaXB0aW9uPiA8L3JkZjpsaT4gPC9yZGY6U2VxPiA8L3htcFRQZzpTd2F0Y2hHcm91cHM&#x2B;IDx0aWZmOkJpdHNQZXJTYW1wbGU&#x2B;IDxyZGY6U2VxPiA8cmRmOmxpPjg8L3JkZjpsaT4gPHJkZjpsaT44PC9yZGY6bGk&#x2B;IDxyZGY6bGk&#x2B;ODwvcmRmOmxpPiA8L3JkZjpTZXE&#x2B;IDwvdGlmZjpCaXRzUGVyU2FtcGxlPiA8L3JkZjpEZXNjcmlwdGlvbj4gPC9yZGY6UkRGPiA8L3g6eG1wbWV0YT4gPD94cGFja2V0IGVuZD0iciI/PpFHTWUAAZ1BSURBVHic7N11WFTbGgbwNUV3d1iEiIoiJtjd3d3d3d0Jdndgd2IXoohIinTDDAMMw8Te&#x2B;/6xvXM46lGPR0WZ9/c897kw7NmzNgdhv7O&#x2B;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&#x2B;KU9AChNxcXFojwRQxgBT8Dj8bh8Lp/L5/P5PB6Px&#x2B;NxuciHAAAAAGUNh2GY0h4DlI6CggJxvpjD4XzhGIFAwOPxeFwej8dTBQMej/fLBgkAAAAAPxYCgDqiaTpXmCuXy7/v6QzD8Pl8Lpcr4At4fB6Px&#x2B;PzPmSDL8cJAAAAACh1CABqR6FQ5AhzaIr&#x2B;GSfncDgCvuDDNAFf9f98VBMBAAAA/CYQANRLUVFRnjivVP6jCwQCLpddYcDn8riqSYNfPxIAAAAAdYYAoC4YhsnLyyuSFpX2QP6GrSZiwwCXz2XXIqOaCAAAAODnQQBQCxRFCYVCueI7i/5LBYfD&#x2B;WsJMv&#x2B;vZQaoJgIAAAD4LxAAyj621ydN/5Si/1LxoR8Rn8fn8ktmg9IeFwAAAMAfAAGgjMvPz88vyFeHchqGYXh83ociohLrj1FNBAAAAFASAkCZRdO0SCQqlhV/x3MLJdLQsHeWFsa21uY6Opo/fGy/GFtNxOVx&#x2B;VxV11I&#x2B;qokAAABAPSEAlE0KhSInN&#x2B;c7yn5kMsXxwDu79l7KE0vYRxzszE8cWqCvr/Ojx/hb4PP5PC6PL&#x2B;BzeX9bglza4wIAAAD4WfilPQD48SQSiThf/G&#x2B;jnVJJXbzyOGDH&#x2B;YxMYcnHZ03vU1bv/gkhSqVSSZQyuazkg3&#x2B;rJuL9bQkyqokAAADgT4cAUKYwDCPOF0skkn/7rFtBIZu3no1PSP/oS8MHt21Q1/PHDfDPwOFwaIqWUbLPfulDNRGPX7I9EaqJAAAA4E&#x2B;BAFB2UBSVI8xRKpT/6llPn0Vs8A98G5lACDEy1C3nbPMyNJb9ko&#x2B;325gRHX/0MP9sDMPI5Z/vpsp2Jfr/rgboTQQAAAC/KawBKCNkMplQJPxXRf/hEfEbtgQ&#x2B;C44khGhoCAb0beFXz3PY2HVSqYwQYm5meOrIQjNTw581YvXAMAyPxyu5oQF6EwEAAEDpwgxAWVBQUCDOF3/7DeX7hPTNW8/cuhNCCOHxuB3a1hs3spO2jmb3fovZu38ej7tmxah/uvunaSY1PSctNbtQUszhECMjvYoV7PX1tH/U5ZQlHA6HpmmZ7B&#x2B;qifgCLpfLF/BLzhigmggAAAB&#x2B;KgSAPxtN06I8UXFx8Tfe/adn5G7dcf7ClccURRNCGvpWnTy&#x2B;ezkna4Zhxk3ZkpSUyR42YUyXmtUrffrca7eCHz95&#x2B;&#x2B;p1bHHx38pg&#x2B;Hxum5Z1FswZoCHgE0KyskT6&#x2B;jra2j&#x2B;9f6hSSV24/EhXV9vG2szW2szERP9nv&#x2B;IPxDDMh72ZP0kHf1UT/X0J8q8fJAAAAJQ9CAB/MIVCkZubS9HUtxwsyivYte/S8VNBcrmSEFLVs8KU8V29qn24y9&#x2B;599Ld&#x2B;6Hsxw19qw7q11L1RIZh7j8MO3DkenBItKpgTFtbk6JouVzBfqpU0ucvPapdy71d6zrxCeld&#x2B;yyUyRRGhrqOjtZb1o0zMf4p9&#x2B;XZ2XmTZm4Nff2OEMLhcEYObTd6eIeyUVdDKSmKUJ/pTcTjqTY04PP5XC6XDQll46oBAADg10AA&#x2B;FMVFRXlifO&#x2B;ZQlHUZFs/5FrBw5fl0g&#x2B;bApW2c2pR5eGNEPSM3ItzI2fPH8bsOMc&#x2B;yVba9Pli4aqbiifv4haveFYVHQyIYTH4zb0rd6mZe2aXi4mxvoURQfdezVxegB7pI6Opr6etlJJzZy3SyZTEELyxJIxLX0&#x2B;uvuPi0/bFHAmPSPH2srMxtq0Q5t6bq4O33H5z19ETZ29TSgsIIQYGOisXjaifp0q33GeP8iXq4k&#x2B;uwQZ1UQAAADwKSwC/vMwDCMWiyVFX&#x2B;/1qVAqj5&#x2B;8s3PvJVFe4T8dw&#x2B;dzOYQolDQhRCDgHdk3193VkRBSKJGuWnvs7MWH7GFNGnlNGd/dwd6i5HNpmtmy/aybi4NrJQd7O3MOh&#x2B;O//dz23RfYr7ZrU3fFoqGqgzOzRP7bz124/IitPqrqWWHimC7eNVwIIXK54uWr2PDIhLj3qdm5YkmhVEtTw8LCqJpnhfZt6unqan10&#x2B;fsOXdvoH0jTDCHE3c1xw&#x2B;oxttZm3/S9Uz88Hk/A/2uDM1VBUWmPCwAAAEoNAsAfhqKonNwcpfIrvT5pmrlw5VHA9vPpGbmEEH09bc8q5dPTc1PSstkSoM&#x2B;aN7N/j64NCSFJSZkjJ25klwRoa2sunjewVXOfr44tLPx9vyHL2ft7l4p2R/bN1dLSIIQUFBTt2nfp8PHbbMmQq4v9xLFd69epolAq79x9dfHKk8dPw/9pVA72FqePLlItJyiUSOcs3HM76CX7aecODebO6KuhIfjq2H44mmYkEqmurjaX&#x2B;&#x2B;eV35TsTcTuaYCdzgAAANQHSoD&#x2B;JN/S65NhmKB7rzb6n36fkE4IEfC5Pbs3GT64rbHRh1KcnFxxWlpOanpOalru7n2XCyVS9vG2rWqzd/&#x2B;JiZl9hyxjJw30dLX37ZjxLVU6Uqls5vxd7N2/gb7OhjXjtLQ0ZDLF0ZO3d&#x2B;29lF9QRAgp52Q9fnTnJo285HLlvkPXDh29kZWdxz7dpZJ9lcrO5mZGObniG7eDxeIi9vGk5KyI6MQa1SoRQmLepUycHsDGEg0N/ryZ/Tq1b/BPg9HU1PhJt&#x2B;YhoTEHj9x4&#x2B;jxCIim2tjK9fmH1H5cBvlpN9GEXZFQTAQAAlEUIAH&#x2B;Mb&#x2B;n1mZMrXrT8YNC9V4QQDofTtlXtsaM6fVQeY2ZqaGZq6Fml/KGjN1R3/&#x2B;WdbebPGkAIUSqpcVM2q0qG5s7s9401&#x2B;ms3nVA1EVqxZLiNlcmZ8/cDdp7PzBQRQhzszEcN69CmVR0ul3P9VvCaDScyMoWEEG1tzV7dGnXr0sje1lx1qmaNawwfu97K0sTVxd6lokOl8naEkItXnixafoDtPmRnY7Zh9VjVwCiKfv3m3dPnEeFv49&#x2B;9T8vOFrEVTQb6Ou5uTm1b127Xqi6P92PuX7fuPLd15wXVp771q/xxd/9fxjCMUqH87HZyf21oUKJpKaqJAAAA/jgIAH8AmqZFIlGx7Ou9Ps1MDbesG1dcLE9Nz&#x2B;FxuU6OVv90ZHBI9NpNJ9mPtbU1168eraOjSQi5ez&#x2B;UnTpQvfT/P2DexaXcf/SmsLBo4tiuH53tweOwE4F32Y9HDWtPU1TnnvPZ81hZmowY0q5T&#x2B;/p8Pk8iKV60/MCV68/YI5s08pozrY&#x2B;FhfFHZ6vmWfFx0BYDfV32U4VSuWzV4WOn7rCf&#x2B;tarsnLpcParCYkZx07duXrjGbsa&#x2B;CP5BUVPn0c8fR4REZE4e3of9kGGYTZvO6sh4NvamNnYmFWqYKt6oW9x70EYIURHR7NWTdde3ZrUq&#x2B;Px7c/901EURVEft5xiq4n4fD6Py2M3NMBOZwAAAL85rAH43SkUCqFQqKS&#x2B;UvT/b&#x2B;3ae&#x2B;l1eFxaWk5qeu78WQPatPxQ4n/h8uPZC3aXPNLIUFdHRysnN1/V9HP&#x2B;rAHdu/ipDsgTF3bsPi8nV0wIMTbSc7C3fP0mjhBiZmo4ZECrHt0as5sDZGfnjZq4gW0oxOVyZk7p1btH06&#x2B;OMzNLNGl6QFj4e/ZZo4Z1GDm0HYfDiYtP2&#x2B;h/&#x2B;u79UPYH2NTEoKFv1ZrVXWxtzeQy5dPgiN37r6hO4uBgeeXMCvbjfYevrdv4IfmYmhicPrboo/3OFErl27cJpmaG1pYmfP5n3t4uKCjS0dH6UVMKLIZhQl&#x2B;/MzE2sLYxZb9dZQCHwym5BPnDtgaoJgIAAChtZeRWo6z69l6f/9awwW0/&#x2B;3irFrVehsacvfCQreYnhOSJJXliCZfLcXWxr&#x2B;3t3rxJzSoe5Uo&#x2B;ZdHyg&#x2B;zdPyFElFcoyis0MNAZ3L917&#x2B;5N2FkFQohEUjxywobomGT20wWzB3Tp6PvVQT59FjFtzna2HsnQUGf10pH16njIZIoN/oHHTt5mR&#x2B;joaDlmeMfmTWqWvFn3qeUWePZenvhDoyS/&#x2B;p7sB9ExSZsDTrMf83jcdatGl7z7p2nm8rWn/tvOpKbnEkI0NASjhrYb1L9V7LvU23df2lib2FiZ2TtY/PCOQ0VFsrmL9ty4/eLD4L3dNq0dq6erTQhRKJXPg6MsLIxsrc1V38w/BcMwSqXyswvW/9rQgPe3XZB//SABAADUEALAb&#x2B;rbe33&#x2B;WAI&#x2B;f&#x2B;GcgRPGdHnzNl4oypfLKAMDbWtLk3LlbPX1tD89/sLlxzf/f&#x2B;dKCNHR0RzYt0W/Xs319XVKHrZz7yXV3X85J&#x2B;uP7v4piqYZWsD/66eRYZjd&#x2B;y5v2X6W7fXp4e68YfVoayvT&#x2B;IT0cVO3JCRkEEJ4PO7Ioe2HDmpd8omsk6f/uvu3tTYdMaQdIUQuV0yfs1Oh&#x2B;FDEMnFs15K7Hd9/FLbJPzA6NoU9c9tWdUYMaedgb3Hu4sPFKw6xsx&#x2B;mJgbrVo1mAwBF0QeP3hDnS2ytzWxtTKt5Vvy&#x2B;G/T3CekTp/qryq5aNfNeNG8we6rs7LyJM7a&#x2B;DnvHfsnAQMfWxozdP8HW2tTG2szR0dLZ0frHzkX8Gl&#x2B;oJiq5oQF6EwEAAPwMCAC/I4qihEKhXCEvrQEYG&#x2B;n71vP86mHBIdHLVx9hP9bQEPTt2WRQ/1aqdkMlqbYZJoQkp2TuOXDFw92ZoZm0jJxXoe/uPXztVb3SuhWj2HvZgoKiWQt2q57SvYvfzKl9NAT8sPD3I8evz88vIoTo6mptXjPWp5b7p68VePbestWH2I9trE13BUw1MtQjhKzdeDIuPo19vHFDr4F9W7Afh72JW7/l1IuXMYQQDofTsmnNsSM7OzpayhXKhcv2B569zx7mVa3iupWjzc0MCSF54sLpc3Y&#x2B;fhquesrbiITXb&#x2B;LikzJEwgJbO/PNa8ZaW5l&#x2B;9Rt4/VbwvMV7i4pkhBA&#x2B;nzt1Qo&#x2B;&#x2B;vZqpvrdTZ23LFearDs7PL8rPT4qMSip5BgN9nT49m366BTJNM3/c6mS2NxEtpxVE8emXPixB5qKaCAAA4L/CGoDfjkwmyxXm/ub/XcLexAXsPP/oSTghRMDndu3UcPiQduzN8WdNm7396o3nXzihp0e5BbP7u1RyiI5JmjQ9ICklmxCioSFYMLt/h7b1CCHpGbnd&#x2B;y5StSfyXz&#x2B;hoW/Vj04iFBas3nDs0tWn7Ke1arquXjaCLfJ58Dhs1PiN7OMO9hYnDi3Q19OOT0jfGHBatatAI7/qE8d2Ke9sw77cpOlbwyPi2S/1691syvjubJVReET8pOlb2Q0WCCE8HldVLkUIadXMe&#x2B;HcQR9tXvYppZJav&#x2B;XkwSM32U/NTA3XrRrFdjtlGGb/kesbtwSyp9XR0axSuVx6ek56Ri7b3ehT2zZPbFD3r8AmzpfMnLfz6fMIa2szW2uzBnWr9O/T/Mvj&#x2B;XPxeXye4G9dibDTGQAAwJdhBuD3UlBYIBZ/pddn6YqMSgrYeY59e57H47ZrVXfMyA5ffbd76YIhLhXtr916Hvsulb2v1dAQ2NmYVXZ3ql61UoN6HuwZzl96tGj5Qbbext7WfOOaMS6VPvT6DNh&#x2B;XnX3b2Ki/9Hdf06u&#x2B;ERg0OFjNwsKpYQQPV3tsSM79u7RlH0XXCgqmLdoH3ukhoZg4&#x2B;ox0qLiNRuOn7/0YVtiv/qeY0d2VvUVffLs7bTZ29kiIm1tzSXzB7VsVov90ulz95etPqzatkwg4Lm5ONrZmgsEfJlMXrd25c4dvr62ISdXPG3W9uCX0eynNapXXLfyw2oEiaR43uK9qvUAzk7Wm9aOLedkTQihaSY7Jy85NfvuvVf7D18veUIDvb8KriKjEidO82eXMSQlZbpVsu/aya/kwQzDSKXyP25FwT9RUkolpZSRv&#x2B;1p8KGa6P9LkFUzBqgmAgAAIJgB&#x2B;H3QNJ2Xlyctlpb2QP5RXHya//ZzbMU/W/cybnQXB3uLf3seqVRG0TS7yLWkE4F3N/qfYu/gG/pWW75oSMkGna07z1LtM0AIadnMu45PZR6Pm5qW8zI0NuRVtFJJE0K0tTW7dPQdPritifFflUhjJ2&#x2B;6e/81&#x2B;/GMyT2zc/JU2xLXre0xdkQHzyrl2a8yDLNz76WAHefYtQfOTtYb14xh5wTkcsWSFYfOXnzIHmlrbTp8SLuWzWp99c3&#x2B;j7wKjZ08c2t2zodl0/37NJs87sPcQlx82sRpAfH/Xw/QvEnNJfMHf3r&#x2B;rCxR49ZTVJ/61quyddMk9uOSKxZ4PO7k8d0G9GlBCJErlHfvh95/ECYukBQVFecXSJKSs1q38Jk3s/8fVyn0H3E4HD6PzxfwP1qCjGoiAABQHwgAvwWFQiEUCT/bL&#x2B;U3kZyaffjYzZSUrJTUHEdHq7EjO1aqYPczXkicL8nMFFasYPfRO7U7917avPXMF57o7ubYpmXtTu3rf9TX/&#x2B;Tpe4tXHGA/1tXV4nI4bMbw9nIZPaKjdw0X1ZH5BZLZ83ffffAhKpS8/05Jy540PUBVf9&#x2B;7R9OpE7ppaAj&#x2B;7dUdPnZz7aYTqqxScm7h2s3n8xbvk0pl5P/37v17N//07eqsLNHoSRvZbqqEkGpVK2zbNElfT1uuUC5ffVi1YoFdr1yzeiWlkjpy4taduy8b&#x2B;lZ/9fpdemaurbVZ/97NoqKTlq85ejFwmbOT9b&#x2B;9irKKz&#x2B;Nz&#x2B;VwBT1ByxgDVRAAAUPYgAJQ&#x2B;qVQqFAlLexR/gBevYi5efhQZnSQSFcpkcj19HUszowrlbStXdqrt7W5lafLpUxISM7r2WcjuH6zi6VFu7MiOdWv/bQ&#x2B;v6JikidMCklOzySf33/cfhc2ct5NdfKyjo7lk/uAWTb3/7eClUtn8JftUCyFKzi18tB7AxER/3crR3l4uH52hqEh2&#x2B;tw9/x3nJJJi9pFunf1mTumtqSn4aMVCtaoVNqwaY25mKBQVjJ20qXYt947t6k&#x2B;dvU1WrGjcyOvBo9crlwzfe/BqVnbe7oCp//ZC1M2Hnc54fFUqUH2AaiIAAPhDIQCUJoZhxPliieQrvT6lUtn&#x2B;w9f1dLXs7SxsbMzsbc21tctIAfdPpVRSvQctjYhMVD3i6mI/blQX1bYAKiXXHqjeOyeE0DSzbdf57bsvsv9MSt61/yuJiZkTpvm/e5/KflpybiEnVzxl5taQV7Eljzcy1LWxMbO1Mbe1NjU1NZRKiyOiEl&#x2B;ExBRKPlSIOTtZz5zSi92HuOSKBUJIn55Np03swdYUjRy/Xltbq2tH39Xrjw8d1GbJyoOzp/WpV9tj&#x2B;dqjGgLeormDtLQ0/u21gApbTVRyCTKqiQAA4I&#x2B;AAFBqvrHXZ0JixrS5O1o399HU4KekZSen5OjpaS&#x2B;Y1R&#x2B;3bl8lFBXcexCampabmpYtyivo3rlhI7/qH71rK1coV649cvL0PfbTkr0&#x2B;xfmS6XN2sJ2OyD9X5H/VrTshcxbtYd&#x2B;25/G4E8d1HdinBTuMV6Gxk2ZsVW2j9i3c3BwH9G7Rspk3n8/7aLcELS2NRXMHqTZ1JoQ0azvN0FBnyvjudnYWCYnph47eMtDXLpYpBvRt8ekMA/xAqmqij5Ygl/a4AAAACEEAKC3f2Ovz&#x2B;q3gTQGn164Y5e7qWPJxuULJ0Iym5pdq0FPSsouL5RXK2f6A4ZZRNM2sXHv02s3nQlEB&#x2B;Xuvz7eRCZOmB6Sl55IvVuR/WaFEumbD8dPnHrCfmpsZrl42UrXqoOR6AC0tjR5dGuaJJWlpOanpOZlZopKtRXV1tdxdHX283Zo2rqH6D1pQKJ01f5dqtwQHB8tNa8ZULP&#x2B;3hRnv3qeePH0vNTWLw&#x2B;U6OVhWdneqWd3F3Nzoo3EWF8s3Bpy&#x2B;cv2prbWZnY2ZrZ2FrbWZna2ZrY25tbXJp/uswff5q5pI8HHTUlQTAQDAr4QAUAoKCwvzxHlf/pPP1oW/eRuvqaGRlSXi87md2jfo17t5SGjM&#x2B;YuPCgulIa9i6vi4r1wynBBSKJHGxqYwhKns5symguu3gncfuLJswZCftFS3jCkulueK8tktfgkhiYmZsxftiU9Iy88vKlkR9AVyhXL3vkvFxXJXF0dTEwOhKP/lq9iLV56oinaaNq4xf1Z/tjdRUZFswZK9V28Gs1/69N5dqaRyhfnifAmPxzXQ0/n0lj3mXcrEaf5JyVnsp438qi9fNPSzWzV/1euwd7MW7Fad6iM8HnfqhO79epfZbQR&#x2B;ExwOR8AXcPl/a0yEaiIAAPhJEAB&#x2B;KZqmhXlCWbHsy4dlZ&#x2B;dNn7Ojto/78MFt2ZygVFIMw4S/jU9MziwqKtbR1dqz/&#x2B;rEMV0EGvzzFx8aGek52FueOffAwcFyw6rR6zaffPD4TbtWdXR1tFq18DE1Mfjyy9178JpwOJ9WxkNBoZTL4Xy17CcqOmnW/F2xcamf/aqHu/PYUR3r16nCfvrReoDvuHe/dPXpwmX72ZXNXC5n/KjOQwa2/o63kOVyxZZtZw8cuU7TjG&#x2B;9KiOHdRCJClLTstlKs7T0HJGoYObU3s2b1GSPl8kUj5&#x2B;GP3769m1kQkpqdp64UFdHy87eoolf9SEDW2Oi4Cf5EAlUdUR87HQGAAD/Ff5m/zrf2OszJjZ5xLj1fD4/Nzf/0NGb9nbmdWt7XL8VfPbCg07tG5QvZ3vl&#x2B;tM7QS9XLhl26NgtY2O9JfOHsJs6tW1Vp7hYNmTUagtz48lju&#x2B;YXFs1duNfayrRJIy/2zHsPXnWws2jauAYhpFAi1dAQaAj4crkiJTW7&#x2B;efa2kilsuch0XVquX1Hv8uy4Vvuy0NCY8ZM2KR6p1/FwsK4QV2Pdm3qlZw9KLkegMvljB/dZciAVt9&#x2B;765QKtdsOHn0xC32U2MjvTXLRtb2cf/Gp5cU9iZu9qI9CQkZhoY6E0Z3a9XcW1tbky1/&#x2B;lRSctahozcuXHnMjtzERF&#x2B;gwadppqBQGhmZGBmZyOfxhg5q8&#x2B;kTGYYRigryxIVaWhpmJoZfLlqDz/qw05n8MzudlVyCrJo0QDURAAB8FWYAfpEiaZFIJPrGg&#x2B;UKZUpqdnJKdmpqlpGRfvMmNVt0mG5ualTbxz3o7itra5NVS0esWX9ClJcfsHGiQqksLJQaG&#x2B;kHh0SvXHd05pTe3jVcMrNEk2dsbdW8Vt9ezdhzPngctmDJ/sCjiwR83p6DVxOTMrt29D126k6vbo29a7iER8SnpOZoaWnUqeWur69DCElMzJw&#x2B;d0fPbo06tW/ws74pZYVSSb1PSE/PEOaLCzW1NAz1dRwdrT5qS0pR9KaAwL0Hr7GfGhvprV0&#x2B;0qfWv7h3z87Omzhj6&#x2B;uwd&#x2B;ynHu7OG9eM&#x2B;Wzz0y&#x2B;TK5Tbdl3Ye&#x2B;AKu8xAIOApFBQhhMfjurs6TpnYo2Riyc4Rb/I/ffHqY4qi7WzMevVo0qKpN/uit&#x2B;6ETJwewB42e1rv3j2aqp6VkpZ983bIoyfh4W/jVdGIz&#x2B;fWrOE6e1qfcth54Gdiq4lKdixltzxDNREAAKggAPx0DMPk5&#x2B;cXSgr/&#x2B;6mUSioyOqmymxOXy9l3&#x2B;Nrpc/cd7SzMzAybNq4Z&#x2B;y7lwaOw1ctGmpsZPnsesXrjibnT&#x2B;1avVpF9olBU0LX3gvmz&#x2B;kfHJodHJAwb2JphmMUrDk4e371eHY&#x2B;zFx4wDKOtrbl01aEuHfwmj&#x2B;92607Itt0Xls4f4ubq8N&#x2B;HDYSQ7Oy8R8/C09JyUtJyiqXy6ZN7/qt79&#x2B;CQ6KmztuUK89lPu3fxmzm1j4bgX8/gxcWnTZmxjS1AKudkbW9nzuFw3ryNV53ZpZL96aOLCCEMwxwPDNroHyiRFOvraU8Y27VrR9&#x2B;SUwQbA07v3neZEGJrbXr2xFJ2GurRk/D9h68/fR7B/kR5uDnp6mm9jUhQ7Xzc0Lea//rx/3bY8EOodjNgFxuoJg1Ke1wAAPCrIQD8XBRFCUVCufwrvT7/o&#x2B;JiecirGB9vNz6f9&#x2B;Zt/N6DV&#x2B;dM72Nmaqg6YNyULW8jE6pWKd&#x2B;7exPvGi5Hjt&#x2B;6evP50vmD30Ymvn4TJ5fLCwqKCgqLNQS8lUuH79h98X182oolw9gtdfPEhecuPoyKTioslMYnZQzs07JbZz9CiDhfUiiR6ulqGxro/uPI4D9jGObAkesbtgSyb9hraAjmz&#x2B;rXsV397zsbTTPhb9&#x2B;HR8Q38qtubWXKPpiZJWrSegr7cY&#x2B;uDefN7J8nLpw9f9f9R28IIbVruS9bOMTSwrjkeS5dfTpr/i6GYYwMdffumFGpgl10TNLKtceCX0YTQmpUr9i/dwu/BlXZwJCantOi3XT2iQP7tpg6scf3DR5&#x2B;Braa6LNLkFFNBABQViEA/EQyuSw39&#x2B;u9Pu/eD5UWy&#x2B;ztLOxszY0M9X74MFLTc3bvu9y6RW3vGi5FRbKFy/br6WkN7Ntq&#x2B;Ji1g/q3bt&#x2B;mzuuwuIBd53zrenZsX3/mvF21arqyi48Zhjl64vbNOy9GDW3PFqtcvfFMS1MzLj4tPCLe1ERfIim&#x2B;euP5Tv8pPt5u4RHx7&#x2B;JSK7s75eVJKlawVV3I6XP37z54vXLxsO/ooA&#x2B;EkGs3n&#x2B;89eDUtLSdPLLGzMduweux3TMtk54hPnb1bLJVJpfLhQ9qxGx2wlEpq4dID5y49JIR4epTbvXVaZpZwzMSNSSnZhJBxozqpVqKzGIbZe/DqpoDTNM1YW5n6rx/n7GyzZeuZg0dvUBRta206a1rfhr5VS776tl0XAnacI4SYmRqeO7nkZ/yQw8/woTcRl/thCTIfO50BAJQRCAA/S0FhgVgs/vJbaOwuVDm5BeXL2SQnZyanZPP5vPWrRn/0busPpFAqMzJF9rbmcfFp23dd4PN5WloaDx69WTp/sECTv2zloWmTetbxqcwevHLdsXfvU7dtmqhq8PLk2dv1/oGjhrRr3NCLEPLwyZvps3ecPrbo/sM323efb9m8lqWF8b6D19xcHQI2TFy76UREZEJ4RMLEMV16dGusIeDTNMPl/u0bcvHy49Pn729eN46dbYAvkEiKuVzO920CPW3WNrbrqLGR3t3rG3k8LiGEougHj95sCghk&#x2B;xd1bFt/7sy&#x2B;WVmiPoOXifIKCSFLFw7u2PZvUw1CUcH8JfvYzQd8vN1WLR1eLJNPnOYfFZ1MCOnUrv6saX3YWiCVi5cfz1m0h6YZPV3t/TtnuLp8Jr1kZArNzYzYUcEf4UM1kSoXYKczAIA/CgLAj8cwjFAkLC4u/vJhaek50&#x2B;bsbNGkZr/ezVQ5gS2q&#x2B;epLZGaJtLQ0fmztTVj4e0sL45LZo1HLSQ72Fg19q6ekZvnWq2ptZdKj36LAY4vLO9tIpbIjJ24/ePR65tQ&#x2B;h47dYBgye2pvfX2dqzeeBew8H7BuApfPnTFnR&#x2B;sWPlUqO3N5vKfP3sbFp4nyCl&#x2B;9jh03slO/3s0LJdKHj980buj1HYXs8G&#x2B;17zrnfUI6&#x2B;3GlCrZurk7i/MKw8PdCYQEhpGqV8uNHd/bxdpPJFF36LEhIyCCEDOjTfNqknqozUBR99sKDjf6BeWKJlpbG2JEd&#x2B;/duEfYmbtyUzaK8Qj6fO2d6P7Y2TIWmmW27zm/bdYEQYm1lGrBxwqe7UhQVyeYt3nP91gs&#x2B;n9umZZ1yztYJiZmFEqmFuVG71nU83J1/6rcFfixVNRGPz&#x2B;Nx/7YFMqqJAAB&#x2B;KwgAP5hCqcgV5lJK6suHPXzyZtW64wI&#x2B;V6mkzc2NPKuUHzuiI4fDadhy4tQJPap5Vrhw&#x2B;XH1qhXq1fGQK5TZOXnampomJvrscxMSMwK2nx0zspOTo9VPvRZxviQ6JlnA57m6OGhra4a9iRszaZOjo5W1pQmXy2nWuGbF8nbT5&#x2B;7o3MG3R9eGSiW1bvPJ5OSs5YuHvnodt3HLqQWzB1SrWkEmU7yJiM/OFhFCGIas23xy05qxmpqCmfN2DejTom7tytNmbZdIi50crLJz8lo28&#x2B;nRtSH76oUSqZamxqeNKZOSMgN2ntPT07aztbC1MXNytMJmZ1/19FnE4lWHkpIySz5Yzsm6Qb0qrVr4qO6zz154MG/xPvbjNctHtGruQwjJzs67cfvFkRO3kpKzOBxOy2bek8d3s7YyDY&#x2B;IHzpqbaFEyuVyNq4ew04KqaRn5M5dtPdZcCQhpH5dj&#x2B;ULh6l&#x2B;gFXeJ6RPnOqvSiYfMTUxmD&#x2B;r/72Hr6NjkvPyCgwMdX1quo0Z0fH75kCgdJXsTVRy3gDVRAAApQIB4EeSSqVCkfDLx7Bvi4a8ilm9bISZqSHDMNnZeQINvrGR/qvQ2H5DVzRsUNXVxbF927qxsSnXbj7X0tLk87nnLz2aP7t/iybeew9ebdemnpWlcXx8WqWK9h&#x2B;9ryYUFoyftmXogNYNfav9xOv8/4UcPHq9RnWXKpWd88SFE6f51/GpPHxw22s3n69Ye/T00cX6etprNh7PFRY08atuYmKw79A1oVC8cfXYNxEJew9cXrF4mERSPH/p/m6d/Dq2r8chnBYdpg8b3LZbJz//7efSM3KlUvmr17Gb145VlSSxfWkuXn48YXRnmUKZmpaTkpLVoqm3Z5XyUdFJj56GR0Un8QX8Fk1q/oLL/xNlZYkyMoUyudLISNfGyuzTVRlHjt9asfao6lNLS2NKSefkigkhWloarVv4DOjboryzDSFEIinu1HNeWnouIWRQv5ZTJnRXPUsmUxw&#x2B;fnPn3ksSSbGervbEcV17dGn46RvA128Fz1u8t6hIpqur1atb45bNatnamD1/ETVhmr/qGIGAJxDwi4r&#x2B;aoE/Z2bfXl0bqz6lKDouPi0xKUNSVMzlcMuXs3Gt5MCWEimVFM0wmF/6/bHVRB81JkI1EQDAT4UA8MOI88WFhV/p9ZknLpwxd&#x2B;er17GD&#x2B;7dydrK2t7Mo52StqSl4&#x2B;Tr26rVnDx&#x2B;/MTU1PLh7liivYPaCPVWrlBs6sA27d1JkVCIhZNHyg717NKnpVWnS9K1yucK7huude69MTPSP7Jsj4PNDQmPMTY0c7C1&#x2B;xdV&#x2B;Qq5Qsjdbd&#x2B;6&#x2B;vHDlSYumNaVS2fwl&#x2B;3t2baSnr3Pl2tMaXi6zp/bevPVMeqZwxaKh5y89unzt6ZoVI&#x2B;1szBMSM6bN2d6jS6OunfyWrTocdD9087px7q6OMe9SyjvbsPdz6Rm58xbvi4hMaOznZWZm0K1LQ1trM0LIk2dv9x68VqG8TfPGNc3MjeYu3C0tlp88tIAQkpiYefdhaNibOJlMUdndecSQdh&#x2B;tQICPKJTKA4dvXL/1PCk5SyIpNjTUsbExr&#x2B;zqWK&#x2B;OR73aVUoW91&#x2B;4/Hj2gt3sx0MHtRk9rD3hcKJjkm8HhZw5/0AoKhDwuZ06NBgzotOnG1ErldT6LScPHrlJCKlRveLKJcPZfkTifMm4yZtfhsYSQur4VB46sHWN6pX4fN6q9ccOHb1JCNHS0jh9ZJGjoyUhJCQ0JvDMvbv3QwsK/7YFm4OdeRWPcsEvY7KyRJ07NJg3qx&#x2B;2KP4T/dWb6JMlyKgmAgD47xAAfgCKpnKFuQq54utHUnRmljA5OSs5NTspOUsmV9Su5XbzTkhVjwptWvn0HrC0U4cGg/q17NJ7QYum3sMHt6VphmEYHo97886LnXsvLVs4NCtbtHnrmTHDO/rW9&#x2B;RwOOs3n3wSHHl035z1m0&#x2B;lpecunjfwybOI4JCorGxxTk7e4AGtmjWuqVRSaWk59vYWH/3hTErJvnj5kSpj/AyivAKGITKZ/N371AZ1PQ8fuylXKPv0aDJ7wW4dba15s/ppaAhu3nkRsP383Fl9JYXFfg2q5hdINgWcPnn63uWzKx3szFWn2nfomomxftUq5dMzcoeNWTd6RIcBvVssWXkwP1&#x2B;ycM5ACwtjQkh4RPyIcevWLR9taKi3fc8FPV3tDm3rVShne/DYjX0Hr96/uQkdS3&#x2B;Um3deTJq&#x2B;9bNfMjUx6NShQY8uDVVtRkvKzhFPmbmVvcvv36fZ5HHd2SqvyKjEidP8U9NzBQLerKl9u3f5sJzg1p2QGfN2ymQKQ0OdzevG16hWKTtHvGjZ/rsPXnO5nOZNajby87IwNwoLj9uwJZB9SpNGXi4V7dxcHBv5Vf8pFw&#x2B;l6q9qIr6qpAjVRAAA/w4CwH8lk8mEQiHN0P/xPBRFX7n&#x2B;rLa3m7Gx/qCRq9LThe5uTob6On17NT1/&#x2B;VFqWu6S&#x2B;YMPH7sRePZ&#x2B;4NFFJsb6RUWyHXsuxrxLnjSu6/LVR/waVCvvbLNs1SG/BtWGDmxtYmLQsee8Hp0btmxWa8qsbWKxpHq1CkH3QhvU9Vy6cPCjJ&#x2B;EJiRn7Dl1bOn9wbZ/PbEZbVCR78DgsOiaZw&#x2B;FUrGDboqn3j33XTSqVsZXcGZnCYyfvDOrfMjUtp&#x2B;/gZc0a17S1NY&#x2B;ITGjoV01V6bF&#x2B;8yknR8vOHXzZJy5ffSQlLXverP6TpgW0aFZz1LAO7Nhu3QlZtf74ojkDgl/FPHryZumCIezagFxh/oDhK7t08B3UryV7QoZh8Cbifxd079WV68/iE9ML8osMjPQszY0ruznV9nbzrFL&#x2B;n/r5vHgVM2XG1lxhvo6O5tIFQ5o3qck&#x2B;fvbCgyUrD8nlSmsr0w2rR7NrEiiK3rL9LLvXWGU3pw2rR9tYmwmFBd37LcrIFAr43L3bZ7Bb3ZVcbdzQt9rmteMw1aOeVL2JuFyugC9gt0BGNREAwKcQAP6TwsLCPHHeT72bTEzMjIhOqONTeea8nVpamk&#x2B;evW3T0kdarCgqKu7Qpq6ens6q9cdmTukdF58WePbu8MHtUlKzk5IzM7NELpUc6vpUXrn2yJCBbVs1r5UrzO83eNmIoe3atq4zeORqTQ2NShVttbW0rK1Mnjx7u27laNUrngi8e&#x2B;X6kx5dGzs7Wt198Prgkeu7tk79Bf1YCgqlqanZOjpadrbmqhs4uVzRoNkEOxuzJo28srLzEpMy27ep26FtvR4DllStXG7uzH6EkNT0nM0BpyVFxdMn916&#x2B;&#x2B;pCOttbKpcPZeqTIqMSpc7b36d6kd4&#x2B;m7AlfhcZOnrm1UkV7uVzBMMzCOQOzsvNyheKa1V3MzY1&#x2B;9jWqLYZhDh69sX7zKYqiyzvbbFo7ll3CLpcrlq46fOb8A0JI3doeq5cNZ3cJEIoKps/Z8fR5BCGkayff2dP7agj42Tni7bvPnwi8SwjR0OBPndDd3NwoISHjyvVnsXGp2tqag/u3GjaozacLx0Gd/dWb6K/5Aux0BgDqDgHgO9EMnSfKkxZLv37ofxYeEb9g6f7xo7v41fcUCgukMpmZiaGmpiAtPWfHnotjR3Y2NzPs1GOesbF&#x2B;&#x2B;7Z1U1JybKxNOrVvsO/QtfsPX69eOsLCwvhVaOziFQenTuzh5uo4Y&#x2B;7Oap7lRw3rwN5kZ&#x2B;eIDQ10NDQ&#x2B;VAFFRiV167tw7MiOI4a043A4SiVFCOHzeRRFFxUVa2tr/tPdVWp6zuMnbzu1r08IKSgsMjb6uOXLd8sTF75&#x2B;854QUqmCLVtVIpMp/JpPtLU1867hmpaeq60l6NureZXKzktXHgqPSDiybw6PxxXnS/bsv/ziZczcmf3cXR3ZUx0&#x2B;dvP0ufsTxnStX9fDf/vZ46eCunbytbez3LQ10Lee58olw4uKZPcehkZFJyuVyrq1PQQCvq6uVmU3px91LWorOzvv6o3nKanZHC5nwugu7HKC1PScSdMDIiITORzOyKHtVD&#x2B;TYeHvJ80IyMwUqbY9fvQkfMeeiy9DYyuUsxVo8CKjklRnFgh4HpWdGzf06ti23g/8qQN18FE1EZ/HZycNUE0EAGUeAsD3UCgUucJcivpKr88f5eadF26ujnY25l84JitL9PJ1LI/HrVTe3tHRcvf&#x2B;Kzm54qkTuvP5vMPHbl67Fbxm2QhpsXzclM3TJ/Xyq&#x2B;/5T&#x2B;ehKHrbrgt7DlyuV9vDf8MEpZK6cftF0N2XfAE/T1wYHBLtv248WzUkyivIzBRpagqcnawfPnmzZv2J&#x2B;XP6V6tSYeL0gCYNq3dsV/&#x2B;fXuKHKJRI379P09LSKOdso8okQ0atiYlN9qtfrbBISlF0146&#x2B;7EoJQkhRkWzBkr08Pm/B7AECAX/NxhPxCRnLFw0xNTHYtvvC/Qdh/hvGP376NvDsvf69m7u4OKxYfTgzSzRiaHsfbzdDA12GYRKTMsPC34vFhUZG&#x2B;g19q&#x2B;nrfX27BviymNjkyOik1LRszyrl69epwj54LPDO6rVHFUpate3xqTP3Fi0/QAhxdLRcOGegva05j8tNzxQqlUpjI307O3Ms84Uf7kM1kcr/5w1Ke1wAAD8GAsC/9i29Pn8fhRLp02cRvg2qagj4O/Zc3H/o2uL5gzQ1NW7cfLFkwSD25lihVG7cEljbx71B3Q/BYNrs7ZlZorkz&#x2B;y1ZebBpoxq9ujXW0BDExad167PowK4Zce/Trt18bmVpYmSod&#x2B;bCA5eKDkqFcs2KkaGv3xkY6Naq6SoUFhga6v76jV2VSioxOZOmaUd7S9WcBiEkITFj6uxtXTr49ureJDs7b/KsrT413UcNa19UVDxrwW4TY/3J47s&#x2B;ePhm1oLdY0d2dK3kGHT/pVQqnzapp7mZIXsGhVK57&#x2B;A1ZycrmUw5c97OOdP79OreJD0j99GT8PcJaYQQH&#x2B;/KfvU9i4pkH&#x2B;2D&#x2B;08YhlEolCUHCYQQmmbiE9NTUrLTM4WtW9SSyZS3777cve9yRubf/sUJBLxyTtZe1Sr16928tNpegRr6WzXR33dBRjURAPxZEAD&#x2B;BYZh8gvyv9rr8/cXG5diYW6saokjVyjbdZ7FENKquY&#x2B;GBj88Ir5SBfuO7er3GbR05dLhvvU8GYa5FRSyY8/F/r1bnAgMatig6sD&#x2B;LQV8fkGhtHufhY0bVh83qvPajSeyc8WL5w3cuvNCamr2isXD9PV1gkOig0MiRwxpn5klVFKMrbUph8P58gLNjExhcbH8x&#x2B;5xplRSkqJi9o38g0dvODla&#x2B;9X3TEjMmDgtYEDf5lU8yg0ctnLUsA62NmZ5&#x2B;YX6ujrVqlZQNa&#x2B;MT0i/dSckOTVbLlcUSeU5OXnly9kOGtBy45bT&#x2B;nrarVv4ODhYHjx8PT4xY/7Mfp17L9i2eZK3l4tSSV298VxbS6Np4xqfjie/QDJ7/m5jI/2Fcwf&#x2B;&#x2B;pj0Rygulm/wDzwZeIeimU7t6zdsUC0jS5SSkpWcmvMmPC47R8weVtWzwpG9s0t3qADk79VEJXczQDURAPyeEAC&#x2B;FUVRQqFQrpCX9kB&#x2B;CrlCGRWdJJXKjI302KKasDdxA4at8G1QzcRYXygqqFqlfOcO9Xv1X9qxff0RQ9oxDPPwyZvNW88MH9y2SuVyU2Ztb9KwetuWtafN2V63tsfwwW0JIfuPXL915&#x2B;Xa5SNev4lbtOxA/bpVUlKzo6IT58zol5MrFudLmjSqUbN6pZLDuHP35aaAM0vmD/KsUv4XXHV2tmjX/qsMTZuaGiSnZL8Ke0cI2b99OttUlBBy8MiN44F31q0YVb687b0HoQHbz/fu0dTczGDZ6iPrV44qOUiGYQaNWFXZzWnKhB7Xbj4/fupOs8Y1Klawu3TlaZG0WFosexka26t7k4ljukTHJE2bvaN/n&#x2B;ZdO/l9&#x2B;1DVbVurWfN3XbzyhBDi4&#x2B;22fcukkkU&#x2B;UdFJ3fstommGy&#x2B;UsXzSsbavapTdMgK/7sNMZu6FBiXhQ2uMCALWmLvcT/5FcLs/Nzf3vvT5/WxoCvqdHuZKPeFYp/&#x2B;hOgEhcYKCvy9a7FxXJdPW0Tp25l5MjDn3zTi5Tblo7NiNDOGr8hlnT&#x2B;ujoaPYbsnze7P7161QRigoWLjtgZqq/M2CK/7Yz7&#x2B;PTA48tsjQ3XrB0P0XTurpaLpUcho9Zq6OtpQoAFEVv3nrm7v3QHl0bJqVk29tbfOOCToZhlBT1fVXgR08FXb3&#x2B;dMqE7o72lm4ujrlCsa2NmUmJjavkCqWVpcmps3cTEjOTkrM2rB5T2c3Jx290l46&#x2B;lSraJyRm5OUVVqtagRByPDBILJa4uzkPG7O2YYOqKxYPW7nuWExsyrjRnSwtjAkh9x6G6epqXbj8eNe&#x2B;yysWDzU01AvYce59fFpBYXF&#x2B;vmRA3&#x2B;atmvtkZYnyC4sqlLP9aJwJiRnT5&#x2B;4YNbS9&#x2B;jS219f/MD31LDjSr9lEd3cnOxszLpeTlJwdHBJF00zF8razpvWpVdO1dMcJ8FVKSqmklB89iGoiAChdmAH4ukJJYV7ez&#x2B;31&#x2B;ceJik5ysLcslsl37780qG8rc3OjIaPWxL1P69rJLyc373bQy6kTe9T1qTxtznYfb/eRQ9vlCvOnzd5eo7rLqGHt8wsk0&#x2B;bsqOzqNH50Z7YARigsmDp7GyGkRdNaAgF3/pL9Y0d2HDqwzeiJm3p0adikkRchJCk5S6FUlne2KTkMtpbGxtps5tTe39H6naaZN&#x2B;Fx8YkZUqnM1NTQq1pFM1PDfzpYqaTY1cYHjlx/9jyCy&#x2B;WWc7Zp6FvVq1ql9IzcDt3nmpsb9ezSqHuXRhRFd&#x2B;2zoH2buiOHtlc9XaFUrlp7LCE5c/7M/rv3XxaKCoYPalPFoxyHw2nfdY6nR/mFcwf06L/Yx9t1&#x2B;qReDMME3Xv17EXU8EFtw8LjKlSws7f90hLwMin09bug&#x2B;6Ex75KzsvMKCopkMoWunraNtamHm1OD&#x2B;p5eVSvinySUSX/rTcTl8Xg8djkyqokA4AdCAPgShmFEeSKp9Ff0&#x2B;vwOSiV1KyikXp0qv0NHmqIiWWRMormJYeibOJeKduZmxnMX7e7Ts1m9Oh6vQmMXLjsweUJ3v/qeb97Gz1u0d&#x2B;zIjqri&#x2B;LA3cfMW7xszsmPzJjXlCuWiZQckRcUrFw/be/DKo6cRB3bOSEvP3b7nAo/D7dalYUhozOuwuOzsPD097b69mq7beGrwgFatWtQqrT4w7J36gSPXG9Sr2rt7E3YFcFR0Utc&#x2B;C1s1r&#x2B;Xm6hj3Pq2Rb7UqHuUmz9jq4&#x2B;3Wr3ezPoOXt29dh80Gcrli7aZTbyPi/TeMP3by9s3bIScOzX8eEnXg8I3qVct3bN9g&#x2B;arDBoa6C2YNOHfx0aaAwMZ&#x2B;XuICyfjRnSqWtyuV6wWAUvRXb6K/TxqU9rgA4M&#x2B;DAPCPlEplbm7up1O3v4nExMxXb2IPHr6&#x2B;YPaAqp4VSns4X/I67J25uZGNtVlCYsbaTSemTejp6GjJfunYydtnLj5ct2ykg4NlWnrO1FnbmzauMahfy&#x2B;iY5CGjV29cPe7ilcdyuWJg35bXb794HfZuyIDWtbxdOYTTosN0DT5/45oxSoqeND3A2EhfT0&#x2B;7R9dGDepWeRuVmC8uNDbSr1a1whfeJH7y7G3su9T&#x2B;fZp/93XFxqVs8j9drWpF1a2/SnJqdlxcqo6OlquLPY/LW7h0X&#x2B;uWtRv5VT936eHchXsXzxtoY2UW9vb946fhzRrX7Nmtcey7lH5DV0wY3fnR0/AqlZ379WqenpE7ddb2Xj2bdG7XYMmKQ/GJ6YP7t/L0KKenp81uogwAQD6pJiq5BBmzZADwTxAAPu936/XJMMxHv8rPnL/v4GBlaKBToZztR186fe5&#x2B;VHTSnBl9f&#x2B;0Y/7WsLNH1W8FdO/lpa2u&#x2B;eRs/d&#x2B;GeOTP61qrpqlRSPfovzs8vqlnDZejA1va25kNGr3Gt6DB7eh8OhyNXKNdtOpmamr188dCbt0P2Hb42YnC7hg2qpmcK9x28qlQovapXkhTJtmw7M3ta3x5dG167&#x2B;TwiMnHy&#x2B;G5sL38zM0M9XW1CyLlLDz09ypdzsi45pDt3X&#x2B;aJCzt38P1Jl6xQKq/dCM7LKxBoCNxdHDwql&#x2B;NyOez1ZmTm9unRtF&#x2B;v5vr6OhevPNm2&#x2B;8LKxcNMTPQnz9ja0LfayCHtv6PGCQDU2V/VRH/fzQDVRACAAPAZYrG4UPIb9fpMz8hdvOLgtk2TCiXSnXsudurQ4O6D1wcPXx8zouOnnWTu3n8dFh7nVb1iWPj7PFGhVCqztTUbMrD1F4pk4hPS38en16zhomoMWorSM3LXbz4lkysnjOnMVvzfvR86dvLmqRO7u1Z0CHv7/uz5Bx3b1x/Yt8XSlYfzC4uWLRyip6u9c&#x2B;&#x2B;lu/dDly0c4uxkTQi5HfRy7qI9Jw4tcLC3GDVhg1Qqq1&#x2B;nStjb&#x2B;BrVKzZp6LXJP9Crhkuvro2lUll4ZEJBvsTZydrezmKjf&#x2B;DbyIS1K0aZllgH/AsolMqIiIRyzjb6&#x2B;jqEkKs3nl268mTJ/CFvo&#x2B;JXrD4ye0bf&#x2B;nWqxMalaAoEDg6Wv3JgAFBWlawmKjlpUNrjAoBfBAHgb2iazs3NLZVen0VFsltBIX4Nqn50Fy6TK2fO2&#x2B;nj7Vq3dpXbd0OqVC53&#x2B;uy9J88i2rWuM2VCd0KIXKGMiEio4lGOx&#x2B;NevvZMJpPdfRBG09TmteO/5T3jyKjE8IiE6tUqfNp85hfLzBLt3HsxL69w6MC2bq4OqsfZ3Yhzc8Xm5kb3Hrxu36auk6PVxGkBLZp5D&#x2B;rXksPhXLn&#x2B;bM7C3XevbzQ00BWKCg4cvh72Jm7hnIHm5kbXbz1ftvpIvToewwa18XB3jotPmz57e9cuDb08K&#x2B;w9eLVIKq9apXx&#x2B;vmT/4Wse7s5e1SpOHNu1UCKNjEqUSmWmJgalW1uVmJipra1hYWEcE5u89&#x2B;DVwf1bVapoX4rjAYCy7dNqIi6Py8YDVBMBlDEIAH&#x2B;Ry&#x2B;VCoZCiqVJ59XsPw7KzRb71PM3MjLhcDk0zkdGJz4IjhcJ8Y2P9zExRVExSTq6Yz&#x2B;M5OVk3b1KTbX8eePZeSmp2WPj7XQFTz154oKWl2bZV7W27Lhw9cevBrc2EEIZhQkJjP2q3r3Ii8K6kSDq4f6tfeqn/gGGY/IKib5yFKJRI2UoeQsiz4MgFS/aZWxhZmhtramq0blFLS1vz0pUnMrnCwsxo9/4rV8&#x2B;vsrc1v3bzecCO88sWDH709O29B6&#x2B;XLx7K1v88efZ2wjT/ZQuHmJgYHD1&#x2B;y8BA18PdOSUtZ9feS8cOzKtS2fknXjMAwJ/gb9VEJSYNUE0E8IdCAPhAIpGI8kSl/iZHYmLmscA7SoWSy&#x2B;N5uDvxuNzwyHgOh/jUdPdrUJUQolRSRdJiA31dQohCqezYYx6HcAiH6Ghrmhjr1/XxcLC3tLc3nzpz29kTSwghxwLvKGTK9m3rFhUV21ibKZRKAZ/P3j1v333B0sK4U/sGnx0Ju9VXpQr2bBv7PHHh0pWHenRr7O3l8gu/H98jJjb5zdv4Rr7VTUz0Dxy5fiIw6MKpZes2n4x9l7p62Yibt0PWbT5x&#x2B;/I6fX0diaT42Mnb128Hr1oy/PipoDv3XpmbGZZ3trW3N09MzkxPz90VMJVt/QkAAJ/1UTWRatKgtMcFAF&#x2B;CAEAYhhHmCYulxaU9kM&#x2B;QyxUCAb9kLLl287lcrlQqlcmpOVqagka&#x2B;1SpVtKco&#x2B;n1CWm5OfmJyVlJyRmR0UmaWiMPl6GhrmpkYuLo43rwTsnrpiDxxQUJihqRI1qxxjROn79St7VG/TpV/emmZTHH52pNmjWvq6&#x2B;solMoNW055Va3UpJFXqWekf4umGUlR8du38d41XXk87pnz91euO1bZ1cnBweLazeD6dTyWzB9y4kzQvoNXb11epyHgJyVlCkUFGVnCxn7VNTQEpT18AIA/z9&#x2B;qif4&#x2B;b/DH/REBKJPUPQD85r0&#x2B;PysjU0jTtJWl6WdL/BMTM&#x2B;MTM&#x2B;KT0uv5VOYL&#x2B;AX5ErmSevT4jUKhjIpJ1tHRmjCm8527r1o08Vb14hTnS67ffHErKIRtML/nwOWXoe8sLYxnTumlr69TXCxfvyWwb8&#x2B;mDvYWXxhVrjCfEPKLl8/&#x2B;F4USaXxCBlvhc&#x2B;X6s7WbTlqaG5maGurr60wY3Tk6NoUQ4lffs7SHCQBQpnxaTcROGqCaCOBXUusAIC2WCoW/Ua/PHyLo3isnR6siqczd1fGzb7QUFBSx3WYIIZlZojPnH7yLS&#x2B;FwOE&#x2B;fR7Ro5m1ooHfzToiGgDewb8u2retIiorXbjwxalgHSwvjmHcpr8PimjTyMjHWV52NoujQN&#x2B;8SEzM2&#x2B;p&#x2B;WyRXP7m39Rdf5M&#x2B;UXSI6fCmrd0sfORu323wUAKC0fqon&#x2B;X0&#x2B;EaiKAn0d9A8Dv1uvz13vy7G1UTHKHtvU0NPiivMJ371L09HRMTPSv3wq&#x2B;fiNYWiyzMDcuKpLW9nEvLpY/fBzesX394BdRe7dPV&#x2B;WKsPD3p87cmzmll66u1onAuwUFkqGD2rBfomkGfesBAOA/&#x2B;rSa6MOSA1QTAfwH6hgAaJoWCoUyuay0B1Ka4hPSg&#x2B;6Hfrn/T1JyVma2iMfl2Fib7d53WZwvmTOjr5GhnuqALdvOvngZpaer7VW9UrNGNdgu9WFv4tZsOtGnR9OWzWqpjpRIijU0&#x2B;V/Yi&#x2B;BTMe9Snj6L&#x2B;C879QIAQBmGaiKA76Z2AUAulwtFQooqnV6fv4&#x2B;w8PeeHuV&#x2B;xpmnztpWxaNc7x5NVLf7x07eDthxbu3yUbV93L/xJClp2UtWHOrfu3m9Oh4/Y5AAAFCGqaqJ2DygmjQo7XEB/C7UKwBIJBJxvlitLvl3sGbD8caNvGpU&#x2B;/xeBJ9KTMw8dOzGjKm9vjxjsHv/FW0tjcdPw8eP7uxSyeELRwIAAHxcTVRiQwNUE4G6UZcAwDCMSCSSFktLeyBACCHZ2XmZ2SIP98/ssRXzLuX0ufvubo6hr98lJGbIZIpNa8aamxt9emRiYiaHy7G3M//sL26lkoqISvxJsxwAAFCWlKwmUk0XYKczKMP&#x2B;RU32n0upVAqFQoVSUdoDAZKTK74ZFFLNo7yHu3NOrjjoXuirsNiU1GwOh1OtSgVNTf67uDQzM8P4&#x2B;PQFswcQQoTCAoHgb5O2oryCt5EJUdHJmZnC6VN6fvbuX6FUjhq/cfrknr/oqgAA4E/GMIxcISefu034qzcR92&#x2B;TBr98jAA/UtmfASiTvT7/XM3aTvOtX6Vfr&#x2B;Z2tubbdl24ev1pn57NWjX3SU3PSUvPefL0LUMYcX5RQUERn8/T0BBUrVK&#x2B;d/cmOjqa7NNXrD166szdNi1qK5TKJQsGU0r6zPn7kVFJHpXL9ejakD1GIineufdSj64NbazNSu06AQCg7EI1EfzpyngAEOeLCwvVutfn7yb4ZfSDh68zMkUKJeXoYFm7ptu3rwxmyRXK9l1m&#x2B;/lWb9Sgqp29uY621tpNJy5cenz94mpba7PMLFHg2XuD&#x2B;7fS1NQIfhGZnJpdv24VK0uTT8&#x2B;Tkpa9cNmBlYuHmZkafvaFlErq&#x2B;Kk7LZvX&#x2B;qcDAAAAPvJXNRH/b7sZoJoIfitlNgBQFCXKE8lkat3rs0xSKJVnzj3MFYkzM4VJyVkZGUKKptPSc/v2ata3V9O5C/dMGtu1srtznrjw0ZPwdZtPmpsZnT666NPzFBRK9XS1vvBWzfI1R4uLZYP7t0pMzkpLy87MEnlVr&#x2B;RbD3sDAwDA90A1Efw&#x2B;ymYAQK/P7yNXKF&#x2B;FxpqaGlQoZ/vVgwsKpfp62r9gVJ/1KjT29LkHi&#x2B;YN5PG4coUyKTnT2tL0fUL6rn2X8vIKcnLEHB7X0c4iTywJC3&#x2B;/fcuk&#x2B;nWqlHz6qvXHHOwsenVvonpEKCwwMfmwwzHDMNt2nS9XzvbKtWd1arvb25obG&#x2B;kbGOja2ZhhbhcAAH4gVBNBqSiDAaBQUpifn1/2ruunUiiV796lXb/1PCz8vZGh3vpVo9nHHz0Jv3z9adeOvl7VKr2NTHj5KqZf7&#x2B;aEkHsPww4du7E7YOp3vNbL0JjqVSv&#x2B;x99rMpmCw&#x2B;VoCD6ziv1VaOy792kd2tVLSc1OSspKTctu1dxHdXNPCAkJjXkREj18cFt2DImJmVm5eTbWprbWZoQQmma27jzv16Dqw8dvtu06v3H1mMYNvf7LUAEAAL5DyWqikpMGqCaC/65MdQFiGCYvL69IWlTaA/kzvHkbv2zV4UVzB0RGJ6Wk5nB5HJqm7e3Mhw5qyx6wesOx8LcJpqYGfD4/I1N4/uKjQQNasl9Ky8gZP7IT&#x2B;zFNM3K5QktL41te9MCR6zduvVg0d&#x2B;DbyIQWTb2/8Vmf0tQU/NOXOByOX31PDQG/nJO1lqaghlcldqYiKTnr6fPIhKS0urU9RgxpRwihKHr3/st1fCp7e7mwz5UWy1etPdqnV7OK5W2rVHZOS89NTs3&#x2B;vhESQl6HvTM3N3r6PKJD2/o8Hn5fAwDAv/BNvYl4f80YcLlcTBrANyo7MwDo9fkdiopkl689tbc1Z1fiFhXJ2H47FEVHRCVeuf6Uz&#x2B;dpCAQJiekWFsaZmaKklEzXio4ODhZ&#x2B;9T1dKjlQFH3u4sPHT8N1dLSXzB/0LDjSx9vtCy93/tIjiqK8qlXatPXM/Fn9jI30v3DwDyHOlxw5fjMtTcgQpkIF29o13VxdHFS/H1&#x2B;Fxg4csaplM&#x2B;&#x2B;KFex5fK4wNz87Jy9XWJCWkcNQtKWliUJJzZ/Vv1IFO/b4qOikXGG&#x2B;dw0XDQ2BUFjwPCQyPVN49tyDvr2ad&#x2B;/i99FLJyRmnLv0qFYNFy6H61PL7aNfyjTNcDgkOzvP3NwIv68BAOC/&#x2B;1s10d&#x2B;XIOMPDXykjASA4uJioVDIkLJwLb9SVHRSZnaeX/0PC1vDwt8/D44skspomq7iUf7Js/DKbk43b79YtXSEvr4OISQnVxyfmFHeyYatqLn3MGzGnO0W5sYelZ2Fonw&#x2B;nz&#x2B;gT4siqSwnJ08iKU5Jy3kREpmVnbdh9VjvGi7HAu8Y6Ona25odCwxaMKv/R&#x2B;/9vwqNrV6t4q//DuTkiuPep0kkUi0tjcruzoYGuuzjSiWVliHUEPDYDkKZWaI79181rF/V2sqUELJ7/5WXr6I7dWjgW68q&#x2B;f90hFJJ3bj94smziBlTeurpaoeFv49PSO/Qtl6uMJ/P56nOTAiRSmXTZm9v0dT7/qOw6ZN6fnabMwAAgB8F1UTwkbIQAMRicaEEvT6/B00zXO4/viuQJy40MtQr&#x2B;Uhqek5aWq6NjWlujvhV2DuKor2qVrC1MZdKZVGxya/D3iUmZyYkZdIUbW1lamNlmpyapaEhmDap56Mnb2yszQR8XsirmEnjun1UD/Pmbfz8xXvPnlhCCFEolQL&#x2B;5yvTklOznz2PSEzKzMoWubk69u/d4guD/4FycsUdus&#x2B;ZNLabTy13LpdTXCx/Hhx54/YLN1eHSeO6saMtKJQOHrXatYKDphZ/wpiuXA5n8YoDk8Z1exkaG7DzXEpK9q6AqbVqurInpGkm5FWMdw2XXzB4AACAL/iomojL5fL5fFQTlXl/dgCgaVooEqLX568UFZ0UFZukq6NV08vln2p4KIpOz8xNSMx48uytUkmnpmUP6NtSJCrgcjhNG9dgjxHnS6RSGfv&#x2B;&#x2B;onAu9U8y7lUcpi/ZF&#x2B;bFj7eNd04HFLyV48or2DxikP2tmadO/iamOgb6Ot&#x2B;9nV/EoVSeer03ffx6XHv08zNjUxNDVwq2vvWq1pyYfGbt/HrN58yMzWQyZUJCRmFRVJrSxNHR0sHOwtTE8M1G4/XrlV589qx7MG7913mCXiD&#x2B;rb8lVcBAADwjT6qJio5aYBgUDb8wQFArpALhej1&#x2B;Wdgf8xK/tbY6B9441Yw4XJ0tDXdXBzd3ZwyMoXWVibVPSucu/Ro&#x2B;qSe&#x2B;QVF79&#x2B;nvU9Ib9LIKydXPGGav7uL45rlI3/94FPSsucv3te6hU9MbMr0yT35fB4hJDNLdONWsDCvUKlQ0jRdvWrFhr7V2C&#x2B;x15uZJUpKzkpKzkxKzkxKyY6NS5VKZVYWxuWdbXwbeDZrXPPXXwgAAMB/9FE1EZ//1xLk0h4a/At/agBAr8&#x2B;yoVAiTUrOfB0Wl54pSkvN5vG5SclZySlZri6OUdGJfvWrVnZ3btywuqWF8fMXUQePXA/YOJF9olJJvQyNtbIydbAz/6eTv3kbX6Wy8y&#x2B;6km&#x2B;TlSUihFhYGJf2QAAAAH6wj6uJeFy2pgiTBr&#x2B;hPzUA5ORkMwxDUTTDYZQKJXLnnygyKmnb7gu1vV0VSmpAnxaqx2maUVLU1RvPYt&#x2B;l5IkkSSmZmZlCTU2NaZN7NKjrSQh58uztraCQqOjkhXMHVCxvp3ripq1nWjat6VLJgRASHBK9Ys3hM8eXEEIoimZXHYSExjjaW5qZGn51bKnpOTZWpvidBQAA8F98Wk3E53/IBvgjW4r&#x2B;1H0A&#x2B;Hw&#x2B;IUTA9oLXJBRFMQzDEIamGIahKYamKRqp4Dfn5uqgKosvicvlaHD5HdrUK/mgUkmpCmyu3wqOjUtbuXS4ve1fb/&#x2B;HR8RnZYksLU3YT&#x2B;MTMpYtHEoIWbX&#x2B;mLeXi5OT9Z79V85fenQxcNmnAUAiKdbV1VJ9mpiYuf/ItfGjO6sWOcjliowMoYOD5X&#x2B;9ZgAAAHXC4XBompbJP7Nc82/VRH&#x2B;fNPj141Q3f&#x2B;oMQF6e6MsHfJgfYGiaZmiGZmiaIYRhGMTNP9GN2y8KC4sEAkFScqZCSXm4OTVu6KVqAZSQmHHrToi1tdmjp2&#x2B;eBUeamhgIBILKro6eVcpn5&#x2B;QRQp4&#x2B;jyjnbJ2ZKXrw&#x2B;M2TIH9VkGA9fxG1Ys2RpQuHaGtrBt17lZ0jrl61Qoum3qoDwt7EfbZ1KQAAAPwMqCb62cpsAPgsmqZpmiaEoWmGphmKomhCczkImn&#x2B;ArCxRgURqa22mpaVx9cazl69iOVxucbFMW1vTycGydcvaqkb7qWnZiYlZ8Ynp7xPSMjKEVlYmFEVfuf6sXes6VatUaN&#x2B;m7qcnpyh67uK9jXyr1anlTggpksos/1&#x2B;m//DJm2vXgxfM7f9PzUk/kpScdfXGs2GD2rJp89c0KgUAACjzUE30A6lXAPgspVLJfh9omqYYijAMTWOi4HdHUXSRVKavp/3R42Fv4nbsuVizpmuRpHjMiI6qxyOjEm1szEruxlVSQmJGxx5zTUwMGzbwVCppBzuLHt0a6&#x2B;tpX7j8OO592vjRnT/auOCfCEUFU2dtYzMGj8tt97mwAaCGYt6lbA443at7k3p1PAghBYXStLRsgYbAwc7ioxk5AIDv8Gk1EXoTfRkCwGcwDDtFQNM0zXBommJoiubgrdw/xLcUet25&#x2B;/Jm0Ms50/tERCa&#x2B;T0g3NNBxd3Gyt7dQvWHPMMyBI9f19XS6dPRlH7l1J&#x2B;Ty9We1arr26tY4M0tk&#x2B;Uknn8ws0eatZ2ZO7X3o2A0DPZ2&#x2B;vZr98EsD&#x2B;LOcOX9/94GrxVJZfkHR0gWDG/lWP3bq9u27L/V1tfkCwfPgSC0tjcCjCz9alpOWnnPvUZhfPU8ba7PSGjkAlBklq4lUfUtRTYQA8K0oiiKEwzCUUkkTQmiaZsgf&#x2B;a0DQkhkVKKOjvaxU7ebNalRo1qlTw&#x2B;IjUsxMTYwNTFgP1294diz55Gmpkad29dLSctVKpUjh7Z/GRrD5/GCHrwe2LeFRCIN2HF&#x2B;&#x2B;uSeATvOV/Ms37qFz6&#x2B;9IIDfkVyuWLT84KvQmI1rx5mbGQ4ZubqKR7lpk3rq6WpTFD1i/Pr4hPRzJ5aqpvKyc8Q791wMj4gfMaRdOWeb12/icnLFWpoCr2oV2e5eAAA/xGeridhJAzUJBggA349hGIqmCUNohmYYhmZohqJprDP&#x2B;QzwLjhw&#x2B;dt2EMV2aNvSyt7f46L&#x2B;aKK&#x2B;AbQGkVFJvI&#x2B;LvPgyjlJS5uSFNMyGvYhMS0i0sjF&#x2B;8jKrmWdHH27VSBfvb915Om9hj/ebAju3rfTZRAKibtPScSdO3mpjor1o6nN29m6YZLpdDUfTDx2&#x2B;27bpgZmYwd0Y/djtwUV7BvoPXHj0NHzqwtamJ0eZtp81MDX283TgczsEj11NSs&#x2B;9e28juvS2Vyt68jU/PyOVwOK4uDpUq2H1lHAAA/4aaVBMhAPxgNE3ThGHrhxia0ISmlFQZ&#x2B;6EpG2iauX7r&#x2B;eMnb2PjUiuUs23XunYtbzdVDAgOiQ5&#x2B;GVUslTMMU71qhQb1PT9dBPziVUxWpigtI5eh6Y7tG9x7ENrYz4u9RwFQc8&#x2B;CI6fN3t6tc8MxIzqylXVSqexZcOTtoJcRUQk&#x2B;tdw6tmvA3rsXSqQHj1y/eTtkQL8WbVvWycwWrVhzpH/vFrVquhJCEhIzho1Z51HZef3KUW/C3&#x2B;89dC0pKcO7ppuhgc7T55EvQ2NXLR3RpqUPIYSi6Lj3qWnpuYSQihXtbFE&#x2B;BAA/FIdwLC0tebwysmwJAeBX&#x2B;LDOmDCUkiKEMAxN0TQmCgCgTNp/&#x2B;NrOPZeWLRzS0LdaTGzyo6dvnwVHEkK8vVzq163iUsme/e0nkymOnLh18fLjbp39unVpWDJj0zTzKiz2wqVHoa/jBvVvWa&#x2B;Ox4o1R9/FpU6d1KNB3Srs0wPP3lu47MDugKlubo679l56Ghzh6VHO0FA/6O6ruPi0Xf5Tavu4s2fLyhLFxafVqun2jav5AQA&#x2B;wtAMn883NzcvMwHgT90I7M/C//8fNtVfOIZhGIahGJqmKUITdrOC0hsgAMCPkZaeI5MpjuybY2FuPGrChoePw7lcTt3alStVsDM01CssKuZwOAqlMvDc/ZOngtq0qnP84HxNTXZPR1IokT57Hnn/0euIqMQqlZ1bN/dZMHtgaFhsl94LWjattXLJMA2ND0e&#x2B;Dnu3duPJoQNbe3g4T56xrZyz9dH98zQEfKWSSk/PyRWKzS2MDh29oaen/T4&#x2B;/eKVJzOn9sLdPwB8H4ZhBB&#x2B;2ni07MAPwG6EoisPhUDTF0AzFsJVEf&#x2B;R/HQAAllyhTEnNTk7OSknNTkrJatG0ZlJK1v6D15s3rdGvV3N9fR1CSGxcyu2gly9exggEPB9vt7o&#x2B;lStVtGefHhIaM3zMupFD2g0b3JZ9hGGY44FBmwNOjxvVqXePpqoXKi6W37n3at&#x2B;hqzbWZjOn9FJS9MNHYeu3BJqZGGxaO1Z1QgCAb0fTNJfL5fM&#x2B;vHtrZmZWZmYAEAB&#x2B;d&#x2B;yiAoqmODRRUhRDGAbbFADAn4ZhmOu3gvccuOJT023IwNbsIntCSE6ueP2WU4lJWcnJmRRN2dta2tuZN/Stzlb2t&#x2B;s6hxByMXAZe4bgkOiAHWcZhsyd0Ze9p8/OET96&#x2B;uZ20KuMLKFvXc8Obeo6OFgSQpJTsydO8zc3M1y9bAS7BBkA4F9hb7f4JaoTEQBKn/oEgE/RNE0IoWiKYQhD0xRF0wxWFADAb00iKQ4Lj6tQ3s7czPCfjikqkqWkZqWkZteuVVlHR5MQMmGa/&#x2B;2glzW9KunpaSclZblUsu/a0bd6tYqvQmMfPgl/8/a9kZF&#x2B;nVqV69fzKLnq9/HT8Glztnfv0njsiI6o/AGA78AwDI/7cecfBIDSp84B4LOUlJJDOAxDK2maYRhCMxRFcdB9CAD&#x2B;cDm54pwcsYGBjpWlKZfLKS6Wz1m4&#x2B;8nziPz8Ik&#x2B;Pco4Olna25o4OVq1b&#x2B;HC5HIZh9h68unvf5aULhjRp5FXaYweAP9Jn7/4JAsDvAAHgq9h1xkp2XYFSSTMMjdZDAPCfSaWyi1eeVqns7OZamptz5RdIUlJzklOyklOyq1Yp713DRaFUzpq3KyI6acu6ceWdbUpxbADw52IYRsD//JJfBIDShwDwfdh1xh82K2CXG2OdMQB8s6SU7IlTN8e8S92zdapPLXfV4wzDPHoaXlBQ1LRxjU83zfhllEqKZhgNARrcAcC/xxAOh/OFW/yyFADwW1K9sD&#x2B;4H2a1/v8fn6Zp5v97lzEMjbkCAPisB4/D5izYU1AgcXdzVN39yxXKi5cfHzxyIzU9Z&#x2B;mCwaq7f3avveiY5HZt6v6y9&#x2B;P5/DLytxkAfjGGYTjkS3f/ZQwCAHzIAyV/6P&#x2B;/zpgmDBsPaJph/tDJIgD47xiG2bHn4snTd0cMabdi7dEhA1oTQvLEhScCg65ce5aQlGFrbXrswNyK5e3Yg28Hvdy2&#x2B;8L796mmpkZDB7VRnScpOWvz1tOd2jeoV8ej1C4GAODvGJrhcDmqdp/qAItE4TO4XC6XyxXw&#x2B;QIBX1NTQ0tLS0dbW1tLS0tTS0OgwefxuRwuW0pU2iMFgJ&#x2B;uUCKdMC3g/sOw4wfmhb6OdbAzd6lov2zV4dETNvJ4PA0tQb3alY8fml&#x2B;xvB3DMHfuvuzZf8nDJ296dm2sUNLzZvbT09Vmz/PgcVivgYsrlLetW7uy6uRJyVn9hi4/eORGKV0cAKg7mqF5PJ5a3f0TrAGA/4JdZ0wzNGGIkqYYhqGVNEHpEEAZEp&#x2B;QPm7qlprVK82Z0Tc9Xdi2yywjQz0Pd6d&#x2B;vZtragqmzNzWuYPvmBEdORwSdO/Vjj2XKpS3HTGknYmJfsfu86pXrbBm&#x2B;Ujy/wmEQ8duLF803K&#x2B;&#x2B;p&#x2B;rk9x6GzV6ws1&#x2B;v5iOGtPtC2aFcoXz9Jq5ieVsjQ71fcc0AoDa&#x2B;sOT3U2VpDQACAPxgFEURwmEYmqYZdlUBxVAcxAKAP1BCYsaEqf4D&#x2B;jbv3MGXEHLs1J3IqMR&#x2B;vZtVLG937NSdgO1nl8wf3Miv&#x2B;t37r/13nImKTnawM/eu6WpvZxkeER8cEnkxcIWJsX6hRDp7wZ7HT8M5HE45J2sHO3N7e0sHe4vE5KyTp&#x2B;&#x2B;sWDy8Xm2PK9eeivIK&#x2B;/dp/ukYMjKFk6YHaGlprFs52sRY/5d/DwCgbGIYhsP5d2U/CAClDwHgz0IzDGEYiqLY1cZKmmLX2pf2uADge2zbdeHGreD1q0anpuds23nB0sJ4zMiO5maGSclZSclZ124G37n7cvmioe3b1GUnEFwr2i&#x2B;ZP5gQwnbtjIxO2rXvkrOj9eZ14xzsLUR5BYeO3mzoW83To9xHLxT8MnrKzK3tWtWZPL47tvQCgB&#x2B;Fpmk&#x2B;j/9pp/8vQwAofQgAfzp2/QDDMBRFM4SmKZoh5A/9aQRQT1KpLPhltIWZkavLXxsCFBXJOvWY6&#x2B;hovdN/8u2gl3MX7Rk&#x2B;pN3Avi1Ugf99Qvr4qVtcK9ovnjeY3e73nxw&#x2B;djNgx7m5M/u3aelz4Mj1Fy9jMjJzCSHOjtaD&#x2B;rV0c3UkhFAUjWAAAP8KwzA8Ho/L&#x2B;de/OhAASh8CQJlE0wwhDEXRhDBKmqIpLDIG&#x2B;MNIJMVvIxOcnaylUtlG/8AeXRqW3C6AjQTDBrcd1K8lh8OhaYbL/cxMoEymWLhs/6vQ2M3rxlWqaE8IiXmXYmlhbGige/d&#x2B;6NjJm6dO7D6wb8vIqKT5S/cWFyvMTA3sbC0c7S3q161SMo0AAHyKy&#x2B;H&#x2B;2/f&#x2B;WQgApQ8BQE3QNE04hPlrOQHN0GhICvCz/NMd&#x2B;Q&#x2B;RXyA5fOxmjeouPt5uJ0/f27w1cOXS4fXrVFF9VVtbU8DnvwyNWbbqsI2N&#x2B;ZL5g16ERAfdDxXnFxLCkRRKC6XFGem5bVvXmTqhB/vGv0RSfOfuy4PHbujparduUbuRX/Wge6&#x2B;eB0ekZYpEonxLC&#x2B;NRwzrUqun6k64IAP4g7M3Dty/5/RQCQOlDAFBnFE0RhsMQmqYYmtBsPCjtQQH82ZRKav2Wk0dP3LaxMrW3t3S0t3R3c2zdwkdD4/v/WH6BQqnk83iquqCsLNGYKZuzMkX6BjrlnW26dPT1rec5acbWV6Gx&#x2B;3ZMd3ayzs4Rnzl//8CR67Om9G7Xpq5coXzwMOzK9afZOeLGDau3aVHb2Fh/x56Lx07eHtCnRdfOfsZG&#x2B;uJ8iW&#x2B;zCe3b1Fsyf1BOrvjajeevw94lpGRxCHGp6DB5fFdjIywpBlAXDMPwuLzve&#x2B;NfBQGg9CEAwEfYlqRKmiY0oQnNUAxFU1hnDPAthKKCKTO3Kilq3fJRSopKSsq6cuPZmfMPRgxpN25Up&#x2B;Ji&#x2B;dxFe5QUvXH1mF85qmWrDj9/EWVubmRtZXrnXoiujvbG1WPE&#x2B;ZIr159HxSY1alC1TYs6jo6WhBC5Qjli7LpCibRKZeeklGxpkUwg4FE0nZ2Vt2nN2EPHbr0Mix01pJ1vg6qGBrrnLj2cu3DvmuUjWjX3eRkaM3X2jqpVyttam0qKikcObW9pYZwrzJfJ5GZmRhqCz7cHKS6Wb9l2hmYYB3tLeztzB3sre1sz/LYB&#x2B;G0xDMPlcP/7vTsCQOlDAICv&#x2B;v86Y7Yh6f&#x2B;Lh/7MH3iAnyc8In7CNP8mfl7TJvcQ8PmEEImkePGKA69ev9vpP8XRwZKmmZjY5PLlbH7SbMBX0TSTkpptZKSbkSE8e/FhcnJWWnqOXElZmhu3bVW7U/sG5y4&#x2B;nLto77qVo1o09SaExCekGxnpFeQXSYpkY6dsKu9sq6HBE&#x2B;VJCMNYWhjHJ6QbG&#x2B;vv8J8ceO7&#x2B;2g0nWjTz9q3naWpiaGlhfP3m87sPw0yM9YWigoiI921b1V2yYPBHg0lNzxk/ZYuBvk4j3&#x2B;rJKVkx75Jfhr5zdrQ6fnC&#x2B;jo5mQUHRuYsPfbzd2KULAFD6GMIrMd/4XyAAlD4EAPg&#x2B;7EQB/eF/DEVRDPkj/wkA/BBnLzxYs&#x2B;GErq62XK6wt7ewNDeSyZWSQmm9ulV6dmsUGvZu9vzds6f3sbM1PxF4d/Tw9tZWpqU95A9omsnKFpmYGGgI&#x2B;JlZokXL9odHJJibGerqatvamvft2bSym9PE6QH37r96em&#x2B;bpqaAYZiUtBwBn5eSluNayWHFmiOvQmPWrxqjWjQsFBbkCMUymUJfT5tmmF4DlrRtVXvezP4lX/TZ84jJs7a2a11v6oTufD6PEEJRdJdeC8T5hVfPrUpNzxk3ZYuHm9PieYO0tDRK4ZsCAH/H0IxA8MPeuTA3N/&#x2B;PRUS/DwQAUHeqhqQ0YWglze5t/If&#x2B;uwD4dgqlctXaY/cehm1aO9bd1VGhVF6/&#x2B;WLmvJ0L5wzo2smPYZjd&#x2B;y4fPXl71dIRNb1ceg9cqqOjuWfbNA6Hk5SctWPPRZEof/b0vsUyeUxsikRSbGKs713TxUBf959eLjExc&#x2B;e&#x2B;S316NnV3dczJFRNCzEwNf/Y1Xr8VvH7TySKpzMraVEMgcHKwnDapR3GxfMJUf2NjvdXLRhjo6xYVyXbtv/z02VsnJ2srSxOaoh8/fxsZmTi4f8sJY7qqeowyDLPv0LWN/oFtW9cZNayDtaWJUkm9eh27bdcFimaWLRgc9z5t7qI97drU861fhcflerg76&#x2B;vr/OwLBIB/QtM0l8Pl8//FPl9fhRmA0ocAAD8VmwpUdUNKivpD/6UAfFZ2jnjiNH8tLY21K0aya2ELCqXDx6wlhOzZNp1hmFkLdmdmCjetHWtlaXL63P1lq4&#x2B;cO76YcDg79lx8F5c6YkjbRn7VHz558&#x2B;TZWycHm/wCyd4DV4yM9a&#x2B;cWUEIYRgmOTnrfUIGw9AVKtjZ25rfe/B67qI9I4a069ur2d37oXMX7Rk9vEPvHk1/zcWy/3jZAgClkvLfcU5bS2PowDbszf3YyZsfPArbvW2apblxQlLG9ZvBt4JCFs0d2LJZLdUZpFLZvMV7w8Lf16/rkZSSnZaWo1RSerpabq5OrVrUqu3t7r/j3J79V2rVdK3s5lRcLA88d09LU&#x2B;NxkD8hhKLohKSMjAwhRdP2tubOTta/5qoB1BlN0Xz&#x2B;v97n66vK0gzAjwxGAGUG&#x2B;y&#x2B;cS7iERwgh7Fz&#x2B;h&#x2B;Ihhm0&#x2B;RGiGpiisM4Y/krSoeHD/Vg19q6ne4Z42e5s4X3Li0IKsbNH4KVuqelZYu2KkhoBfUFC0KeB0lw4Ndu69nJiSMWJIu3q1PdIzci9eeZKZKdQQCPLzC3l8nkJJDR/UJk9ceOjozdtBLytWsHVytEpKzrw6zb9V81rPgqPWrx5To1qlLdvOnj53f&#x2B;PacZVdHX/ZxZb8R8rn8yaO6VLyq4P6t3S0t7h05bGlpUlEZGJiUuah3bNKVvAnp2ZPmLLZ2Njg5OEFRoZ6H508v0AydvKmnFzxqcML2Gqi8Ij4wHP327etxx6waPkBhiFmZoYpyZlXbwa3bOa9dsUoQkhqek7wi6hGftU1NQQKhRLTBQA/CkMYgUCAv85fhhkAgO/31zpjhtA0/WFFwR/5TwrUXX6BRC5XmhgbHD5209BQt8P/71&#x2B;Xrzl69MStalUrjBzarn6dKkJRwbxFe/LEkl7dmzg5WtIUvXnb2cjohPUrRhfLFPMW7&#x2B;3RtdGQAa3ZCvg8cWHjVpNdKtpvXDNWW1tj1rxd9x&#x2B;9aVDXQ1osf/0mzsLMaPf2aXY25v92qDTN5OTkaWgK9PV0fvY2wDm54skztnp6lJs0rtunrxUblzJhypaqnhUWzhmoqSkghFy/Fbxw6f7Rwzv0691clFcQEZkozpcoFEojQz1RXsHcRXuXLhzcsW19di2BUkl7epQXivI7t29gZ2t&#x2B;7tKjzh3q5&#x2B;SIGYbxrulmb/uvvzMAQBjC4XB&#x2B;UqFOWZoBQAAA&#x2B;PEoiiaEpmiaXWpMM9imAP48cfFpO3ZfzM7JGzKwtWq7rn2Hr63beLJ1Cx9XF4f09Nw791&#x2B;ZmBhsWj0mKyuv/7AVc2f0797Fjz0yNi5l5rxd7q5O82b1S0zKmDBli7ub04SxXe1tzSmKHj1xY2xc6pljiz59T/0Lbtx&#x2B;ceb8fbFYoqWpkZCUUSgp7tWt8eTx3X78xX&#x2B;D&#x2B;4/CZszZwd7rE0Ioit4UEHju4qO1K0Zpa2uuXHdMR1uzQd0qpqaGRUXF&#x2B;w5dzRXmr1oy3K9B1f2Hr&#x2B;/YfXH4kLbdOjfU19NmGGbHnos7dl&#x2B;oX6&#x2B;qt5eLMK9g977LDvYWLZvVehUam19YVKGczYwpvU2MsWsBwNcw5McW/X&#x2B;kLAUAlAAB/Hg8HpcQruoNCOZD/9EP64tpmqYYiiAUwO9KnC/ZsOVUUnLWqGEdvGu4lPzSwD4tfOt5CoUFJib6KSnZ&#x2B;vo6I4a009QU3Ln7iqaZl6HRxsa6Obn5jx6/efwsYuaU3t27&#x2B;F2/Fbx4xYFJY7t17eRHCJFIimfO3yXMKzi8Z1bJu//omCRtHW0bKxO2u86n5izc8&#x2B;BR2IFdM9kyeqWSWrTsgEyukCuU/9Sw/6fyred55&#x2B;p6bW1N9tPL154mJmcdPzjPytK0bqOxGpr8pQuGMAyJjU2&#x2B;fO0pl8c9fmCelaXJtNnbI6KTDu2dVbG8HSGkUCKdNX93YmLGsQPzXV0cGIZZv/mUpqagVXOf9q3rjhnRcdzkTddvBY8e1tHEWP/ps4jzVx4nJKTLFUoDfZ3atdyHDGj9T98uALVC0zSPy&#x2B;Phn8M3wwwAQOmg6Q&#x2B;9hmiaoRmKphiapglKFuEnePY84uGT8P59Wpib/azGOzTNPHn2Nj4hXUtLQ1tb6&#x2B;zFB&#x2B;NGdPSoXG5TQOCla882rh7j6VGOEBKfkD5hqn9ldydVzQwrMTFz87bTSSlZ6em5FcvbbVo39qOGQjTNNGk9WZRXMGpYhwF9WnzUZDM7O08oyjcw0P1NupSGR8SHvn6noChba7Og&#x2B;6FKuWLB3IGivMIJUzZbW5muXDKcrfiPT0gfN3VLOSebFYuG6upqSSTFsxbsfp&#x2B;QtnntuHJO1gzD7D14dceeiysXD2vc0IsQkpaeI5crHewti4vlw8eti4hMvHN1nZGhXnaOOOheaHRsYla2WEuD7&#x2B;Xl0q2TH4IBqI8ftc/XV5WlGQAEAIDfC8XuW8YQmqHZdQVYyQTfjWGYA0eur998ysbK9NKZFSVvCjOzRFeuP6tUwa5eHY&#x2B;f9OoKpfLduzRLS2O2fCUxMXPslM29ujX6cv8fpZL67M2rUFiwY&#x2B;/F46fuWFkY794&#x2B;nS2Rj45JWrb6iKWFMWGYR0/fautoHts318LCWKFUPg&#x2B;Oqlje1sLC&#x2B;FuGmivMT03NdnVx&#x2B;HmbnaWl5yQlZdXyduNyOYSQ8Ij4UeM39OnZdMSQdhwOJzExc9yUzQ4OFiuXDNfT1S4qks1dtCcqOnHTunEcDufKtWcRUQk8LlemUEqlcsIw8Qnpq5ePsLE22&#x2B;h/OjUtu0uHBl7VKmlraR4LvHPydNDa5SMbN/QKC38fEhrz/n16UZHUytKkc0ff8s423zJUhVLJ4/LYcQL85mia5vF4PO6vSLwIAKUPAQDUxP/XGX/Y0piiKKwogG/ENq98/iJKKCqYM7Nvr66N2ccjo5IOHLl27ebz6lUrrls5&#x2B;rctLo&#x2B;MStp/&#x2B;GqLpt7s&#x2B;9&#x2B;spSsPHQ8MOrB7Zo1qlYSigtS0nMLCIi1NDSMjvVXrj6Wk5Zw8uEBSVDxpRoCmhmDN8pHs1T1&#x2B;Gn777svRwzuamhh8&#x2B;kJh4e8nTvNv3tR76oTukdFJG/0DG/tV79PzF3UpJYQoldTu/Zc1tTQG9mnB7rQwfsoWKyvj1ctGXL72bMWaI3Nn9O/Yrq6GhiA6JmmDf2BaWu6WdeOj3yXPnLdr1NB2gwe0Vi1QViopQsiV68/2Hbzq6uLQvEnN8s426ZnCidP8HewtTxyaT9PM1p3no2OTly4YbGigyz6lSFqsmnKJi08bN2WLa0X71ctGsEnsxu0XB4/eGNinRdPGNX7Z9wTgW9A0zef9&#x2B;Haf/6QsBQCsAQD4rZX4XcN&#x2B;8OHtSYpigwFF0wzNMBRFlcbo4PeVlJw1YeoWdzenRn7Vgu6Hdm7XgGGY&#x2B;4/eHDp2IykpMy09d0Cf5pPGdWPv8BRKpeBnrpz7Pgxhbtx&#x2B;ERwSnZKa4&#x2B;RkVVgoffAoLPT1u01rxqam5qxed9zezrxSRXsNDf67d2nnLj308XY7vGd27LvkCdMC2rT0mTy&#x2B;O4/HZTfw2nPg8vKFwwwNdG/eeXHjZnBcfJq4oIjP5Xbt5GdiYrB244nZ0/q0a1OXEGJhbjRpXNfKbk6fGQ/D3A56mScubOhb7cfuYsbn80YOba/6VE9Pe/G8gZXdnXk8bmFBkYmxwdETt4JfRBRJZfcehjVu6HXswDyKpmbO29nEr/qwwW0/&#x2B;qZNn7Mz5FW0saF&#x2B;cmr2jdsv7GzNtbU1CyXFnTo0KCgomjlvZ3JK9pZ149m7/1xh/pSZWyVS2YZVo/ceuJKfX3T/UZi9nUWvHk2kxXJ9PW1CiIOdxcwpvTzcnX/gJQP8AAzREGDL7e&#x2B;EGQCAsoD5/0JjmqEIw2EnCmiaRvmQerr/KGzuoj0jh7Rr2dynaZupQwa0srQwPnXmXlXPCoYGOkdP3pozvV/rFj73H4UdOX6rSFqcm5ufJy7s2tGP7ahTXCwvlEh/wU69X5WekXv3fmhKajZFM5YWxh7uzjWqV7oVFDJ5xtZe3Rp36eibK8x/Fhxx6sy9zh0aTB7f/eKVx8tWH1k4Z2Cblj6EkEKJdMGSfbHvUresGx8bl7Jq/fE6Pu69ujVxqWTP5XL2HLiyYUugtZXpprVjXSs5BOw4dzvo5dZNE2yszT4aBsMwQfde7dhz6W1kgp2N2bmTSz9ahPBrJCZmJiRl&#x2B;Nb35HA4RUWyXgOWpKRl&#x2B;9avqq2tkZSc5e7qNHta7x17Lm7ZdvbI3tlVPSsolMqUlOyklOzk5EwzM8OKFezGTdlSoZwtu&#x2B;SAEPI2MmH81C21argunDNQIOAvXXXw8rVno4a1L5LKiqWyAX1brt14QiwuXL18pJ6uNiFEJlNk5eTxuBwrS9NvLBAqKCjS0BCUXO8B8N/9sqL/j5SlGQAEAIAyi2EYNgMoaYqhGOZDF6I/8p88fCO2p&#x2B;SJwKB1K0d5Vau0MeD07n2XHRwsu3b07di2/rZd5x88Ctu8blylivYKpTI7O08uV&#x2B;rpaXM53LZdZjXyq75s4ZCklOyJUzdnZIp8armnpGZpamr06taEvZ&#x2B;mKPoLffflCuXDR2GxcalcDqdFcx8Hu5/Vxr5QIr145UlaWo6&#x2B;vg6fzzsZGDRxXNeWzWq9T0jv0G2udw2XhXMHyeXyJ0/f7j9yvUrlcssWDDlxOsh/&#x2B;7ltmyb6eLuxJ8kTF44Yu15HR3PdytECPm/mvJ0ZWaLN68bZ/v3un73137bnopOdhZOT9bZdF7ZvmaRqilq6aJpJTMrIyc3X09V2crRk&#x2B;xGdPnd/0fIDHu7OtWu5i/IK3kYmDO7fqmWzWhFRiYNHrG7aqMaSBYM4HA5NM8dP3d4YcHrcyE79ejdnZwYSkjP9141nmyylpueMn7LFQF9n3crRMpn87IUH9x6EaWtr6Olph79NUCgVKxYP963nSQhRKJVZ2XkMw5ibGn10o//4afjU2dvbtqo7a2qvkm9GiPMlDMP8qw6wACo0TXM53J/a7vOfIACUPgQAgO9GUTQh/29ISlM0hYmCsuPcpYe37oQsmDXA3NyIELJg6b6aXq6tmtcS5RVOnhmgq6O1etmIh4/Dz1x4oK2laWVhTAgJDY&#x2B;LjEzs1a3xjCm9njx/O3PezpbNavXq3qS8s83byISe/Zf06tZ4zoy&#x2B;7xPSx0/d4luvyvRJvQghDMPcexDm6GDB3i9evxW8duPJ1i18Krs7FRfLW7fw&#x2B;fVdaGQyxa59lyOjEjQ1NXg87s07L8YM7zh0UJv8gqIGTcd713Dd6T&#x2B;Fx&#x2B;PmF0guX3u2fdeFtq1qTx7f/X1C2oSp/lWrlP&#x2B;oMVHJW/&#x2B;RwzsYG&#x2B;l36DantrfbmhWj2ANuB728fe9l904NhaJ8Ho/n16DqF8Z2O&#x2B;hl4Ll70yf1ZL9dP1VOrvjdu1SZQmluZlihvC3bI3Xz1jM7916qUb2ij7ebSFR498FrqbR4/aoxtWq6JiVnjZywwcHOfM2ykWx7InafsjYt606d0H377gvHA&#x2B;8MG9S2W2c/dh4gV5i/fdcFP9&#x2B;q9Wp7jJuyWZwvMTLUT8/IiYtLbdmi9opFQ9nv3r5D17buPD93Zt&#x2B;ObeuXHN7L0JhJ07dW9aywcvEwHR3Nn/3dgDKGoRken8fllM5dOAJA6UMAAPhR2HXGhBCKpmiK7UxKY6lxWSLOl4yfsrlGdZcxIzqeOntv6cpDc2f2a9a4RkJSxu2gkHMXHk2f0rNDm3rs1MGqpSNq1XQlhCQlZ42dtKmyu9Pi&#x2B;YPuPwibv3TvuFFdenZtRAhhG1amZ&#x2B;ZuWj3m0tWn&#x2B;w9dyy8ocndz7N29Scd29QkhBYVSTU1BqbTnV1F1E6JpZtX6Yw8ev&#x2B;FwiLOjVXRMilCUv3je4DYtfW7cfrFgyT7VZl4s9tZ/667zUdHJzZrUbNLQy8nR8uCRGw8ehV08vdzM1JCmmYAd53buvVSzeqVKlew5HE7Lpt73H4XFxCZn5eQJ&#x2B;PxKFe0G9Gnh5GjFvnrAjnPHA2&#x2B;vWTaybu3PNFx68uztk2dvB/VvZWz0E1dj0zQT/vZ9eqZQX087v6Do3sOwsSM7stMdg4avCn4ZvXbFyFo13UyM9fcfvua//Rx74z5rwe5790MP7Z392fZBucL8/HyJQkkZG&#x2B;pJZYqO3ec0bFBt/arRxcXy&#x2B;Uv2hYTGbFoz9qOVAycC765af3T44LZs76Ofd71QNjGEy&#x2B;WW4i04AkDpQwAA&#x2B;Lk4hKYZmqYJQ9P/37/sD/11ASUlJmaePn8/V5hvamKQlJIVGZmwfvUYJwerWQt2Z2YKN60da2VpQgi59&#x2B;D13EV7hg9u27dXs83bzp678GDj6jFVPSsQQuIT0sdP9ff0KLdgdv&#x2B;CQumUmVt5PN7CuQPF4kJzU6M5i/co5ApCSExsipWlycolw1wqOXx5SGfO36dpht0m7BeIjUvR1NR0sDOPjEraGBA4ZEBrNvAQ1bv&#x2B;uy9YWZr26tZInC9JTMpMTskOeRmdkpYzb2b/Hl0b5hdIps/ZkZ2dt2zhUFeXvy4tJDSmQjlbTQ3BhctPFq84MGVC90H9WrKlNSGvYnt2b0xTFJ/Pr1a1Als5o7Jt1wU7W/PWLXy&#x2B;UF71U0XHJN198FqppIYPaXsy8O6JwKDli4d6uDsXFclq&#x2B;Y5yc3XYumGioZFeamp2QmJGI7/qSclZO/dcio1LcbC3MDU1LC6WvXgVk5CQ0aFtvYVzB2Rl542fskVfT3vdytEley4plMplqw5fvxm8cslwvwZVI6ISt&#x2B;260L5NHQ2BQCQusLY09ape8csr0R88Drtx88WwQW0cHCx//ncFfi/sXx8Bv5QXkyAAlD4EAIBfjP1dwTAMxdAMzdAUzTAMRWObgrIgKjrp9Zv3ndrXY7vgb9t14URg0JoVI729XLbtuhCw49yxA/OqVHYuKCg6dfbe7v2Xx47o2LtH07Dw95NmBLRqVmvSuG5sv51cYX6euFDA4xub6O09eO3Q0RuBRxba2ZnfvR9683ZIemauKK9QVqxo0shr&#x2B;qSeaRk5BfnSg0evv4mI37J23C&#x2B;ojfmqZ88jgh687tCmnpvrX3f2UqmsY/e5ZubGh3bPiotPnTBli0flcovnDdLS0lAoldeuP38aHJkrFNM0kRYXE0JS03Lr1HJfOHdAUnLWuClb&#x2B;Fxu&#x2B;zZ13VwdaYbeu/9q8Mvo3QFTa/u4yxVK/21nTU0NBvRpUXpX/BUXLj8&#x2B;d/Fhdo5YW1vD0c7Cq4aLb90qXXotNDc3On5gHofDiX2XfOnq0zMXHkwZ3613j6Zs7VDr5rVnTOlVsgYsO0c8cZp/fkGR/7rxjo6Wl64&#x2B;nb9kn52NWUPfaiYm&#x2B;g8fhz99HtGja8N5M/uzx0skxXHvUwslUhNjg0oV7TkcsufA1W27zs&#x2B;b2Y&#x2B;dYgK1wjAMl8v9NZ3&#x2B;vwwBoPQhAAD8JiiKJpwP64tpmsZEQRkglcqUFM22gDweGLRn/xWaod0qObwKi&#x2B;Xz&#x2B;BtWj/aqVunM&#x2B;ftrN52cP6t/y2a1EhIzduy5mJEhdHCw0NHRKsiXXrr22NTUcMu68ckpWWs3nmzkW613jyZsScy&#x2B;w9fevHk/d1a/Tf6Bp889sLE25XI4NbxcZk/rffnac3c3h9&#x2B;t3WRUdNLJM0E9uzUpKCwaN2nz8CFtB/ZtSQgR50v6DV6ur6&#x2B;zYvEwB3sLiaT49Ln723adHzOiY99ezW7dCVmwbN/oYR17dW/CNsxhGGbSjK3BIZHnTy6jKXrCNH9NTcG6laONjfTnLNqTkJBeXCzPzsmzsTFjl&#x2B;2W9nV/nlyu2LXvckRkAs0w5mZGz55HSGXydStHe3u57D98bcu2s3Om9&#x2B;ncwbfkU16HvZswLcCjstPKJcO1tTTXbz555vyD2dP7tmtdhxDCMMy8Rfuu3ny2M2BKFXfn85cenzl/X0lR5Z1tGIZ5&#x2B;ORNxfJ2ZqaGL0NjN64ZW6Wy85vw93a2FiYmv&#x2B;nmFfDD/eJO/1&#x2B;GAFD6EAAAflsMwzCEoT8EAoaiKfL/CQT4gVLTc86ce/DqdaxQWCBXKMo5WQ8b1Iat0vkZlEoqKibJ0tzY3Nzo6bOIXfsvz5jcs1JFe6GwoHWnmRUr2m5YNUZSWPwqLPbQsZsGejprV466cOXxtp3nd2yeXL1axY/O9ux5xNTZ21X74KamZU&#x2B;fs1NHR2vtipFsf/q790OPB96ZPa2vg71FVHSSjq72z2sr9O1K9kFKS8&#x2B;ZMM0/PT3X06OcubnRzTshfD5v3crRXlUrbtl&#x2B;dve&#x2B;y0MGtJ40rit7cGp6zorVR94nZmxaM0acXzRlxtYWzWpNn9SDfZs8J1dsZKjH5/PeRib06Ld4QJ/m0yb1LLWL/DcUSqVcptTV1YpPSD8eGNSmZW1Pj3IlDwg8e2/Z6sPDBrUZNayDOF8yZea27Oy8LevGOzpakv8vJomMSty0dqxCrpgxd6ejo9X0yT1VSw4OH7u5ct2x6tUqbFg1RktLY&#x2B;a8nTGxKZvXjmOLrxRK5eHjtyzMjNkuVV9w4/YLsVjSsX2933C/C/gChmH4PP7vM8&#x2B;MAFD6EAAA/iA0TRMOIQyhyYcSIlZpj&#x2B;sPFnj23vrNp2ZN7d2sSU0tLY3omKRREzfVquGycslwmmaGj10nLpAc2zf3F7TiUSqp46fuRMckc3kcUxPD44F32repN3VCd0KId/0RNbxct26aqCHgxyek8/h89iZ&#x2B;/&#x2B;Fru/ZdWr5wGNs552VozOQZ2zq2qzduVGcej0vTzPbd54&#x2B;fClq7YpR3DZdtu85v3XmhYnlbXT1tLoezftVobS3N6NikvLxCbW3Nap4V2PaXpUsqlT0LjnJ1sbeyNDl45MbT528LJNK09NxWzWrx&#x2B;bzwiIQ8cUGXjn5dOvoGnrm7aeuZudP7NvStdvTk7eCQaD6fy&#x2B;fxCgqLMjNFeWJJi2Y1587sVzbuUzOzREeO3/Sq5tLQt2psXMqYiZsqVbRftWQ4uwtBUlLm2MmbTU0N1q0cnZEp7DdkeZuWtRfNHai623sZGjNhqn/TxjVmT&#x2B;&#x2B;Tlpo7bsqHg9ndnXOF&#x2B;ZNnBIjFRZvXjbO0MD5z4cH9h68zMoQ0zVSsYDt6RMdyTta5wnw&#x2B;nxew/dyFy49XLR3&#x2B;hU5Nj5&#x2B;GR0Yndevsp9oRGUodwzA8Lu&#x2B;3uuG2sLD4fdLIf4QAAAClg8PhfMgBNMMwNMXQNIVI8K18m01QKJQb14xVNbanaYbL5eSJC7W1NOVyha6u9jdu1fTzHDp649ylRzK5wlBf197OvHXL2r71PHfuvbRl29lThxewb&#x2B;Kev/RoycpDSxcMZotehKKCuQt3ZwvzN60eY2CgO3PezvcJGWNHdPSrX1VHR/PO3VeB5&#x2B;4plJRX1QoKJX3pyhOZXH77yjoBn58nLrx2M9ivvqehgV6xTG5spPdPf6dfhsZcvf68X69mP3UtqUKpDAmJycgWGhvqu7k4WFgYUxS9cNmBp88jNq0da2tj1rnXfBMTg71bp&#x2B;nr66Sm55w&#x2B;e//IiVsTx3Xt1bXxzxtV6coV5psY67P/XUR5BTPn7SrnbD1lfHc&#x2B;n7d&#x2B;86m9B68OHdRmQJ/mNM1ERCVcuPT49t2Xs6b26dbZ78HjsOmzd7RrXXf65J5spg2PiJ8wzd/To/yyBUN0dDS79F6QkyM&#x2B;dmCujbXZ28iEbbvOt29Tr6aXy/Q5O54&#x2B;jyCE2NuaV6taYdTQ9kbGeu/fp1eqaF&#x2B;yA2lRkWzZ6sMVytv27dW0bESvP10pdvr/MgSA0ocAAFD2qNYZMwy7iRlDUTTWGX9WRFTi0pWHwsLft2rmvXzJMPau5XbQywVL900a161LR9&#x2B;LV57Exae1bOqdkSnS1dWqVrW86s5GrlAuX31YKpUtWTDk13fqPBZ458TJIGNjvc3rxmtq8L0bjLK0MJ43qx8hJORlzKmzdxs2qD5/Vv&#x2B;UtOzxU7d4Vi7HtucXigpmzN355Nlb33pVGjf0cnSwcrC3mDJrm1QqCzyyMCo6ecK0LUJRQa0aLtnC/JZNva0sTG4GhUyd2N3OxvyjV1&#x2B;/6dTkCd1K3mcLRQVrN53wqlqxayc/mmbeJ6RZWZqwPe9/LIVSqVRQ2tqahRLpstVHIiMTLSyMzc0M7z98zeVy2cUVP/xF/whCYcHeg1eiYpMZmrGxMr336DWXw920ZkxVzwpx8Wlde833rFL&#x2B;wK5ZhJCcXPHh47cOHL42Ykg7VS/RZasOnzp719nRenD/Vu3a1GXPGRGVOGGqv0sluxWLhhVKpPn5Er6AP27SpoysvJpeLilp2S4V7RfM6nfmwkM7W/PmTWqW5vVDCb/t3T9BAPgdIAAAqA9VHqAZhqIphmb&#x2B;0F9c/4VQVHDm/IPKbo51fCqzjzAMM2bixvuP3lw5u9LWxsx/x7nzlx5tXD3G3dVx9frjp87ebdLQy8nROjU95&#x2B;Llx53aN1gyf9C9h2HPgyNevIwpkEj9148v9xs03rl7PzQ4JIrL5eroaF249Khf72a9ezS9HfRy3uK9o4a1Z9vzMwzTa8BSiqE3rxmbkpaTnJyZkJiRkJQll8sXzR30PDhy2eoj/fs069OzGbt&#x2B;gBBy5&#x2B;5LQyO9GiXup&#x2B;UK5ZIVhx48CtuwanTJNQnsbWLVKuWWzB&#x2B;sra25duOJ1&#x2B;Fx82f1d3K0Cth&#x2B;Tk9PZ&#x2B;jA1j/1O0DTTEpKlp6eDha2qshkCqWSYiuFUtKyZ87bFf72vYW5cTln65BXsXwed&#x2B;WS4VU8ym3fdcHZ2bpXt8aEkOzsvAEjVqWlZd&#x2B;7scnQQPfytWcLlu4b0KfF2JEd2Tu220EvZy3YVaumW58eTSq7O&#x2B;loa&#x2B;XkiidND5DJ5JvWjbe3NY&#x2B;MSnz4&#x2B;E10bHJubr6OjmY1zwr9ejfX0tIo5e&#x2B;FmmFohsf7vcp&#x2B;SkIAKH0IAABqq8REAaFpit2vgCFlPBW8e5/aued8RweraZN6lHO2zs8vunP31akzd6dO7OFb33PG3B3FxfK1K0YRQqbM3Kqpqblo7gBrK1NCyK69l3YfuLJt00SvapUCz95btupQl45&#x2B;CqWSYciIoe02B5x2drIu52wjEhU2bexVsnF7aaEoOujeK3MzQ9WCZplMUbfxWEd7i&#x2B;FD2gn4/HfvUzkczvDBbZVKau2mkzduBW9cPcazSvkvnDMrSzRhmv&#x2B;bt/GuLvbVPSva21k4Olg6O1qFvolbsvLQqGHtB/VrmZKWk5EprFqlvIaAn5MrnjQjgBCyYdUYM1PDX3HZ8A2kUllIaIyDnaWDvYVcrhg3Zcvjp29r13K3sjBOSc0ulsknjO5S28d9977Lm7edWbtiFPu&#x2B;PsMw/tvP7T98beHsAar5AbY3UfVqFZcvHPL8RdTmbWdMjA26dfarUtmZy&#x2B;XuO3Tt8LGb82cN6N7FTyZT3Ln3MjQsTiQq0NPT8vF2b96kZpm5C/ytMAxT6p3&#x2B;vwwBoPQhAABASTRNczgcdqaAIjShSdlbZxweEX/p6tPUtByZTGFna1rds2KjhtXT0nLGT9niW7/q9Mk9I6ISJ04PaN&#x2B;m7riRnXg8Lrv10vOQ6M1rx1YoZ3vo6I2dey8tXzy0QV1PQkhMbPLEaf4cHrdh/aqWFiaWlsaivMKge6/EYkmBpMjBzmLwgNbeXi7/aoQ0zRBCfsbag4TEjKD7odk5IkMDvQrlbL1ruigV9JRZW5UUpbpHl8kU0mKZkaHeR88Nfhk9ZebWxn7VB/dvnZqWnZCUmZCYEZ&#x2B;Q8fhpuIGBztrlI&#x2B;vW9rh7P3T2gt1DB7UZ1K/lm7fxE6f5N/arPmNqLx6XFxefampsiLfnf09CUUFmplChpBzsLVT/6Vt3npWelt2uTb1xIztp62jOnLczOiZl09qx7q6O7AGBZ&#x2B;8tX3N01NB2Qwe1WbPx&#x2B;InAu472Fhwu19zM0MHO0s7W/O6D0Lj3aYFHFhYVyYaMXlOhvM2wwW0FfP6hI9cjYpJWLx1R2c2p1K65jPr97/4JAsDvAAEAAL6Kw&#x2B;HQNMUwHOrDGuOyFgkIITduvxDweY38qgeHRM&#x2B;av2vW1N5NGnkRQrKyRBOnB5gY669YPExHR2vBkv1h4XH&#x2B;GyY42FsQQq7dfL5k5cGxozr36NxIdb&#x2B;ekSk0NNDV1tYMexPXe9CysSM7jhza/ttHwm6R&#x2B;yw40snByt7espyTVQ2vSmzY&#x2B;BkKJdL4hAxXF3t2bUPo63cTpvn37dl02OC2JQ87euLW&#x2B;i2BMyb36tb5r52Gc4X5U2duyy8s2rxunLWlacCOc8cDb69ZNrJubY8z5&#x2B;&#x2B;vWn982MA2FhbGDx6FZWaJ3N2c6tf1qOzutH7jKVMzQ8/KzmnpudZWpg19q5XW3r3wZUolFRmdxOEQD3fny9eehb6OHTmsPTu7pVAqV609dvna05VLR/jV97x7P3Ts5M0Tx3QZOqgNISQ7Oy8pNSs5JSslJad923oOduYvQ2NGjNtgaKDbu0eTnl0bl1w6DD/K71z0/xEEgNKHAAAA34FhGEI47A4FhDBs&#x2B;ZCSKmvrjBmG2bP/CofLGdy/FYfD2XPgyoYtgRPHdOnQrr6Jsf76zSev33qxcc0YD3dnhmFu3H5x605IoUTK43ILJdK8PEmuUNyquc&#x2B;MKb2&#x2B;/QY3Ni5lwpQt7m5Oc2b0zc4Rv49P23fw2tvIhL3bp9eq6fpTL/YL9h&#x2B;&#x2B;duJU0Kqlw0sWCLENZGpUq7R43iCFQjlz3s70jNxN68ZbWRqvWnvseGCQlpaGV7VKTRvVqFe3sq21GSEkMTFz3JTNMpm8das6Dnbmx08FvY1M6NWtcV5eQVJKtpaWoHePpi2aev&#x2B;rsUVFJxkZ6VlaGJexn73fnFBYEPwyyrWiA7sRwcvQmGFj1pmaGLRsVktHRzM6NiUvr8B//YT0zNzgF1FtW9fV19MW5RWcCAzy336udi333VunlvYVlDW/1T5fX4UAUPoQAADgB/prRQHDUBRFMzT5I381fp5QVHD9VrBEUty/T/Pd&#x2B;y69eRu/bMFQtqZl0fIDFy4/PnVkYTkn68ws0dkLDw4evTF9cs&#x2B;Obeurnl5cLB83Zcv7hDRHe0snR8te3ZtULG9X8vzXbj5fsHT/yGHtB/Zpwf51zBMXDhuzVqmgju6f&#x2B;zv06VdJSMyYMnNruzZ1B/ZtGRefNm7KFncXhyXzBxdKiidO8xcIeH6&#x2B;1dZtPLlm&#x2B;YhWzT/sLXX3fujshbt7dWsyalh7Pp&#x2B;XkJgxeORqa&#x2B;v/sXff8U1VbRzAz7nZs83oSFeSDvbeIAgICIoLRVyA4gAVt68bxa2giAs3LlRQEAFlyt4ge6826Uy60jZ73XveP25b0pUOupI&#x2B;3/fzeT/l5ubmFKHc557fOY/6ofsm9u6VfOFC9gOPfnjrzSPefHWGze5asnTTufPZJaVWPo&#x2B;Xlpow/e5xcRp1tTH4/fT8j5atXrtHwOfZHW5tYnRiYow2MbprF&#x2B;314&#x2B;tpaAWaXWmZ/eTpjGKLVSoW6XSxybo4isLLVmx7&#x2B;/0lA/t1Hn/tID6Ps3vvqZOnDW/PvX9Av84w7dOcCMIU5lAt3q6kuUAB0PagAAAAtBxCSHmbAkLYTYcIuwFRaP7ADOLnXzdt3HKIy8HapNjtu44J&#x2B;PzAqHQgm92VmWW2lNhGDOtZ&#x2B;U8gTTOfLFrx/c8bEuLUo0f1TUqKEfC4F9Nzt20/Om7MgIdmXL//v3PHT1xKN&#x2B;QRgpL1mql3jYuvcUNc6dz5rKMnL90wYahM2vxbcNZ0&#x2B;NiF4mLruGv6l5TaH3/2s&#x2B;5dtM8/c&#x2B;el9NzJ97w&#x2B;/Z5xzz99FyHky29X/7J083tvlvcs27Hr&#x2B;Etzv51&#x2B;97Uz77&#x2B;RonBWdsFjT3&#x2B;SmBC14P1HhUI&#x2B;w5D9B0&#x2B;nJscLRfyVq3d9&#x2B;PEfzz41ZcbUCYEfWmyxPvviF6Wljk8XPJ6UGG2zu7JzCjKzzJlZ&#x2B;WNG96tWWYE2lGE0HT5yoczqkIgFqSkJ/fqkrd908KNP/7j5xuGPzrwJ2gVcuXbY56teUAC0PSgAAACtjBCCMGInCghBFV3MwmRRASEkv6BEIhbKZOIGvqW0zP6/l74qs9pfeW5qaZnDmGVyOt1cLjc1OW5g/y5Ll2/9a/Wu8eMGXjOqn04bcyk9996H5k0YO&#x2B;CD9x5hGPLFN6szM00TrxtqKrBoE6ITEmKOn7j07vxfnnliSmBYv/X5/P5flm4WCnh33n7N2/OWHD5y8dMPH0tKiiGEfPXd30uWbnrvjfJiYNfeEy/M&#x2B;eau28fMfODGrdsP7z94pqCwlKaJ0&#x2B;UWi4QZhrzePZPff3tm4J0imz5KjI9atPApdo9LEBIyM/Pfmr9ELhU/Nfu2Fu0f14EQFBKh/2qgAGh7UAAAANoJhiEMYhBTvqKAZui2HlFrOHc&#x2B;64n/fda/bye2UVfgSw6He&#x2B;bjH1EU&#x2B;ui9R6OiItmDa9bunfPG4s8WPNG3T&#x2B;oLc745fiJ9zKh&#x2B;yclxPC4HYzzvo6VcLlcqEfbtk/bc03cUF5XRDNOuumKdOJn&#x2B;5&#x2B;qd90&#x2B;7XquNIYR898Pa739e//bcB/r0Tp0xc55CIZ3z4rS0lASvz//X6t0LP1v&#x2B;wL3XPThjYuC9wsrVO9/94LduXbQms6Wk1JaUEJWUFDt0UPc7Jo&#x2B;yO1zPvPBlWZndT9PZOQXxGvVjD09iF3P7/TRDSOv3awOBnE6Pze6MiVa09UDCAkGEEB6vvW/4U6twKgDgZwoAAFwRisIU4qCKeWxCCEVRNMMwNIMQoRmGEMbvD7d1xlk5BU/OnjxxQi2Z9e9&#x2B;Wnf8xKUNa&#x2B;axd//5BSXffv/P1h1HP1/4pCZWeee0N3v3Ttu4Zj471WApsT374he9e6UsnDdbLhMXW6z/rNv3068b33vrIfZqVpvj869WDx7Qhb0hbiu9eqZUriSmaWbokO7jxw1KSow&#x2B;fyHL6fKUlNo&#x2B;WbRSJhXt3nuSppkP3psVuP0Ru/PMuo0HFs5/lD3u9fqMWfnZ2QX9&#x2B;3VCCEklonffeEAiFopEgh27T8x&#x2B;6uPs3AKEENuOID09b&#x2B;KEIYXFZX16pdx289VHjl3s2SNZqYBtSVuPWCyA/X&#x2B;aBbvhT4je/YcZmAEAAIDWQMobGhOGMAwdzhMF23cee&#x2B;WN72QScVpaos3moChq4oQh148fvGvvydff&#x2B;fHxhyfdNWUMeybbhXfk8F4v/O8uHpfrcLjnvPm9wWBi8/GoYnOhvn06zX15emFx2cpVu46fTHe5vSWWsj590gb173IpPXfKbaPZk2uVbshb&#x2B;Nnye&#x2B;4YW9lBuSV4vT4Oh&#x2B;NwurZuP9qvT6fA8bA38Tarq/KbqpRrKvrpl03nL2QKBAKhkO90uS9czLbb3TOmTXjs4VvYdgQajfrWm4anpSbwuBwOh3rqhS/y8grHje5/&#x2B;lxmbl7R&#x2B;LED57w49dRpQ2FRmV4b27NHcpjVmSCcEEQwwlxOCD96DqcZACgAAACgDRBCMKbYjmU0IYQmBBGaDpN1xgxDCotKGYaJjlKwu6Zs3X7kk0Ur574yvTLYc/zEpfsf&#x2B;eDRmTc/cO/1CCGTuXjWYx8lJkR98O4j7NPWDf8efPPdnx97&#x2B;Ja77xi76u/dH3y87MVn7r5u/GAul/Pxoj9/WrL&#x2B;w/ceTUuJP34yfevOY7l5hYSQOI160o0jRl3dm/2If7ceeu3NH2Y9eON9VVfitqYLl3LOnDVeO2ZgtUfIGUbTHdPeHNCv06cLHudyOBcuZv&#x2B;xcvva9Qfeef2BMaP7rVy98/0FS59&#x2B;bPKdt1/D3nBs2Xbk5de/mzhh8KwHboqJVqQb8m6&#x2B;fU5EhPiakf01sYodu06cPmt8782Hbrx&#x2B;KEKopNSWmZlfUmqTysRdOydJJa2xqBqAIEJxyW9N4VQAhHAdBgAAoQtjjBChEEYUh0IIccoPXt5xiEE0ohk/E4olAUXhaoHpa0b1u2ZUlQxPfmGpVCJa&#x2B;sfWEVf16pSa8OpbP2QYTa&#x2B;9cq/D4Tp09PwfK7adOJ3xyYLHu6Qlrtt4YP7CZVKJSCIR7tx9fPuu46fPGL7&#x2B;/H9shwE/wwwc0CU2RpmVU3jz5JdcLu&#x2B;oq3vTNPPZV3&#x2B;tWLn94/mzBw/q1qrffFWdUhM6pdayt49MIhp9dZ8MY96sxz6KiJDu2nMiWh2x5PuXdNrYt99f8u/Ww199&#x2B;jRbLDEMWfT1ql&#x2B;XbZ731sxRV/dBCB0/cenJ5xbdeP3Ql567Wy6TOJ2efQfPJCVEXTWkB0LowMEz3/20Xq&#x2B;NRQjt3ncyz1T02UdPBEaSbHaX3&#x2B;&#x2B;PjJCGza0MaOcIE6qh/zAGMwAAANCusT&#x2B;kCWHYRcaEEJqmSbj0KfD7aS6XgxDasfvEP&#x2B;v2llmdMVGRW3Yc0SbGLJw/u7TUPmPWvEk3D59y6&#x2B;j/Dp8vLbVFRsp6dNN17aL97/D5f7cezs7Jxwg5nG6/n3E43DwBd9GCJ4Qi/vOvfF1YVPbpgseD7Drafvj9dHZOgVoVIZOJ/163b&#x2B;euY889fWd0tAIhZLM5X3z1m8ycgs8&#x2B;fFyv0yCElq/cMX/hsmeevP2uydcghLKyC5549jOVSr7g/Uci5JIMoyk/3&#x2B;J0egRCniJS9tsfW7bvPLbsx1ejoxWbthxau2G/pdQmFQkNmWaapp949La23XMJhD1CCIUpDidkdvoPLpxmAKAAAACAEFO&#x2B;zphmCCKEYWiGYQhN&#x2B;5mw&#x2B;ZfJ76dLy&#x2B;w//7rxUnpupEKWlV2QlZ0vk4n79&#x2B;n07JNTIuSSeR8t/ePP7Ys&#x2B;enLQwK4Mw&#x2B;zee3L&#x2B;R0t790p9/ZX7snLyn3z2s149U15/5T6hkN/W38qVOn3WePjIhVtvGSGViPx&#x2B;&#x2B;u15S7buOLrg/UcH9uuM2K1IX/lm0k3DZ8&#x2B;a9M33f2/acmhg/87J&#x2B;jg&#x2B;j2vMyl/6x5akpJjPPnw8w2B6e96SIYO7P3jf9Sn6OISQ1&#x2B;d/7c3vO3dOuvO20Ru3/Ldl29GSUltxUVmZ1dGrZ/Jbrz0QpY5ACHm9Pj4/2IPbi&#x2B;k5QqEgMT6qdX43QGgJs7t/BAVAewAFAAAAVEMIQYgwDKJpGiHi94fwRME9M94xmYt/XzKXvRP1&#x2B;&#x2B;mnnvt8/39nl/8yV6/TvDPvl42b/9PrYuPjo86fz7qUkfe/J6dMu/vaTVsOzX3rh0dn3jzt7mvb&#x2B;jtoEXaHi2EYuUyCELpwMfvteb/cMfmaiRMGf/jx7z/&#x2B;svHJR28dOaJ3aZnjv8Pnfl&#x2B;xrVfP5Pffmrl56&#x2B;E5b3z/7hsP3jRxWOClCCHLlm/97Mu/Bg7o8uwTU9gFyr/9vvndD377aN6j144ZsH3nsRdf/XbG9AmzHriRfcu581kul6dXzxQOhyKEfL347&#x2B;9&#x2B;XPfGnBmVm0G99&#x2B;Fv6zbs//TDx/v2SWvd3xjQ7hBCOBwOhUM79F8NFABtDwoAAAAIju1nXL77EAmID4XCj/2Tpw1/rtpx&#x2B;lwmn8uNkIt9fiYtNe6uKWNrPmw&#x2B;fOyCUMDv3lW3/8CZBZ/98dxTd7JrAzoUk7n473X7LCU2Po9DcTjL/tg6/Z5xjzx0M8b4hskvFxeVrVv1viJS5nZ7z57L7NM7FWP8xrs/rdt44I7bRmXlFJpMxQwiMerIsxeyOqcmfLrg8W&#x2B;&#x2B;/&#x2B;eHJRvfem3GhHGD2I9Y8tumjxf9&#x2B;fzTdw0Z2PXpFz53u71ZOYWjru4zfsyAcWMG8Pk8isL5BSUiEZ&#x2B;tT0BHRhjC4YT8kt&#x2B;aoABoe1AAAABAE7AlAcMwDCKIITTN0AzNMOETHwLVbN1&#x2B;5Nsf1uaaiqRSsSJS1r2L9qEZE51Oz8TbXrr5hqveef0BhBBNM4VFpQihnLyitNT4V&#x2B;YuvnAx&#x2B;7MFj3fulIQQ8np9c9/&#x2B;ce/&#x2B;0wvnP9qvT6es7ILHnv5EpZI//MCNuaYiiUSUmhL/&#x2B;LOfde&#x2B;ife/Nh9gVHfkFJQWFpQI&#x2B;V6/X8EKw4StoMva5Q0jv9RkEFABtDwoAAABoPpgQhiDC0IQgwlRo61GBluL1&#x2B;V&#x2B;Z&#x2B;92W7Ufj49RymdjpdHfrqnv1xWkCAe/eh94/dyHr7xXvsvs4HTl24Z35v/J53E8&#x2B;eCw6WsGuOrjphqv&#x2B;9&#x2B;QU9l5/&#x2B;85jL7z6zZRbRz312OQTJ9NXrt51/GR6UlI0n8c7djLd4XDNf3vWyBG9EUI&#x2B;v7&#x2B;gsBQhFKWKCL60ACGUZypat/Hgzt3H337t/qSkmBb/HQHNge3zxQ3fkg8KgLYHBQAAALQc9p8G9v/ZYoBmGJoOt37GHRwhxG53CYR8Pq/8js3n999yx6uZmfkD&#x2B;3VWKGS5eUWnzxon3TTi1Zem8Xncn3/d9PGiP197edotNwxn3/7lt6u//3nDG3NmDB/WY&#x2B;7bP544mf78M3eOHd2frQ0KC0u/X7J&#x2B;1PDegwZ2nf3UxyWl9ogISWFhaYYh76phPT9b8EStf5wOHDyzZNm/NpvzriljrhnZt8zqfPXNxTRN9NrYpMTopKSYbl20alVEa/5GgYYIj53&#x2B;g4MCoO1BAQAAAK2OEFKxqIBhCGEYQmg6bFsad1hZOYUejycmWrF2/X6hkD/pphEIoZJS24ixTybGR81&#x2B;eNKEcQPdHu&#x2B;Lr35z4WLOpx8&#x2B;npISd&#x2B;f0t9we75LvXlYqZDUv6HC4S612miZKhZQQNPHWF2OiFX8smVvtXurkacOHHy&#x2B;jMPXUY7f17pWKKjoepKUm3H7ryKzsggxj3u49J0tK7S&#x2B;/cA&#x2B;7CypoJwghXA43bG6O6xJOBUDYTtMAAABobhhjtoUZZvv7VqwzZghBTPmWpFAShLykhPKV1ndNGVN5UBEp&#x2B;&#x2B;2HV44cv8jncxFC8z9aRtPMH7/MjYyQnjiVcf5C9qgRvfl8LiHkUkZuSYl90IAuWdkF3/249vyF7OhoRYRM4vF6z13INhhNA/p1&#x2B;mje7MAbKa/Xt&#x2B;DT5es27J/z4rTxYweyB1eu3vn2vF&#x2B;m3jn2ydmT2T9vCKElv22a99Eyp8PdSr8XoGF4XOjzFWJgBgAAAEBzwhgzDKnYk5QhhPj9NM1AfChsMQz56deNW7YfKSoslUiE2qTYgf07D7&#x2B;q1&#x2B;13vx4fr/71&#x2B;1eEQn5WdsGW7Ue&#x2B;Wfz3DdcNfeHZu9iMECu/oOTRJxcKRcKP5z0aFRWJEPL5/fM&#x2B;XLpsxbbJk66e9cCNsTFKjLE537Lir50/LFl/zx1jnpw9mSFMRkaeyVwiFPBSU&#x2B;MhFNQmwj70X004zQBAAQAAAKAVlK8zJgyhCc0whDAE1hmHMYfD/fHnK06fNXK5nCh1xKnThoKi0ldfnHbrzVcHnlZssU67/x2NRr1o4ZNs47Zii/WZFxaZzJa&#x2B;vVONmfnZOQVuj1ciFsbEKK4a0nPSTcMzDHnLVmw3mYt7dNfLZeKTpzJOnjbMeuDGxx6&#x2B;hb3m0WMXNRpVbIyy8lNomvlk0Yp1Gw9&#x2B;tuCJrl2SWvG3IZx1tLt/FF4FQAf6zwYAAKDtEIwxRhhxEAdxUEV8iGHKJwoYhmEYwhAmRB9LgWokEuErL0yt/KU53&#x2B;Kn6YS46m0cXnn9O5&#x2B;fWTj/Ufbu/9QZw5PPfa5NjGHDRdVOLigoee6VrwqLyua8MHXo4O7srRi7OOHYiUsIIY/HN/ftH/5Zv793zxRCiNPpmXjdEEuJ9cLFnKPHLy147&#x2B;HOnRJb9tvuMNjQf3gv&#x2B;Q1vUAAAAABoA&#x2B;zdG0VhhHDV2wjCMIgQQiMa0QTWGYeHwOfxlc6cy9y999Tbc&#x2B;9ne4cd&#x2B;O/sY898etstV1fuMRrI6fTcN/N9gYD/&#x2B;5K5MqmIPWgpsT338ldKpeyl5&#x2B;7OMxU9&#x2B;fyi0hL7qy9OHzqku0oh43CoTVsOLfr6rx7dk8ePHfDtD2tN5uI&#x2B;vdMW/7j21puvvmpoj5b&#x2B;rsNVuPb5qlfYPP5HUAAAAABoZzBFIYQwB1GIU7nOGLGbDpXvSQolQVg4ecqAEBpxVS/2l4MHdt237fOat/6si5eys3IKR1zVk2EYmmYMmaZNWw79vnzb0MHd5r8zK8NoevbFLwb37/LG1y&#x2B;KxQL2LZu3Hn7r/SVTbrvm&#x2B;afvYC/7z/r90x549547xgwZ1I09x2A0PffKV716JM95YTpFYVSxZ5FELKw5BdFwfj9d1zcS6ghDeDxY8hvyYA0AAACAEFPRz/jyOmOaZvy0P5yez3UEBQUlfAGvgffZhJBly7du2nKooKhUIhZqE2N6dNePu6Z/nEa99I8tH3z8&#x2B;2MPT5oxbQL7Z4AQ8vlXq35YsqGyawFNMx99&#x2B;seyFdvennv/ddcOZq&#x2B;5Y9fxF&#x2B;Z8M37cgDkvTrNanUuW/rtr9/GICCmfzz189GJSYvSwwd3PXci&#x2B;c/LoMaP7BRmbzeZ8ae53DE1/8O4jEolw1uMf&#x2B;Xz&#x2B;7796/op/h9oXmqY5FKdDhf6riYkJn550UAAAAAAIeYQQiqLYJQTsSgKaoWGdcUdw4VLODz&#x2B;vn3jdkOFDe1Ye/P7n9R99unzuy/fefutIhJDX53/8mU9PnzF8u&#x2B;g5dhGw309/8/3f3/247rln7rxr8jXGTPP0B98b0K/zG6/OYPNFb7&#x2B;/ZMWqHV9/9mz3brrs7IJPv1yZl1fscnvcHm9aSsIdk0dfO2YA&#x2B;1nphrzHn/1MESH9&#x2B;IPHotQRVptj1Phnbr1p&#x2B;JwXp7XF70dLYRgGQv/hVAB03DIOAABA2GDnBDDCGLPrjBEPcQkhGFOXG5cRwjAMzdAh&#x2B;uQL1KpTasJ7bz5U7WBKcnzfPqlfLV4jFgsnThi8dfuRPftO9eqR7PF4T5xMP3nasHzlDkup9ZtF/&#x2B;vZTb/h34MrVu20lNh8fnrn7hNWm2PL9iMlJbYvP3l68MCuCCG9TjPnxWnxGjVC6Oixi9MefI/L5bAFwPadx1549Ztrxwx87eVpPC4XIfT9T&#x2B;v9fv&#x2B;U20Y1ZPAOh9uUX8zn8xUREplM3Ly/M82IIFjyG25gBgAAAEBHw&#x2B;5IShjCsFuSwqKC8OZyeX7/c9uZs5kIoZhoxco1O&#x2B;Pjoj798HGVSn7zlFcRIZ8ueNznpY&#x2B;dvOT3&#x2B;RUKec9ueq02JjMz/69/dh8/cQkR5PX5PV4vl8MtK7OLxYIvPnk6Oiryq&#x2B;/&#x2B;/mbxmuf/d3dlW&#x2B;Kde0489vQns2fdMuuBG4OMp8zq&#x2B;GXpv/9uOczhUnKp2Jxvyc4t7NldP/fle7t0bne7lBJCOFRHXPJbUzjNAEABAAAIQ1OmvSkU8JP1Gr0uNiU5Tq&#x2B;NjdOoISAOahUwUVA&#x2B;V0DTfhqyQ&#x2B;GLYYjb7f39z2179p&#x2B;SScV2uysry2yzu7RJMYMHdZt1/w0ikWDN2r2vvfX9lFtHz374lgi5hKaZLduPvD1vycB&#x2B;nd&#x2B;e&#x2B;wAh6MXXvj124uKC9x8d2K8ze9kN/x586dVv7pt&#x2B;/ZOP3hrk003m4qkPvCuTiL/45Mk4jZo9uHT51mV/bJ086eppd18b5L1en5/Pa9XsBkaYwwnP1cxNEE4FAESAAEAIIXO&#x2B;JSe3qHevFF6Y7tvQ0ZjMxbl5Rbv3naw8IhDy9FpNsk6TrNPodbHDh/WMUke23QBBO4IxRohgzH7B4XAQj8etZZ0xw/j9sM44HFAU/vCTZX/8uePrz56p3AzUZnfd&#x2B;&#x2B;C73/&#x2B;07vrxgzulJpjzLRTF2XPglLmghMOhjp9MLyoqffzhSQ/OmJidU/jEs5/xBNxlP73K3sG73d4PP/593aYD7775UOUK47pcuJiTn1/iU/jPnM3UxKrYP1F33X7NXbdfE&#x2B;RdZ89lffHt6m07jvbsrv/txzmt8OeQYRgOxYG7/3AFMwAAIGOm&#x2B;bpbX/S4fV27aFf8MlckErT1iMCVGjHuydy8oiAnfPDOzNtuGdlq4wFhgF1nTNjsUHnXMsZPw4qCkHQxPef7n9YfPXaRy&#x2B;cmxKm5HI65wBKnibp/2oQ&#x2B;vVPZc3x&#x2B;f2mJne1QtmLVztSUuBHDep06Y5g5e8HwYT3feu1&#x2B;gYBHCFm/6eDCz1b065P69OO319ruoKbtO4999tVf5y9kd&#x2B;mc&#x2B;NarDwRvTsze&#x2B;p87nyUS8jOMpo/nzx57Tf8r/x0IDpb81iqcZgCgAAAArdt44LFnPmW/fveNB&#x2B;&#x2B;cPLptxwOu3BUWAK&#x2B;8sVgmFSXr4/RaTUpynFIha4ExgnDAPohlmIB1xoShoSoIHTTN2B0uHpdb2T2gXm63Vyjkezy&#x2B;f9bv&#x2B;2Xpv8l6zQP3TezWRcsw5I&#x2B;V2/fuP/3oQzcFRvm9Pv/OXcdN5uLAeA&#x2B;7UenXi/8eNqTHN58/U&#x2B;sHnTiZ/s33/5y/mPPgfRMHD&#x2B;xy611ze/dI/uGbF67k&#x2B;20IhjBcCu7&#x2B;axFOBQBEgABAQwZ1UynlxRYrQkgiEbb1cEDb27n7RGD9IJeJU5LjdLrYFF1csl6j12l02lgBH1rhAMTe6GOMcEA7Y3ZFQfmepITQDM0wDEPDooL2iMOhIuSSRr3F7fG&#x2B;M&#x2B;&#x2B;Xi&#x2B;m5Vw/v&#x2B;dVnz8REKxBCZ89lvfX&#x2B;z1FRkU8/dptepwk8n/bTL839zuv1KRTy8eMGsJsFGTPNx0&#x2B;my6SiB6ZPqPkRJ06mL/pmdXpG3kMzblj4wWwel/vkc5/7fP4Xnr3rCr7XBiGEwN1/RwAzAKBD8/vpXXtPisWCOI36jxXbYmNVd0&#x2B;5BjK&#x2B;YeAKZwDqfTtF4bhYVUpynE6nSdZrUvVxOm2sJlbV9BGDsEYIoShO&#x2B;RxBxVyB3&#x2B;8nKCT/Ce7gCCGXMnLTUhIqj7jd3j9X7ezZI7lXj&#x2B;Ra33LytOHr79YcOnLB5/dHqSIIIQqFfNTVvW&#x2B;7ZaRQyM/IyO3cKYnNGh05duHrxf/8d/ic1&#x2B;tPjI9KSY7TJsWIRMKvvltz2y0j3pgzo0W/L4xwR&#x2B;7zVa9wmgGAAgB0aG/N&#x2B;&#x2B;WHn9cjhGY9cMMLz9y1dcfRdZsODBnQdfIkSIeHtpYuAGolEgv02tgUXZxeF6vXx6XqNampCTBRAILAGNGEIIYQwtAMIYT4fD54BhHGvF6fx&#x2B;Or3PLf76dvu2uuSCSY/&#x2B;7D&#x2B;fmWL75elZ1b&#x2B;NCMG269Zbjb7cvOKTBmmtMz8r75/h&#x2B;JWLjur/eVypaKIzIMQ1EUlwN3/3XCGEdHR7f1KJoN/JcGHdqlS7nsF9/9uG7WAzc98sRCn59euWqXy&#x2B;Oddue45v2sF1/79sB/Z1OS4&#x2B;6eMuaakX2b9&#x2B;KgPXA5PWfOZrJ7jbM4HKpTWuKQQd1Gjeg1bHAPDgdm1UEVhCAKYURhhCgOBxFChAI&#x2B;Ibh8nTHDEALrjMMKn8/jBzwU4HI5q5e/jRDyen1Z2eY7bh89ZnQ/NiPEk3K7ddF266L96deNhJBZD96oVMpsdhdN05ER0uYdFbvTP2z4E1yY/TWEf41Ah3bH5FHsFypVhIDPRRUP3rbvPNbsn&#x2B;Wn6cys/K3bj544ldHsF29NhJBff9/yyFMfv/DqN&#x2B;s2Hmjr4bRrNM2cPZf5w8/r731o3pBRsz/4eFlBAcxegjphjAlB7J6kHA7F43H5fL5ELJZKJGKRWCQSCoQCPp/P5XJhliDM8Pm84UN7Thg3iFcjgSOViKbdPW7qXWP/WrPrqmse&#x2B;&#x2B;zLlQghm9315bdr/vhzh99/pT3sCEO4HC7c/Xc0MAMAQo/BaD5y7LxeF5esj4uMaNzirWquHz94&#x2B;S&#x2B;vHztxcdyYASKR4JXn73nzvZ8JQeOuGdBcow0/3/249r0Pl7JfL1&#x2B;5I&#x2B;P0r207nlBRbLF&#x2B;&#x2B;e3fi39aP2PahNmzbpFKRG09IhAaLq8zRhSFyx/cURTFMAQhhmYIYQjDMDRD0zQNhUH4ue2Wq9kvbpp41Y3XD&#x2B;NyOes2Hlj42YrRV/eZctso7pX1riGEQD3ZMUEBAELPpfSc5175BiHUtYt27Z/vXuHV&#x2B;vdN6983jf16&#x2B;t3XTpwwxOfzN3Av547pn/X7&#x2B;Xzur9/PSYxXb95&#x2B;tK2HE2K8Xv/Xi//5e/2&#x2B;Be89MnhA14a8JT0j78Chcyl6jV4bGx2taOkRgpDAlDcqxhwKIwohxCGEy&#x2B;FwaJpBCDEMzTCEIELTNAMtjcMFmyHctuPo4aPnv//6&#x2B;cT4qCu5GsMwFKZ4XFik1EFBAQDC09YdR/fsP63Xxfbqru/VI6Xhb1Qp5S03qqaxlNjWrN1739TxbT2QcoSQhPgotmq6e0qw1pWgLnl5xffMeOe1l6ZPD9gXvC4Zhrw5byxmv5ZIhDptbFpyvFYbm5Icl6zT6LWx0LoOIIQwxgzDsE9yOZVxbh4PY0wTBhPMMH6aITShaR9MFISw0SP7jm6OVWQQ&#x2B;u/goAAA4Skz08xu7zN4YNelP85p6&#x2B;E0kaXE9t2Pa3/6bZMyUtZOCoD9B8&#x2B;kJsevXrv3&#x2B;Mn03j0bUVmBahiGvP7OTw6n55EHb2z4uxwO9&#x2B;kzxtNnjIEHU1PiN62Z38zjA&#x2B;GCEEIhjDDicLgcDiKESwko9jjDlC81ZhNEbT1S0EoIIRSm4O6/g4MCAHRoZ89nrlm792J6LkMzkQpZr&#x2B;7JE8YNbA/5n2KLdfFP6376bZPL6UEIocj20ol21uMf2ewuhNCUaW8OH9ajW2ftoIFdRgzr1dbjam3axGiaZvLMxQxzRftCfLBwmUQsaMg8QBD5&#x2B;ZYreTvoUDC&#x2B;vP03RWGK4iDEwRhjjBnCdjQmbILI7/e37VBBS2AYhs/jt/UoQNuDAgB0UDTNvP7Oj7/&#x2B;viXw4Ko1u9&#x2B;Z/8vtt46c8/y0hreFb14FhaVfLf77tz&#x2B;2eD2&#x2B;yoNXuMyrGb3ywtTzF3OMxrz0DNOOXce37Th2/lJOBywApt997Yzp13m8PmOmmd2oOyPTZDCY0jPyrDZnoy711vtLOndKbOB6AABaAtuxGKHyPUk5FIUQEgmFDEMQKi8LGIbQNO2n/RAfCmEEwd0/YEEBADqo&#x2B;QuXVbv7Z9E0s2z5thOnMn77YY68oldL66j11l8RKZ1&#x2B;z/hpdzVzU4Imm3LrqMqvvT5/Zla&#x2B;x&#x2B;Ntu&#x2B;G0MQGf1zktsXNaYuDB4mLridMZx0&#x2B;mb995rCFbvtI087&#x2B;Xvlq/6n3YFwi0K5WrhykKI8ThcBCXyxFzRAy7/RBhGIYhDKwzDg0Mw3AoDqfdPEsCbQ4KANARZeUU/LhkA/t1fJz6mccnd&#x2B;uqM&#x2B;dbNvx7cMVfO2maOXM289mXvvj28//V&#x2B;vade04s/nH9oWPnaT8dESHt37fT2JF9b5g4jM9r4l&#x2B;oPFPR14v/&#x2B;X3l9sBb/6SE6AdmXD9l0kiBoJ0&#x2B;sOHzuGkp8W09inZHpZKPvrrP6Kv7PDX7tuzcwq&#x2B;/W7N85Q5f0L26c/OKvvx29XNP3dlqgwSgCdh1xgghjBAHUxwOhTjsOmOKEIYQxJR3LSM0A83L2hdY8guqgQIAhDCb1dG0N67fdIC9IZNJRX8seU0Tq0IIdU5LHDm89/ixAx&#x2B;avYCmmS3bjh747&#x2B;zggVWCGYSQuW/9&#x2B;MvvmyuPFBaWbth0cMOmg198t&#x2B;bLj59KS01ownjuuvft7NzCyl/27K6f9cCNE8YNoqj2ONWeYTC988EvOq2mR1ftpJtGtPVw2rXE&#x2B;Ki35z5w79QJjzy5MMNgCnLm4p833D/tepWq3W1CBUC9CGEQQvjyOmNCUUI2WMQwhGF3JWUYmoZ1xm2A7fJLUdD4FVQBfyBACDPlW5zsGtlGOnXayH4x6aYR7N1/pVEj&#x2B;ky9szxv88df26u98cdfNlbe/WOMo6IieRUzqhkG0&#x2B;1T3wh&#x2B;k1cXpuJRWVpqwtIf56z&#x2B;4&#x2B;3rxw9un3f/CCG3x7ttx7Effl7/0Wcr2nosoSEtJf73n19LSogOco7X41u6YmurDQmAloMxJoQpX1RAYS7F4fN4IqFQKpFKJWKRWCQUCvl8PsRRWgGb/IG7/2YRZr&#x2B;NYfXNgI6GppkVq3YEP6ek1F7zoKXUxn7RuVNizVcn3XQV&#x2B;8WefacDj9sdro8/L7/lHTO6376tnx3YvujEwe8&#x2B;/&#x2B;gJtj2T1eZ8fs7XjfwmqkjPyN2196TXB5tvhBuVUv7Buw8HP2fV37tbZzAdjcfjDR7BAq2AEMLGhCiEORTF43KFfIFMKpWIJRKxWCwSCQUCPo/PoTiQHWoW7MJuPo8fZretbSjMlr/DHwsQ2t5b8Ntff&#x2B;&#x2B;uuRVjYXEZ&#x2B;0VuXmHNf/uFgvLeh253LQtYU5PLYzwFBSV2h6vy&#x2B;NYdR9kdMHXa2MqbfoGAf/34wX/&#x2B;OjdCLkEIHTl2ce/&#x2B;U439LqbfPU4g5CGEGIZ88c3qu&#x2B;59q6CwtLEXAe3cwP6dqyXKqskwmIyZ5lYbT0ewftPBibe93K3//V363Hvj5FeWrdh2hdu2gubFMAxCBCGEMeZwODweVyQSymUyiUQiFouFIqFAIODyuHAL21jQ5RfUC/5SgdDmcfueffHLLn3vHTxq9suvf/fTrxs3bv5v2YptvywtD&#x2B;o4HO4//txe7V0p&#x2B;jj2i8NHL9S8plgs4FdUCIETCEePX2K/uP3WUQJ&#x2B;lR&#x2B;s8XFRMx8ob&#x2B;e0eu3exn4XD824YevaBcOH9qz8oJumzDl/Mbux1wHt3DUj&#x2B;wQ/4fDR860ykA5h8U/rZj/9ydlzmeyj0NNnjS/P/W7GrPlud1Nyg6B1sBuOIkLYdcZcDkfA44uEIqlEKhGLxSKxUCDkcXk8Li/MHsc2I&#x2B;jzBRoCCgAQwhLi1EqFDCHk99OFhaXLlm97492fH3ny45fnfhf45P7Nd39a9M3qgoKSyiPjxw5iv9i4&#x2B;b9a77MFFfv52AL2dLcUW9kvutQWHJo4YTD7xb79p2u&#x2B;Wi9NrOqnb1949YWp7Jb/BQUl98x4B2qAMNOrvt7Jp89ltc5Iwl5OXuH8j5bVPL5r74knnlvU&#x2B;uMBV4YErDOm&#x2B;Hwej8eVSqRSqUTCThQIBTweD255Ebvkl8PhcmGLF1APKABACIuPj/pz6Zv9eqfWdQJFYW1SjM9PL/jkjyGjH&#x2B;vUe/ptd8994dVvDh87z&#x2B;65TtPM/Y/MP3XG0JCPE1W0Bqt15/ukhGixRIAQyskrcrma8ogRYzxj&#x2B;nVLFr&#x2B;kiJQihCwltukPvZ&#x2B;TV1jvG1&#x2B;a&#x2B;&#x2B;0Lr37z7Q//mMzFTfhc0GpUyojgJ&#x2B;Tk1v&#x2B;fGzTE5q1H6sr9b956&#x2B;N8th1p5PKB5YYwZhiYMQexEQcU648pFBSKhiM/jd7SSoHzDHwy3dqB&#x2B;UCOC0FO5RlYk5GsTo1f89sa5C1nbdx2nMM4wmjKz8vMLSjBGuqSY&#x2B;6dfn5gYfc&#x2B;Md3LzihBCfj999PilyiQPy2Sy3Dzl1VEjeo0c0adzWqJep4mOiqz1c2NjlOwXBw&#x2B;fnzBuUM0T1IqILEcBQignt7Bp&#x2B;4EihAYP6Lr0xzn3zpqfn28pLCx95MmPV/z6erXEUTUnThnOnstECOmSYqttagTaFaq&#x2B;0IKtkV2EQV0Ki0qCvPr7yu3jxgxotcGA1lHZzxghRFGYorhcwuFwKELYXYnYxmWEoRmf3xd&#x2B;CSJCCIT&#x2B;QcNBAQBCT0lZeS5foym/2e3SKalLp6S6zl/9x9tvz/tlzdq9dbWrJIRs23l8287j7C8lEmGtu4teNaTHp1&#x2B;sRAgtW7F16h1jk/WaaidIpOWdXF1XFjLulJb4y3cv3T719dIyx&#x2B;kzxk8W/fn809AiKhxYSqzBT7DZoQBoHlFqRZBXT55u0KQfCHUYY4YhFeuMKQ4HcRDCPCzCQlKBZhiGZvyMn4TsAnFY8guaIGTniQjs6dZxnar4xzshPtjG6pWUCtlH7z9y8cTPW9ct&#x2B;GXxS6&#x2B;/cu&#x2B;9U8ePGNYrIU5d60Mgh8Nd6z50A/p16tZVixByu7x3zXh789bDde0o4nLVkhEKeLX&#x2B;8iAlOe7LT55mh/fdj&#x2B;sMxivaHGbthv0nTqWzWxiBNnT2Qj0Rf6GwnXZ9Djmjr&#x2B;4T5BFv6N7qgSvHrjNmf8hjjLkcDp/Pk4olgeuMBXxBqKwzZhiGy&#x2B;FC6B80Vqj&#x2B;iaH3v4cEkVikRCIVFqmRUImFKiSAJprhiW0nyeFQCKHTZ42r1&#x2B;5hjw/s16nhF8EY67SxOm3ssCE9Kg96vD5jptlgNGUYTBmZJoPBlGEwldXRYBhj/P6bD02e&#x2B;obX4yssLJ35&#x2B;EdqVUSf3qlpKXF6rUan1Xi9viADKCkpbz5gMjUoqT94YNf7pk344ef1fj/92ZcrP5r3aIO/1&#x2B;penvsde/e/7q/3gkyVVON2e86cy0rWx0VGSJr80SDQqjX17PQvFgpbZyRhT5sUc9stI1b8tbPWV3t007XucEB7Vzk/zK4zRggRQolEQrZaoAnDtjHw036Grn0muU0QQrgc2CYVNEWoFgAIEeQpIZ4SVJp&#x2B;&#x2B;UkOxcNCJRKrkVDFfoGFSsQRtOEoQbOw2V0Dhz8cG6OkOFR2TgH73D06WtGnVy3Lf7dsO7pp63&#x2B;jRvS57tpaYvrVCPi8zmmJndOq7OpjKbFlGPKMmeZ0Q161e98e3fQ/ff3Co099zG4PWlRctnnr4c1bD1e77Lc/rt2z7xTDMKNG9uvZXSfg8zKzC/47VL7D476DZzwer0BQ/7PeRx&#x2B;86ddl/3q9/rUbD7z28r1XfiNec8rCnG954NEP9drYrl20s2feHPhSkcU6&#x2B;Z7XEUKJ8VE7Nn18hR/dcIePXjx7ITNFp9HrNJXrLtqb4hKbx&#x2B;sLvjajmqXLt1Zbf1JTfDws4Wg2r79838VLOcdPZlQ7TlH4kYdurvUtAFTCGNN0edaAgymEEaIQj8ulKIqNFTEMYRiGpmmapglqgzml8iW/cPcPmiR0C4DaMD7izEfOfIQC/i7ypFikQkJl&#x2B;USBWIUEkQh3rJ0BwoDPT2dX3SDl5efu5tboJG8psT3y1EK/n16&#x2B;cscnHz42oG&#x2B;nx575tKCw9LGHJ91x26gGfpZSIVMqOg/o17nWVwcP7Lp1/Uff/rB2xaqdgVuLBtq6/ejW7UcRQl98uwYhJJOKHE535c13scX61AtffPjOwxJJPY97VSp59666o8cv&#x2B;Xz&#x2B;NWv3TL/72gZ&#x2B;Cw3np&#x2B;mz5zLPnsvctedEtQKgUmlZLd2UW86Jk5femvcL&#x2B;7VILEjWapJ1Gr0uVq&#x2B;PS9Fr9FpNvb9vreCLb1Z/&#x2B;e2aeI1Kr4tLTtbotbGpyXE6bawmVlUzNlBssX77wz/f/biu3st2Smni2nHAupiee/qsUSYR9e6VolZF/LL4lTff/3nFXzsrQ30iseCtOTMG9q/9bzcA9aqcK6AoTFEcDoeiKAFCFeuMCaEZhjDE52vBdcYMw3A4HC4nvG7hQOvqAH96fHbisyNr5uWSAFNIEIlFKiRUYXFFfIgvbcMxguCq/RhVqeQvPnPnTdcPq3kmIYSumJ/duu1InqmIfeb68tzv&#x2B;vftlJoc1yzjiZBL/vfklGefuN1gNJ8&#x2B;Z8wwmIxG0yVD3oUL2bXuPFgzfL/x3/927DquUsr79k4dPbJvanKcXqdhdyatxlMRK1q2Ytu0u8YF/xeFqW3pQkhzOT2nzxpPnzVWHhl7Tf9vPnum7UZ0GSEkJ68oJ69o194TlQeFIr42MSY2WqFUyTHGtI8&#x2B;fynn4qUcumGxgYEDurTYeMNcYVHp0y98WdmHm6LwTdcPm/PitHlvzXx05i079xwvLrbGaVRjR/dnm4cA0CwwxoQErDPGiENxMMYioYAQVGWdMe2vdXVZY7F3/xwKnmO2tpBYE9JwHaAAqIkwyG0hbgtCFy//XeTwsVCFRGosUiChGolUWKhEHFiQ1y7IpKLTh77PLygpszrEIkGyPo7NaNakUsqfeuy2hZ&#x2B;tQAgNH9YjQl5e1xFCsrLzm6sAYGGMk/WawL2Ahl7zeH6&#x2B;BSH05OzbcnILdu456XC4PB5f5c2fUMR/7sk7DAbTL79vdru9uXlFuXlF/6zfz76qVkcm62KT9ZpknSYhPorH4&#x2B;3cffzM2Uz21XPns9ZuPHDDhCE1R1K59qDYYmvGbxA0gdvlPX8h&#x2B;/yFpnRwi49Td&#x2B;&#x2B;qa&#x2B;4RdQg&#x2B;Pz3j4fmVf1kQQgxDVv2z5&#x2B;jxi8t&#x2B;flWbGD3tznHscbvDtXzljovpORER0oH9Og/s3znM/lEH7UHAfqTl64wRhyOkBAghhmEIQQwp/5/f37iqAEL/bahZ6rf2o0MWALWivcRhQg5Tlf&#x2B;8fDkWKZFQVTFdoEL8CAQtNtqCSCTQaWMbcubjD0&#x2B;6fdJIn59OjI9CCD3x6K1/rtrZravuqiHdW3SEJaX2wsLyRNDDD95YmQ73&#x2B;emcnMJiS5lQyE/Rx4lEAkKIOirysy9XVnsqXFRUWlRUevDQuZoXpyjMMOTF177BCE0YNyiw/vF4vJXNwi6m5wQfpMcTbJlySAjjnfLvvmMs3Iw2zT/r9wXe/VfKzC54/NnPf//5VfY39r/D52c//UlRcVnlCb16JC&#x2B;cN1uva9DPFgCuRJV1xphCFCKEEgmFTPkCY4ahGQYxtJ&#x2B;ua8dqhmFCZW8i0P5BARCU10q8VlRmDIgPcZBQUV4PVC4t4InbcIygpsCVo0/Nvu2p2be1woeuXL2TTfnrtLGBa0N5XI5eFxt4h4ExfuKRSXfeNuqbH9fmmy00IcZMc4bR5K3j7lwg5H3&#x2B;4RNPPP&#x2B;50&#x2B;F5/NnPMMbqqMirhnTXJsZEyCVbtx/1uMvfuHLVzgfvvS4&#x2B;LqraFWhS/s&#x2B;JpaTOKQJ/Hf/ktDfuK&#x2B;ux0G6pVPKpd45t61GEqsNHztf10qEj57fuODZmVN/CotKHZn9orVpAnjiVcfvU1/9YMrdmWw8AWlrgOmMKY4rLQYiDuDyK4jAMU7nOmGEYmqFpmubzIJUAmg0UAI1EaOQqIq4iFLjOmCvAQjUSqrBIiURqJFJioRJR0JIjPPn9dLXFxz4//deaXfMX/s7&#x2B;ctw1/RtynehoxZznp1b&#x2B;kmGIyVyUYTRlGEwGo9mYabaUWAlBXTonPXjf9Z3TEl97cfpLr32LECKEFBaU1LqhpM3uuvXu1x9&#x2B;4Ma&#x2B;vdN69UimKIwQOnTkvNNRftN8&#x2B;Oj5MaP6Vvl2fOX//LicngbuTdTS&#x2B;EHHUFraoBXJDAmNeqbSW6/OkElrWQQCGsIfdInF&#x2B;n8PjBnVd9mKbdbapo8sJbYnnvtszR/vsH9fAGhzDFNRFVCYojgRESpCSGFhYfB3AdAoUAA0B7&#x2B;H2HORPTcgPoQRX45FKiRSXQ4RCSIQgn9gQt6jT39y/GR6vEalUkVgjB1O97lzmSUVd6U8HvfuKWOacFmKwvFxUfFxUSOG9ar1hDtuG6WIlL729g8FBaW1ntCvb9rJU4bCwtK33l&#x2B;CEMIYx2lUEokow5BXec73SzYMGdTt6qsuf4Q531L5dXZuUfMuk2iaaHVEkFezcwu9Pj&#x2B;fV8/PLrstlLqePTbrlgnj6t&#x2B;1FtQlJejz&#x2B;9y8IoTQqTPGuk44czZz6/YjYxtWugPQ&#x2B;iD2A5odFAAthCBvGfGWobKMgDYFXCxUIJEKCdVYWNHCjNv2GxqCxiosLC0sLK31pTfm3KdNimmhz712zIBrxwzIzCowZpvy80syDHk5uUXFFmtEhGTwgK533zFmy7YjTz&#x2B;/iN2JiBDC3vdU4vO5Xo/vvpnzBvbvPOKqXtqkGJGA/9XivytP&#x2B;HXZ5rkvT2&#x2B;hwTdc8N9AhiGnThv69UkLfhGXO1gz5nbliUcmPfXY5LYeRWi74bqhH378R617cCGEpBIhQohXY9fgQNt3HWvnBYClxGazu&#x2B;I1qprbHwMAQGNBAdCKGD9xFiJnIarSpkCEhWokVLLTBeU5ImhT0I7VlRPo3Cnx&#x2B;afvHH11n5YegDYpWpsUXetL148f3KVT0vNzvj5xKsNf9WaoezfdR&#x2B;89Mn3mvPx8y3&#x2B;Hz/93uJbM9E&#x2B;/bkQITbtrXNvmoVOS48USQWVsqabN2w4HLwAKCkv9ddwLVpLJrqirWr8&#x2B;aXKZOD0jL9dUVLO9WgPFxirfff2BUSP6XMlIAEJIE6t6dNYtnyz6s9ZXR1/dDyHUo7t&#x2B;3cYDdV2hoKisrpfaicNHzs96YiGPy0lKiknWxyXrYlP0cTptbEpyvCIStrEGADQOFABtzecivmxky64SHxJEXN53SKjCQhUSyCA&#x2B;1E4s&#x2B;ujJPHNxXl5RfmGJxWKTSYVCoaBbF1072UgkWa9Z8evriN0dKLcoz1zkcftiY5XduugoCv&#x2B;x5LX/vfRlzbt/LpfTu1fK4SMXfvp140&#x2B;/bhRLBPokTXR0ZOuPHyHE4VBDB3Xbsu1oXSf8vmLbQzNuCHLTc&#x2B;5CVv2fcmX76E0cP3jG9OsQQl6f32g0GbPy0zPyMowmg9GUYcgrLXMEf3untMS7bh995&#x2B;TR7WHRRcPRNFPXDrxt7rFZt5jzi39fsb3a8T69Um6/dSRC6NabRny86M&#x2B;6ltpr2mvP6Wp8fjo9Iy89Iy/wYGSEZNHCJ4cObtmNzkCTsT&#x2B;NEUJxGpVIJGjr4QCAEBQA7RJBnlLiKUUoPSA&#x2B;xMNCJRKz8SEFEqmxUIW48HOkDXA4VGJ8FLvHaHsmEPBTkuNSqmb6E&#x2B;Ojfv/5teMn0zdvPXz2QlaeqRghFButePjBm9JSE&#x2B;65/51z57MQQk4H236rbUaOELp&#x2B;/JAgBUBJqf2ZFxZ9/fmzda0EWL&#x2B;pzge9lVSqYCsNGo7P43ZKS&#x2B;yUlogCln6UlNrTM/Iys0y5Jos5v9jj9Xk9frFYEBOl0Os1A/t3TqixU1NIeOG1b/buP63XaVK0Gr1eo9fFpiTHx8Wq2kNVwOFQ773x0Ihhvb78dg3bOY7H495y41Uv/e8eNvwTHRX54jN3vfnez7W&#x2B;fWJtHTZCRWmZw16j2yBoD7JzC&#x2B;d/tOzfbYfZypOicNcu2puuHzrlttER8iuahATgCkEBECIYH3HmI2c&#x2B;qhIfkmCRGgkVWKRGQiUWq5EgEuJDHUdxsfXN9352ebyPP3xLz&#x2B;7JCCGPx8vj8erdzKR3z5TePVNqHl/52&#x2B;vf/7xh7cYD585ntW3Hk&#x2B;uvHfTuB78WF1vrOmHH7hOT7577/lszu3XRVnvp2In0v2rbIqma&#x2B;DjVlY6ybopI6YB&#x2B;nQb069RyH9FWzGaL2WzZt/905REej6vXaXTamK8&#x2B;eboNB8a6fvzg68cPttqcVpsjOkpRrUS8b&#x2B;p4u8P18ecrqqW2pt997SDowQya2&#x2B;kzhrtnvBPYCZ5hyOkzxtNnjEuXb9u6bkEbjg0AKABCmc9BfA5kzQxoU0AhQWR5gwKxGgmVWKhCfOh7H55&#x2B;/m3T3&#x2B;v3IYT&#x2B;O3Rux6aPF/&#x2B;47vOvVyXEqb/67OmunavfFjeEUCh4dObNj8682WpzXkrPNRjzMozmDKOpsKi0mYdeH4GA//ADN74z/9cg55w6Y7zhtpcH9u989fDeXTolRcjFZWXOnbuPL/tzm8/nD359pUIWpY5szhF3YD6f/8LF7AsXm9L8uIXIZWK5rPb2LI/NumX01X0W/7T&#x2B;4OGzDrtbmxQz9c6xt91ydSuPEIQ9v59&#x2B;5qWvbHXMzNT7MwqAlgYFQHghDHJbiNuCAicKOHwsVCKRmt2QFInUWKhAHIgPhTy5vPwWp8zqSM/I&#x2B;33ldkJIdm7ha2//uHzJ3Cu6skzcr09aXQttIyMkw4b0MGTmteiqlGl3X7tsxbZqWeea6lrQHFzvXrVMgIBWZne4pJI2aH3Qvavuo/cfaf3PBR3Kjl0nLl6qpzU7CC0cTlglLKAA6ABoL3GYkcNcZc6bJ8MiFRIpL8eH&#x2B;BEIt32QFzTcPXeM2Xvg9LYdx/r0SunWJalPr5RNmw&#x2B;hBrfKarI4jfqXxS8hhLwt&#x2B;RCLz&#x2B;N&#x2B;PH/2rXfNbYlHZdeM7Nfs1wSN9cyLX&#x2B;49cEqv1aTq43Q6TbJek6zTJOs0sEoShIGTp9PbeggABAMFQEflsxGfDVmNAfEhDhIqLrctY/&#x2B;fB6uU2i&#x2B;hULD4i&#x2B;ccDrdIJKAoPO&#x2B;tmUqFLCen6OEHb2idAdTbjesKde&#x2B;qm/f2zGde&#x2B;KJ5L8sX8EJ6xWc4cTo8bCQ68GBsrHJg386ffPhYGw0KgGZQUlLlQQyPy5n3zqxOqQmWEuuOXSdOnILyALQxKABABUIjVxFxFaHA&#x2B;BBXgIUqJFRjkQKJ1EikwkIlonhtN0pQnURS3ksuQi559/UH23Ywze6WG66yO1yvvflDM17zjltHRUZAZdt&#x2B;mc2WI8cvtvUoQC0IIf8dPi&#x2B;RCLt31bX1WNo7qaxKvO3qEb1vueEq9uvhQ3s29mptuysDCEtQAICg/B5iz0P2vCo/e/gRWKREIhUWqpBIhUUqJIiANgWghUy9Y6xYKHj59e&#x2B;83mbIAikVMmi72xEwDDEYTTl5hez2i0plREK8KiY6NDb7b4fyTEUrVu1auWpnVk7BB&#x2B;/MhAKgXin6KlswX&#x2B;FWuVAAgGYHBQBoPG8Z8ZahMkNgfChghXFFbcBrg&#x2B;V9ICzdevOItNT4p1/4IsNgupLrUBReOP9RaJsa3o4ev/TL7/9u3Xa0zFq9HVtUVGTf3qkjhvW67tpBSgVsj1Y/j8e7btPBP1ft2nfgNNyDNtBb836hMK72B2znnhMmc7EmtgV3HwagUaAAAM2B0MRZiJyFqEp8SIhFaiRUYZESCdVIpMRCJaLgjxxoip7dk9f&#x2B;&#x2B;e6X36759qd1LqenCVfg8bjz35k1YlivZh8baCfyTEWvvvXDth3H6jqhsLB00&#x2B;ZDmzYfeuv9n6dMGvXE7FvVzdQPLvwcPX5p&#x2B;V/b/1m33&#x2B;6AFmONs//gmbPnMqsddLu8t93z&#x2B;kP3TRw8sGuKXhNaLcBBWIK7MdBi/G5iy0G2nICnRhgJIth6AIuU5dMFAjnEh0BDCAT8px6bPPWucUt&#x2B;&#x2B;/e35VuCtAmrqXOnxA/emdWjm77lhgfa1oH/zs58bEFd265X4/X6f/l988p/dj372O33TZuAMfwIKldQWPrn6l1/rtpxhbNtoCaz2fLW&#x2B;0sQQhjjOI1Kr9U88eikAf06t/W4QAcFBQBoTQR5SomnFKGMy1UBxcPCgBXGIjUWqhAX9gEEtVOrIp5&#x2B;fPITj966/&#x2B;CZLTuO7j945uKlHJpmaj2Zx&#x2B;UMGtj19ltH3jBhaL0NkkHo&#x2B;u/w&#x2B;XtnzWPj/g3ndHjemvfL/kPnPpn/qFDYoX/meLy&#x2B;rduPLl&#x2B;5feeeE9XaJINmRwjJzSvKzSu6&#x2B;YahUACAtgIFAGhrjI84C5CzAAXGh3hiLFIjQUU/Y5ESCZUIh1UPDnAlOBzqqqE9rhraAyHk8XjTDaa8vCJTvsXl9jidHrlUHBEh1ibF9uim6&#x2B;A3dh1BUXHZo0993Ni7/0r/bjn0wOwFP3z1fEtva9s&#x2B;nT5j&#x2B;GPljr/X7S0tq75kAgAQxjrizzsQAnxO4stCKCtgnTGF&#x2B;BFYzDYoYKsCFeLDMj6ABAJ&#x2B;ty7abl20bT0Q0DbemfdLsaURebCa9u0//fo7PzZtF11CyOGjF3fvO3n&#x2B;YrbJVOzz0zKpKDZamZIS172rbvCArpUb9bYrxRbr6r/3LF&#x2B;14/yF7LYeS7iZeufYQ0fPG43m9Iw8q83Z1sMBoHZQAIAQQRjkKSGeEoQuXa4KOHx20yEkVGGhColVWKhEHHjiC0BHcfFSzuq1e6/8OsuWbxs9os&#x2B;4MQMa/haaZv5as2vR16syswvqOofH4w4b3O2uKWPGjOp3hRtBNgufn9656/jvK7dv33nM76fbejjh6a7br7nr9mvYry0ltvSMPEOmKcOQl24wGTPNmVn58DsP2gMoAEAoo73EYUYOM6oSH5KWTxGIK/oZCyIRbvt/ekEIWbvyPYPRlJ6RZ8w0pxvzDEZzhtHU5JAJaDm/LNvcXJd6/b2frh7RW8BvUKPDnLzCp55fdORoPQ3LfD7/jt0nduw&#x2B;kZoSP&#x2B;eFqVdf1WabUF3KyPt9xbZV/&#x2B;xu1Op5cIWUCpmyf&#x2B;eB/S8H/f1&#x2B;Oie3MD3DZMjMS0tNaMOxgQ4OCgAQdnx24rMjq7FKfEigwGIVEirLawOhGvGhFyyok1wm7t0zpXfPlMojhJA8U5ExM/9SRq4xMz8pKbYNhwdYhJANm/8LcgKHQ904cVi/PmkMzZy/mL1l&#x2B;9GCgpK6TjaZLEv/2Hrf1PH1fu6Fi9nTHnq/sLC04UO9lJ5738x50&#x2B;&#x2B;&#x2B;9uXn72mTxQbzFy7bvPVw638uqIbL5ei0sTptLEJ923osoEML1QIARyYTZzHyWgOf/AJQO8IgdzFxF6PAPy4cPmY7l7FtCsQqLFAgDuzNDGqHMY6Pi4qPi2JXHoOa3G5PKy&#x2B;5TjeYgtyFiyWCXxe/EljFvfaS7413f1q2fFtdb1mydNO991wbfFfQwqLS&#x2B;x6e36i7/0o//7bJmGn&#x2B;6tOnQnRtOl/AG311n149Uuo/FQDQvoVqAUB1vQchhBg/cVuQy4LcRcRlQe5i4ipCfndbjw6EAtpLHCbkMFWpIPlyLKoIDolUWKRCfDnEhwBoiMzsgs5pia35iWfPV2&#x2B;3FOjxhycF3v0jhAR83jtzH7CU2DZtPlTrWwxG85Fjl/r3TQty2edf&#x2B;dpstjRhtKyde048/r/PvvrkmfawJKCB2Pv&#x2B;68cPHjOyn1gckqULAKCaUC0AylFcLI5G4mgU2ErK5yLuIuSyEHcxchUjdzFxlyDG33ajBKHDayVeKyozBMSHOFioRJebl6mwUI14ojYcIwDt0/qNB1q5AMjJKQzy6uSbR9Y8iDF&#x2B;45V7t2w7UlfviO07jwYpALZsO7pj94nGjrPmRT7/etWTj956hddpaUIRf&#x2B;Tw3nDf3zSlZY4Tp9L1Ok28Rg1NSEA7FOIFQK14IsxLRLLEgL9wBHnKCFsMuCzIVUxcEB8CDUNo4ipErkKEzl/&#x2B;48IVBsSHVOUtzKhw/NsEQIMt/nn9rbdcnZQQ3cDzr3xRtcvlqeulhDi1SiWv9aWYaOXwoT3quo/fs//Us09Oqeuyi775q7GDrNXnX/01fuyALp2SmuVqzUskFoy5uu/1EwaPvrqPQACpyCbKMxXdN3MeQojP5&#x2B;q0Gr0uNkUfl6yNTU6O1&#x2B;tiI&#x2B;SwCA20sVC9ZfH8sA8rJVgpoZRirJJQCjESBPleMBJEYkEkQimXq4Ly&#x2B;FAxclXEh9zFEB8CDeJ3E3susucGVJAYCSLYeqA8PiRUIYE8cGoKgPDmcLinP/DeV5893cD7Wpu9zi3Svb4GzdkGebCqVkcEeePA/l3qKgDOXsiiaabWfM75i9nHTqQHHxKfz42JUlhtzjJrsL5aNM3M/2jZ9189H/xqrQnu&#x2B;1uI1&#x2B;u/cDH7wsUq/RYWvP/IpBuHN/wihMDzStDMQrUAIGYbMdsQQpW76WKJAKkklFKEVRKskFBKCVaIUJB5t9rjQ87y&#x2B;JDLgtzFyFVM3BZEYMteUC&#x2B;CPKXEU4pQxuWf0xS3ok1BZXxIhbjtsSsQaM8GDez69adPZ2Sy25LmZxjyLCW2th5U7bJyCm6c/MqN1w2deN3Q3r1S1Mran8EjhDwe74VLOXW9WlJi83i89d6Gcrh1dgevK&#x2B;HDSkqKqXNgbl&#x2B;euTgxPqrmSxvrWDnAoij83NN33Dd1goDPI4ScOZe5&#x2B;Kf1q/7eXdf523cdP3Mus/00sLvvnvH/e3JK8AXQoLkwNNxXgDYWqgVATcThQQ4PnRVwiMI4QoRVEqwUY6WEUomxUoKlQYOMPDHmJSFZUu3xIScbIipGXhvEh0D9GD9xFiBnAarSpkCMhYFtCpRIqES4zvsYACLkkmoNqsqsjgyDyWDIy8g0pxvyiorL2mpsNdE0s&#x2B;qfPav&#x2B;2YMQ4nAonS62b6/UZH1csk6j18bGxqpkUpHd4VrwyXKHo84ZV7&#x2B;f3nfwzKgRfYJ/llJRZ4FRErRGClKZIIQKCkprLQAOHT4f5F2PP3LrrPtvZL/GGHfvqvvo/Ue6dUl694Pf6nrLkqWb3nvjoSDXbE1ffrsmMyv/g3dmiUQQ9wcg/IVPAVALhpASJympOsss4GKFuLwkUEqwWkxFNiE&#x2B;5KuIDxUTdg8idzHy15lGBeAyn5P4spAtq0qbAn7E5bZlQmVFfAiA2kXIJX17p/btndrWA6kHTTPp6Xnp6XmBB7lcTkM6oX706fKhg7sHb8sVG62o66WcvKIyq6OupDU/6GUtltoLqnMXsmo9jhASiQUP3Tex5vEH75u4Z9&#x2B;puuJGGzb99&#x2B;ar9/PqnsdoZes2Hsgwmr75/JmEuFrqHwBAOAnrAqBWHj8xW4nZigLjQ1IBKl9OIMYKCaWS4Mjg8SEeFscgcQyqPT5UMVHgLoH4EKgfYZCnhHhKELpUpU2BQIHEaiRUYaESidVYqEQceDIHQl5D7v4RQqfOGO996P3578wKsqo4NWgj1V17T94wYUitLwmFwcJFvtpG6PF4g8y0DBvcra59ch6deUtdBUCZ1XH8xKUB/TrX&#x2B;mqbOHc&#x2B;6&#x2B;bb53zz&#x2B;f&#x2B;C74UKAAh1Ha8AqA2xe5DdQ2cFbO1MYRxZvpwAK8VNjA8RBnnLLgeH3JaK3YcAqA/tJc585MxHVeJD0vIpApEaiVRYpEQCBbQpAOHq4KFzY65/dvTIvmNH9&#x2B;uclti1s5bPr/JvVlJClFQisjtctb59yW&#x2B;b6ioAgnO5askmebzB1iV366yr66WB/TurVRF1FQ8HDp1rnQLgofsmXryUk5mVX&#x2B;&#x2B;ZJaX2qQ&#x2B;&#x2B;8/mHT44ZDa1qAbgszFbIQAFQB4YQi5NYnAgF7DPNxodUYkopwUoJVokphRjx6/49xBQSKLBAgVBq9fiQsxi5i4irBOJDoBF8duKzI2tmlfiQQFG&#x2B;&#x2B;5BYXR4f4kvbcIwANCOaZjZvPbx562H2l1KJaGD/zp3SEpJ1cTptbEpy3PCrem7YdLDW9/53&#x2B;Pzf6/fdeN3QVhinOirYpkN9eqdWfgvVnDpjaJkRVTewf&#x2B;cNq95f&#x2B;PmKxT&#x2B;tD75CGiHkcfseeWrh/Hdm3XLDVa0zPADaP4oKq8dtUAA0RkV8KPBnZ3l8SBWwrqAp8SFHQHDIAvEh0FCEKd/BFl2sEh&#x2B;q2aaAA/v6gSvF&#x2B;IPdOKamxF9Kz23RAdgdrm07j23beazySPB&#x2B;us/P&#x2B;To6KnLwgK5X/tHBk/rioJkiXd2bDl2seyukZicQ8F989u7rxw9&#x2B;8n&#x2B;fZ2YXBD/Z76f/99KXAj7vumsHXflHW21Op9MdG6O88ksBAJoFFABXqpb4EKdi9yGFBKvEbKcCLAkeH5JgngTJg8SHionLAvEh0CC0lzhMyGGqslMVX14RH1IhoQqLVYgfAfEh0Ch2Z5379giEvCXfvfjg7AWnzxhbcUT1bPfpcfum3v/ujGkT7p9&#x2B;3RXefYpEAr6AV1fzMocz2CxukKYE2TmFhJDWjBb06pHyz5/vzXlj8eq1e4OfyTDkqec&#x2B;F4ufHTm89xV&#x2B;6IGDZ2Y9sVAsEeiTNCn6OJ0uNlmvSdFp9Lo46DEMQJuAAqAF0EHiQxJKKcZKCVZJKIWo0fEh2ks8JchZVNHSuIi4ixHtbclvBoQLr5V4rajMEBAf4iChorweEKmQSImFasQTt&#x2B;EYQTtXV9oeIcTncmOilSuXvrnk100//LIhN6&#x2B;oaR&#x2B;RlBDtdHmacWNTmma&#x2B;&#x2B;3Hddz&#x2B;uS02J75SakKKP02ljmtZVKV6jMhjNtb4U/PvlceqcPfD5/EXFZVHqyKYMqKkkEuHC&#x2B;bOHDun&#x2B;6ps/&#x2B;IL2XPP56YefXPj7T6/26pFy5Z/rdHhOnzWePmsMPBgTo/x18cvJes2VXx8A0HBQALSWWuNDssrdhyRYIaZUEhwRND7E4dcSH/LaiZsNDhUht4U4i5GnFOJDoH6ERq4i4ipCgeuMuQIsVCOhCouVSKhGIhUWKhAVbM9E0HGUldXZ3VapkCGEeFzO/fded/&#x2B;91x05fnH133syDCaMcX5hiTHTHPxGk9W9q&#x2B;7LT586fz7nocc&#x2B;bM5xI4QQupSee4UJpbTUhLoKgENHgrUICK60zNHKBQBryq2jknWaR578uNgSbG7Z4/bNfHzh38vfbqFB5udb3B54jAVAa4MCoC0RmwfZPHRm1fhQpAgr2fhQxdKC4PEhvhTzpUiurRIf8pRWLCeoqAp87bR1KGhf/B5iz0X23IAnpBjx5VXaFIhUSBARWISCjsDvpy/VHVhXKGSBv&#x2B;zXO61f78v7SNI0k2cuTs/INRjNxkxzrqnIZLbk51t8Pj&#x2B;Xy4mKUvTorrtu7ODRI/tQFE6Ii3pjzn1vvPsTw7Svfou9e6ZuqqMZ8NHjl85dyOrSKakJly0rs1/ZuJpuQL/Of/3&#x2B;5v0PfxC8NCooKHn06U&#x2B;W/jCH225aFgAArhAUAO0MTUixkxRXiQ9hIRdFirFaQinEWCXBKgkVKUb8un8QYwoJlVioRIH3aLSXuC3IVRkfKob4EGgYgrxlxFuGUMbl2zGKi4VKJFIiobqiTYEKcYVtOErQ0k6eNtS6QT4rMb7O3foRQhwOlRgflRgfNWpEgz5r2l3jEhOi5rz5fV5ecWPH2XLGjOzzwcJldb364qvfLvtpjlDY6ER7vXvytKiEuKjff37t/ofnHT&#x2B;ZEeS0w0cufPvD2kceuqnVBgYAaFFQAIQA4vajuuJDKglWirFCTKmkOEJYT3xIEosksaiu&#x2B;BDb1RjiQ6AhGD9xFiBnAarSpkAUEB&#x2B;q2H0IwyPDMLFk6b9BXtXrYpv340aN6LPlnw&#x2B;Xr9q5ctXOYyfSm/fiTdMpLbFzp8TzF7JrffXEqYypD763cN7sxPgQa6OriJT&#x2B;/N3LD83&#x2B;8OChc0FO&#x2B;&#x2B;SLP68dMyAlOa7VBgYAaDlQAISqOuJDAc2MlVcYHyomzqLyPUl9bTZDDUKJz0V82ciWXSU&#x2B;JIjAIhUSqcpXGwtVSCBvuyGCpiCE/PDzhlV/7w5yTq&#x2B;ezbBItBqBgD/1jrFT7xhrtTn/XLVj/39nbTaXz08bM03FxW2zJdr0u6995fXFdb165OjFsdc/O27MgOHDenZOS0zWayLkktYcXpPJpKLvv3z&#x2B;jnvfDLKJk9frn7dw2TefPdOK46rFxUs5fD4vPk7dofJIDNOW00QgLEEBEEZoQoodpNiBUGHlM3ws5KLK3UiV0vLmZbyGxIfSAuJDHuIuQc4idroAuYqI2wLxIdAABHlKiacUlaYHxId4WKhEYtXl&#x2B;JBAibiwFWB78deaXZ8sWpmYGB2ljpRJRS6357/D54N3kMUY9&#x2B;vTqeWGJJeJZ0y7bsa06yqP2OyuDENehiHPYDRnGE0ZRpMh0&#x2B;Rx175HZzO6fdLIb77/J8jvhs9Pr9t4YN3GA&#x2B;wvFZHSlOR4l6sZWj0yQbcucnuv9HsXiwU/fPX8bXfNzc4trOuczVsPHzuR3qdX8xd7Dff1D/&#x2B;sXLWLx&#x2B;UkJcXodZpkXWyKPp7tCqesuhAFABAEFABhjrj9yFRGTGVV4kNyIWI3HVKKsVJMqaRYHjw&#x2B;JGDjQ1XO8NrK40OVzQo8pYjAUwpQH8ZHnPnImY&#x2B;qxIckWKRGQmX5/4tVSBAJ8aE2wTBMVk5BVk49jaIC9e/bKTKiVR91y6Si3j1TegdMOxBC8kxFxsz8dLYqMJgMxrxcUzFp2pafdeByOe&#x2B;98eA997/bwMuWlNrr3SCozFrn3kqBMrOD1WANvEhwalXEt4uevWnKHK&#x2B;3zi2bfv5tU59ej1z5Z10hn59Oz8hLz8gLPBgXp9r976dtNSQAQgsUAB0RsbqR1V01PkRhhQgrA&#x2B;JDKgkWB&#x2B;0dy5dhvgzJdVXjQyXEGbD7EMSHQAP5HMTnQNbMgDYFFBJEXm5bJlRioRrxpW04RlCXW24c3tZDQBjj&#x2B;Lio&#x2B;Lioq4b2qDzo8XiNWfkGoyndYMow5hmN5vSMPKvNeSUfNGRQt6cfn/zRp8uveMjlHmY7ZGk1QgFfJBR07Zo0fszALp2SAjtkud2eP1ftCnKRs&#x2B;cym2UwndISX37untff&#x2B;amuE9Zt3P/6K/fKZe2xYYjNGuy/bGmZ48xZg04bq4lVNarz2sX03KXLt1Z0LtNAP2MQHqAAAAghhGiGFDlIUV3xIQlWSbCyIfEhFRaqUJXdhzzEbUHOIuK2IHcxchVDfAg0CGGQ20LcFoQuXq4KOHwsVCKRGosq2xQoESdopQpamCJSeutNV9V7mslcvHXHsdIye3yceuTw3orI1qjlBAJ&#x2B;57TEzmmJgQctJbaK7FBeusFkMJqysvKDbHBU0&#x2B;yZN5eU2n/4eX1zjdPp8FSG73fvO/nt92sRQjExyoR4tVoVIeTzDhw&#x2B;ZzZbglxh3YYDzz99Z7MsOZh217i/1&#x2B;87fORCra96vf4t2w5Puqlh2zm1J3mmoqkPvIcQEor4eq0mWadJ1ml0utjU5Di9TiOViOp6o8Vi/XHJhspfisSCZK0mWafR6zV6nWb01X3aZzkEQHBQAIA61RIfwgjLhEhZ0aCAnS6IEKIgT1M4AizRIImmyhkeK1sPVKw2LkbeMogPgfrRXuIwI4e5SvyCJ6uyzlisQvwIhKm2GmNH89Rjk&#x2B;vd&#x2B;/Lzr1d9sujPyv0uBULeIw/ePHvmzRxOG/xnUipkSkXnAf06Vx6haSYnryg9I9doNBsyTXEadfArYIxffWFqfKzq/Y&#x2B;W&#x2B;htTOTRKfr4lPz/YTX&#x2B;gMqvjiWc/X/TxE0FuZBsIY/zEI5PufWheXSf8u&#x2B;1IKBYAldwu79lzmdXmTD6a9&#x2B;gtN9RfxyKEXM4q/YyX/jhn8MCuzT5IAFoaFACgMUhFfMgYsDl3eXxIgsu7Gouxsr74kECOBXIUERgfopG7hLjYqqAIuUuIqwj5miHVCsKfz0Z8NmQ1BsSHOEiouNy2TKjCIjXiwVO65jdkcLe7p4wJfs6yFduqBWY8bt/Hn68wGk0L3n&#x2B;kMoxBCNm05dCW7UdsdldSQvR11w5utcWmHA6lTYzWJkajkY141/33XjdkcLfX3vrhyLGLLTa0Rti198Q11//v/ukTrhs3SJsUcyWXumpIT7lMXFdWauee4x6vT8APqwbhtL/&#x2B;TtUAhBMoAMAVuxwfQgHxIR5SVDQvU0uwot74EAeJ1FikRnXGh4qQs5h4SiA&#x2B;BOpHaOQqIq4iFLjOmCvAQhUSqrFIiURqJFJioRJRYXUT08o6pSV&#x2B;vuCJep/if/XtmlqPr/pnT9&#x2B;&#x2B;adPuHIcQcrs9Dz/x8c49Jypf/faHtTddP&#x2B;z9tx5sQmutVtOti3bFr6/v2H38p1827th9onkXHDdBUVHp/I&#x2B;Wzf9oGY/HlcvEaanx48cOSkuJa2zwnaKwUimvqwBwOjybtx6eOGFI8w0cANDaoAAALYK4fUHjQxKsFFPKJseHistXGEN8CDSc30PsecieV&#x2B;UejR/B1gNYpERCFRapkCAisAgFdRk/buC8t2bWm34uLXME2VDo869W3X37GA6Hen/BssC7f9aadXsLLWU/ff1CO9/xfeTw3iOH9y4sKt2y/ejefaeOnLjY5g2MfT5/scVafNC6/&#x2B;BZ9kjN4LtOq5FJa88LFRSW5tS9GShC6MdfN0IBAEBIgwIAtJa64kPKyuUE4vLdh0QNiQ/pq8aHLMRlCdh9qAj5rmijD9BReMuItwyVGQLaFHCxUIFEFW0KRCosUiOusA3H2MooKtgTfS6XM3RQ9/vvnTByeO&#x2B;GXS1YNVVYWHrqjKFrF&#x2B;3yVTtqPWHf/tPf/rD2kYduashnta0odeSdk0ffOXk0Qshqc6Zn5BkMeYZM8yVD3o7dx92uNp66rDX4rlZHJutik/WaZJ1Gr41LTFALRYL0jLyPPl0efG3D4SMX/t1yaNyYAS08agBAS4ECALQpmiGFdlJoR4HxIREPKcRYxa4okGKFiFJKELfumxLMQaIoLIpCgU9u/R7iLkauIuIuQa6i8t2HmBbvEwRCHuMnzkLkLERV4kNCLFIjoQpHpiJBhBNHi0RcihOeEwWTbhox6uq&#x2B;GQZTTl5hnqnYbne43D6RkK9UyFKS4/r0SmvUlv9ymTghTp2TV1TXCQUFJRFyictZZ6us735cO/P&#x2B;G9pkuXCTyWXivr1T&#x2B;/ZORQjRNNN76IMt91kCIa/JHdCKikqLikoPHjrXhPe&#x2B;NPe7zp2TkhKiG3IyHbSRbZtHpwDogKAAAO0OcfmQq4zkVY0PyYVIIaHUEqyobF4mCBYf4gqwNA5J42qLDxUTVzFyFROXBeJDoEH8bmLLQbYcLNdiWbwEobJS7749hVIZTyrjyqQ8WQRPJuWKxGHyE1URKe3fN61/37Rmudpdd4z9YOGyul6NilJIJMEmWEpK7ecuZHXvqmuWwbS&#x2B;E6cynI46y5vOnRKfeOTWSxm5GQbTnn2nii3WRt0NjxrR&#x2B;4Vn77o5aOuuFmIpsd0x/a3PFzzRkD8nxRZbkFetzdHFDICW1qj2Ee1fmPxzBcIcQaTMjcqqxoe4FFsMYKWEUrLNy8RNiA8RtwW5LMhdRJwW5LYQN8SHQIM4HH6Hw59vvnyE4mKZlCeTcaUynkzKk8m5UhmPxwulR9ct4f5p4/9Zv6/WTlUJcepePZIpCiclRAdZKuBwuFtygC1r1ZrdQV7t0U1/3bWDAo8UFpUZM82GTFN6Rl6G0WQwmnJyC6vd32OM&#x2B;/ZOvfv2a265aQRF4ffefOjZF79skdEHlZ9vmTLtjWtG9RkyoFu/vp1690ypK/F19ESwjZKycgqHDm6ZIQIA6gAFAAhZ/vriQ2opjhRTSnHw&#x2B;BAWRSFRFEKdq8aHKlJDriLkskB8CDQE4ydlpd6y0ippb4GAI5XxZHKuXMaTSHkyOVci4QZPxocZgYD/87cv3jdrXmWvKxaPy5n/ziz2t2LG9AlvvPtzXVdISmxQzqQdOn3G8PvKbUFOqDmzEaWOiFJHDOzfOfBgUXGZyVzsdHq8Pl9khDRZFxc4bTLpxuFCAf/5OV&#x2B;3fqVECNmy7eiWbUcRQhjjhHh1t666VH2cXhur1WqioyMRQtt3Hfv7n71BLrJ52&#x2B;E7bhvVKuMFAJSDAgCEldriQxjLBUgpoVQSrBBTKjFWSrFcGGyjF64AS&#x2B;ORNL5qfKiMuC3IxTYvKyIuC/KUBabEAaiVx0N7PHRxQAYeYySW8OQynkTGlcl4UhlPLucKhe16o5srpFLKV/z6&#x2B;m/LNq9Yvevc&#x2B;Sy&#x2B;gDu4f9dnn7y9Z/dk9oSpd47buv3Yrr3VNwJCCF19Va/YGGXrjrd5HPjv7OynPwkezmHXCdRLrYpQqyKCnHDdtYP69Un97Mu/Vqze5fW0zdMKQkh2TmF2TuHGRr5x6/aj23YeG311nyscgMcbto9pYJkEaHZQAIBwR0h5fMhQNT6kFGOFGCul5c3LVBIsDLolvCACCyKqx4dcFuSuWE7gLibuIuRztdh3AsIEIchh9znsPmS6fJDDpWTl9QBXJuPJZDyJlBtO8SEBnzdj&#x2B;nUzpl9X66scDvX1Z08989JXGzYdDDweH6d&#x2B;/62HWmWAjXDxUo7d4dZpYxWR0pqvOp2evftPLV&#x2B;1898th4JfRy4T9&#x2B;imb65RxUQr3577wMvPTf132&#x2B;HfV2y7lJ7rdLndLi/T7u8dCSEPP7HwmScm33fPeIEgaIwTIau1zoim1&#x2B;t3uTwiUfttHAFCWpiVYVAAgA7Jz5ACOymwI1RQJT5U3qBAjNXS8uZlweND4igkrrb7kJtcLgkqdx&#x2B;CHpOgHrSfKS3xlpZUiQ8JhRypjCeTcWVyHvuFRMINs4VolYRCwRcLn9y198TqtXsvXswRCvlDB3e/f/p19bYaaH1rNx749IuVCCGJRKiJVSkVMrlcghCy2Zxmc3FWTmEDbxRGDu/d7LsbicWCmycOu3niMPaXXp8/M9NsyDSnG0wZhjxjljk9Pbe0rCmLbh9&#x2B;8EZtUuxLr33brOMt5/P55y1Y9tW3f18zum9SQkxaSvyIYb1ksuptCtxuz7Hjl4Jc58TpjMEDurbECAEIvkVyyIECAIByxOVDuaUkt7RGfEhKqcRYIaZUEqyU1BcfEtaIDxHksZa3LSv/f4gPgQZxu2m3my4K6MiEMZZKudKKiQI2PiQQhE98aMSwXiOG9WrrUTSUw&#x2B;G&#x2B;lJ7b5LffctPwZhxMrfg8blpqQlpqQuDB0jJHekaeMTMvw2hON&#x2B;QZM/MNRpPPV/tzCozx0MHdn5p964B&#x2B;nRFCZ89l/vzbphYabZnV8dfqy2umIyOkXbokJSVEx2nUsTEKj8e3&#x2B;p89RcVlQa7w&#x2B;5/b6yoASNCtSGkGfiCDjgUKAADqdjk&#x2B;FHCwMj6kklLKiuZlweJDuDw&#x2B;hJIvVwWMn7hLUOVyAncxcRdDfAjUixBis/lstipZZy6Xksp5cnb3IRlPJuNKpTwONzwnCsKGNjF6xLCebfLRkRGSatu8MgzJNRVlGPKycwvNZovT5cEYqxQynTZ2YP/OUerIyjNff&#x2B;XeyEgpOwHS0krL7PsPnNl/4EzD37Jqze7rxg6stUOZuaA0yBttNtj8DXQsUAAA0Ei1x4f4SCnGKnFF8zIxpRSjIJP7FLf2&#x2B;FBlzzJ35e5DEB8C9fD7mVKLp9RSZbN5kYjL7j4klfHkMp5UxhWLuWGaHgpJTz42mcttL1M3FIUT46MS46MacvJTs28b2K/z3Hd&#x2B;zDCY6j&#x2B;71T32zKcPP3jTvVPHKxWyyoM0zSxdviXIu4L0qgMgLEEBAEAzIC4vyvVWjw9FCLFSglViHCmm1BKslGBZffEhWQKSJVSND5URVzFyW8rjQ85i5LVCfAjUy&#x2B;Xyu1z&#x2B;woC99TGFZTKeVHp5qbFUxhMIwirVGipGj&#x2B;xzyw1XtfUomu6qoT02rp6/ZfuRNWv3bt91zFl3I&#x2B;cgBELe&#x2B;GsGrlkXbIfQJvD56c&#x2B;&#x2B;&#x2B;uurxX/36pncNS0pMlKKMd6682i1XWir2bn7OMOQDrU/L&#x2B;jgoAAAoGUQQkpdpNSFMgIO8jhYIcYKUXl8SCXBSnF98aFILIhEKKVqfIhtXlZIXCXIVUTcxcgfwp2SQOsgDLGWea1lVdYZ83iUTF7RvKyisTHFgdugFtSlc9LH8x9r61FcKQ6HunbMgGvHDEAIXbiYs/7fAwWFpX4/nZmVn2EwBU/qI4R02tgF7z3SravWmGU&#x2B;cSoj&#x2B;MlN4PP5Dx&#x2B;5cPjIhQaebzCav/953YP3TWz2kYCwEWYbMEABAEAr8tGkwEYKbNXjQyq2n7EYs80K6o8PRSNxNEJdLv808rlIeWqoGLFzBe4SiA&#x2B;Bevl8jKXYYymu8gRXLOFK2U7GUp5cXh4faqsRhpmrhvb4/KMnZNLq&#x2B;9uEtE5pCZ3SqqwzttldBmNeekZerqk4z1SUl1fscLlpPx0ZIU1LTRg&#x2B;rMdVQ3qyj9sXf/lczSZxbeLdD347cz5r1v03dE5LbOuxANDi4Gc6AG2MuLwox0tyao0PVTYvk2C5MMhFEE&#x2B;EeYlIllhbfKiYuCpamEF8CDSA0&#x2B;F3OvwF&#x2B;ZePUJyK&#x2B;JCcJ5WWzxjw&#x2B;RAfagSVUv7UY5Pvuv2ajpAzkUlFvXqk9OqRUu&#x2B;ZKqV8xS9zP/psxY9LNvj8dL3n1wpj3Cx7tK9as3vVmt3R0Yqe3XXJuriU5DhdUqylxHblVwagvYECAID253J8KGBdGo&#x2B;DlWIcKcZqCaUQY5UEq8RY0Nj4kK989yFXwO5DEB8C9WFoUlbqLSutEh/iCzhsakguq2hTIOV2hLvbnt2TrxnVNz0jLy&#x2B;vqN57VrFEMHxoz/FjBlw/YYiAH7TbYEclEPBf&#x2B;t/d90&#x2B;f8MfKHStX78rMyq//PQH4fO6C9x7ZtuvYylW7mmU8BQUlWwpKtqCjzXI1ANonKAAACBE&#x2B;muTbSL4NnUdV40MSrBRTbDPjyHrjQ7yK&#x2B;FDAamSfszw&#x2B;VNnY2G1BpImP4kDH4fXQxR66OKBKxRiJxVyZnC&#x2B;VcmQyvlTOk8k4IlG4/UMzZlTfMaP6IoQYhuQXWLJzCouKy0rLHGVldo/XhxDi87iRkbJodURaakJiQnRHKIquXEy08vGHJz3&#x2B;8CS73bVh00FjVr6f9hsy83NyC3NyCmz2WnZJlkpE144bMPuhW/S62HFjBvi9dLMvKQYgXIXbz2UAOpSK&#x2B;FDJ5fgQhbFciNmeZQoxpZZghbi&#x2B;&#x2B;JAY85KQLKmW&#x2B;JCr&#x2B;HILM68N4kMgOEKQw&#x2B;F3OKosPuFwKZmMy3YnKN&#x2B;ZVMrj8cIhPkRRWBOr0sSq2nogYUUqFU2&#x2B;dWS1g1abM89UVFBY6nS6aZoRCgRJiVE6nYZXsZUqn8ddOP/RHt11Cz5b7nH7aly1Ts0VHwIgtEABAEB4YSriQ&#x2B;k14kOVzctUYqxsWHwoslp8yILKqwILcrO7DzVl&#x2B;z/QodB&#x2B;prTEW1pSJT4kFHLYfsZydlGBnCuRcMNskw3QjOQysVyW1KVTUpBzMMYP3jfx&#x2B;vGDv/hm9YrVu7ye&#x2B;ssApUL25SdPvzP/l5bYiQiA9gwKAAA6gMr4EMq/HB8SV8SHlGKsklAKCVaIUZD9HykeFscgcQyqPT5UMVHgLoH4EKiX20273XRR4eUjGGMJ26OgYqmxXM4VCNtLqywQKuI06rfnPvD8M3dt&#x2B;Pfg1h1HDxw8W2Z11DyNw6FuvG7oi/&#x2B;7Ozoq8ttFz06Z&#x2B;kZmdkHN09oJmKNoD8LsCQUUAAB0UMTpRU4vya4tPlS&#x2B;&#x2B;xDbvEwQ7Co140OEQd4y4qysBywVuw8BEAwhxG7z2W1VntpyuZRUzpMHtCmQSnlcblj9Mxx&#x2B;zPmWP1fvOnsuUy4X9&#x2B;&#x2B;TdsN1QwUCfiuPQS4TT7l11JRbRyGEsnMLL1zMyS8oKSwqdbncMplEmxQzbHD3ylbBUerIFb&#x2B;98dTzi/bsO9XK42wgKABAs4MCAABQodb4EJ&#x2B;DFWKsFGNlZXxIggV1/&#x2B;jAFBIosECBUGr1&#x2B;JCzGLmLiKsE4kOggfx&#x2B;ptTiKbVU&#x2B;aMiErH1AFcq58ll5W0KwuvZXAjbsu3IE89/7qroDbxs&#x2B;bYFn634ZP5jA/t3bqshJcZHJcZHBT9HpZT//O2Lazce&#x2B;GTRn&#x2B;kZea0zMADaEBQAAICgvEHjQyoJVkoohbgp8SGvg7iLyqcIyv8f4kOgfi6X3&#x2B;XyFwbkNTCFZdKKqkBWvqhAIID4UGszmYsf&#x2B;9&#x2B;n1dbgms2W6TPf&#x2B;/HrFwYP6Fp5cMO/B5f&#x2B;sc2YaYqMlA4b0n363de2&#x2B;VpqjPENE4bcMGHIoSMXNm35b9&#x2B;BM&#x2B;cvZvub2poAgHYOCgAAQKPVHh&#x2B;KEGKlFKvEDY0P8SWYL0Fybd3xoWLiskB8CNSLMMRq9VmtVe47eTxKJi8vCSrjQ5wgZSq4YitW7ax1Bx6P2/fU819sX7&#x2B;AzQK99uYPv/y&#x2B;mX0pO7fw5GnDkmX/zntz5sQJQ1p1uHUY0K/TgH6dEEJenz/DkGcwmtMNeYZMU0ZGnsFottqcbT1AAJoBFAAAgObAEFLiIiUulB5wkM/uPiTBKgmlKG9hhhobH6K9xFOCnEUVLY2LiLsY0d46LwIAQgghn4&#x2B;xFHssxVXiQ2Lx5YkCuZwnlXFFIogPNZuLF3Pqeik/3/L3un2TJ43csv1o5d1/JafD8&#x2B;Rzn8tk4quv6tXCY2wEPo/bpVP1rYeKLdYMg8mQacow5GUYzVJJ0E2WAWivoAAAALQYL03MNmK2IRTQvEwiQErx5fiQUowjg8aHOPza4kN24maDQ0XIbSHOYuQphfgQqJfT6Xc6/QUBrWYpDpZJeVIZVybjsTuTymQ8Pj8c2hS0PqlMFOTVvQfPTJ40cs0/e2p9lWHIS3O/3bZ&#x2B;IZ/Xru9MVEq5SilvwyUNADSLdv3XDAAQfojDgxyeWuJDKinbrIBSS7Ci3viQFPOl1eNDntKK5QQVO5P6bC33jYDwwNCkrMxbVlZlTonP58jk5cVARXyICw196zWgT6dly7fV9arD4UYI5eUX13WCyWTZsu3IddcOapHBta7UlPg1y99ON5gMhjyD0ZxhNGVkmirXRgPQ5qAAAAC0tcr4UCA&#x2B;FytFWFkxS6BqQHxIqMRCJQqcKKC9xG1Brsr4UDHEh0BDeL10cRFdHLAbFsZV4kPs6gKRCP4NrWLidUPmffx7YWFpra8mJkQhhBSRsiBXOHEqPTwKAD6P26Obvkc3feBBc77FmGm&#x2B;ZMjr0lnbVgMDgAU/vAAA7ZLXX3t8SCWhlCKskmCFhFJKsEKEgjyX5fCxJBZJYlFd8SG2qzHEh0B9CEEOh9/h8OebLx&#x2B;kuFgeEB9iawMer&#x2B;PGhwQC/oL3Hn7g4Q98NTbPoSg8&#x2B;ZarEUIjruq5eevhuq7g9YXz38TYGGVsjHLIoG5tPRAAoAAAAIQONj5EZwUcojCOEGGVBCvFWCmh2DYF0ibEh0qIy4LcxcRZsTOpz95S3wYIF4yflJZ6S0urzCkJhByZlCeVc&#x2B;VynlTKk8m4YkkHig8NH9rzy0&#x2B;ffvbFL6v1333luXvY1bRTJo388ts1ZrOl1rd3SUtsjVEC0OFBAQAACGUMISVOUlJ1Yz4Bt6J5mYRSSrBaTEXWGx9SYaEKobSA&#x2B;JCHuEuQs4idLkCuIuKu/ZYFgEAeN&#x2B;1x00VV4kNYImFnCbgyeXmbAqEwbNsUXDOy75Z1C35Ztvm/w&#x2B;dKy&#x2B;xpyfF33zGW3VgTISQQ8D/94PFpD71bc8PQ2FjlDde1i51AAQh7OET7S5tf&#x2B;L2thwAACCVYKkDlywnEWCGhVBIcGTQ&#x2B;VCvGhygeQsjtpo/8Z7HZfA6HP0R/ioK2xeVSUhlPLudKpZXxIS6X21HiQ0ePX3r2pS&#x2B;NmZcDVdHRisVf/K97V13bDaqdioiIdLvdVit0RGljcrlcJAq2z1VogQIAANBRURhHli8nwEpxg&#x2B;JDNRBC7Ha/3ea3231Wq89u89tsPo87nHPMoOWIRFyplCuVl&#x2B;8&#x2B;JJNxxRJeuLYp8PvprTuOHjl2weX0du6cdPPEYRLYU782UAC0ExEREUJh&#x2B;PwRhQIAAAACsPEhlZhSSrBSglViSiFG/MalJX0&#x2B;xm732ax&#x2B;u91nt/lsNr/N5qP9IfnDFrQtTGGptCI&#x2B;JCuPDwkEYRsfAjVBAdBOhFkBAGsAAAAggMdPzFZitjIBx8rjQyoxlRZFaeRYwEOcYFENHo9SKAQKRZXJBJfLb7PRdqvPZi&#x2B;fKHBCfAjUhzDEZvXZrFXi8jweJZXz5DKuVMqTyXlSKVcq43GCdNMDIQ5&#x2B;UIBmBwUAAADUg9g9yO6hsyz00ZzyQ1wKy4Xl8SGVmFLWHx8SibgiETc6&#x2B;vI5DEMcDr/d5rfbfFabz27122w&#x2B;jwfiQ6AePh9TUuwpKa7SVUokZoNDXKmMJ5fzpFKuSMwN1/gQAOAKQQEAAACN52eIxUksToQKLx8sjw9JyusBlYRSiILEhygKs1FvhC4vLPP5GDY1ZLf5bDaf3ea32SE&#x2B;BOrncvpdTn9B/uUjmINlUp6sok2BVMqVyXl8fkdZZwwACAIKAAAAaCa1xodklbsPSbBCTKkkOCLY7kM8HqVQChTKmvEhv83qs9t8djtts/mcDh&#x2B;EAkBwhCbWMq&#x2B;1rEqbAh6Pksv5UjlHJuPJZHyplCOV8TpOmwIAACtUFwEX7zrNWJyk2E5KXMTiQH6m/vcAAEB7wME4UoSVbHyIbV4mxpLG7T7EMMRh99sq40M2v83m80J8CDQexkgs5kor1hnL5DyZjCsSwfPB9iIiItLlctlstrYeSEcXZouAQ7UAKC0tufwLgojNTSwOpthJShzE4iTFDlLmRqH5rQEAOiI2PqSWUAoxVkmwSkJFihG/cZu9eL2M3e6zW/12u8/G7j5k9zEQHwKNR3ED4kNSnkzOlcp4PB7Eh9oAFADtBBQA7UKVAqBWNENKXEyJk1gcTLGDWJzI4iQOTz3vAgCAdqM8PqSSYKUYK8SUSoojhI1tXhYYH2JnDJxOf2j&#x2B;4AdtTCDgyGQ8qZwrl/EkUp5MzpVIuBAfamlQALQTUAC0C/UXALUhHj8pcZIiB1sYEIuDWFzI62/24QEAQIvgYBwZ0MxY2cT4UOVagvJ1xlaf1wvxIdBoGCOJhCeT8SSyiuZlcq5QCG0KmhMUAO0EFADtQtMKgFoRm4eUOJhiJ7FUVAWlLsSE5G8LAKADwkIuihRjNbv7kLS8eRmv8fEhdorA7rNZfXa732bzMTT8JASNxuFSsop6gF1XIJFyIT7UZFAAtBNQALQLzVgA1IIhpNTFFDtIqZMUO5hiJypxEBvEhwAAIQPLhYjddEgpxkoxpZJieePjQ06/zea3Wn12u88O8SFwBYQijpRdVCDnSWU8uYwrlnAx9CloACgA2onIyEiBoHHTre0ZFAAN5qXLg0PFDqbESdiqwA3xIQBAiOBQWCHCyoD4kEqCxfxGXSMgPuS12fx2q99m83q9sA8baDRMYakkYPchGU8m5woEEB&#x2B;qDgqAdgIKgHahDQqA2hCnlxQ7iMXJVMaHSlyIhn8LAQChAQu5qLyZsQSrJFjZxPgQu5YgsHkZxIdAE3C5lFTOk8u5UimvvLGxlMfhduiJAigA2gkoANqFdlIA1IIhxOpmKooBpsiBLA5ic6OQ/G0GAHQ8GGGZECkrGhSw0wURQtTItIbT6bez8aGKpQUuiA&#x2B;BJhGJuZVbkcplPKmMKxZzO056CAqAdgIKgHah/RYAtfLRTImLlDhJsZ2xOInFiSwO4vK19bAAAKBhyuNDElze1ViMlY2PD9HEbi/fitRm99mstM3q9flgyhQ0GqawTMaTSrkyGU/KThTIeAJBeK4zhgKgnYACoF0IsQKgNsTtuxwfgpbGAIBQg4U8pBCXx4fUEqxoanzIWj5FYLf57Da/1e4jEB8CjcfjUTI5TybnyqS88qUFUh7FCfmZgoiISKfTabfb23ogHR0UAO1CGBQAtYCWxgCAkFYlPiTBSjGlbFJ8yOG32wPiQzafywXxIdAUYgk7S8CVSnlyOU8m44rE3LYeVONEREQ6HA6Hw9HWA&#x2B;nooABoF8KzAKgVtDQGAIQ0DlXesExRsa5AJcGixsWHaJqwW5HabOVVgc3qg/gQaAKKUxEfkvNkUp5UzpVKeXx&#x2B;&#x2B;40PQQHQTkAB0C50oAKgNtDSGAAQ0rCIjQ9JKIUYq6VYIaKUEsRt3E2Yx1N19yG73wbxIdAkfAGHnSiQy3lsvwKJlEs1sm9GC4ECoJ2AAqBd6OAFQK2gpTEAIIRhtnmZhFJLsKKyeZmgUfEhQsqbl7ETBVZr&#x2B;e5DLTdqEK4wRmIJTybjSaUcmYwvlfPkMq5Q1AZtCqAAaCegAGgXoABoEGhpDAAIaVyKLQawUkIp2eZl4qbEh9j5AavPbvdZbX47xIdAk3C4lEzGZTcdqlxawOO1bHwICoB2AgqAdgEKgKaDlsYAgFB2OT6kFGOVFCvElFLc&#x2B;PgQbbOWbz1ks/ntdr/N5iMwZQoaTyjksFuRytj4kJwrkXBx8/UpgAKgnYACoF2AAqB5QUtjAEAIwxjLBUgpoVQSrBBTKjFWSrFciBpzD0ZIRfMym89uvbz7UIsNGoQtjLFUypVWLDWWynhyOVcgaGJ8CAqAdkKhUPD5jZt&#x2B;bM&#x2B;gAAB1gJbGAICQxqWwUowVYqyUljcvU0mwkNeoa9D&#x2B;as3L/HYbxIdAU3C5FLuQIDA&#x2B;xOXWX6RCAdBOQAHQLkAB0DagpTEAIJRhEQ&#x2B;VNygQY7UUR15RfMhm9bHZIbvdD/Eh0AQiEbe8k7GcJ5fxpDKuWMytlh6CAqCdgAKgXYACoP2AlsYAgBBWHh&#x2B;SUioxVogplQQrJU2LD9msPpvdD/EhcCUwVdGmoGKuID5B7fe7oQBoc1AAtAtQALRr0NIYABDSKuNDKimlrGhe1vj4kC2geRm7&#x2B;5AfHo6ARpLLI6&#x2B;7QQ0FQJsLswIgxBpig9CAEZYLsVxI6VSXD0JLYwBAqPAzpMBOCuwIFdAVx7CIj5RirBJf3n1IESw&#x2B;xOHiyEh&#x2B;ZGSVOwaPh7ZayzuXOdidSR0QHwIAtDYoAEBr4VBYLeGoJQhFVR6DlsYAgFBBXF6U6yW5pZef4WOMI4RYKcEqMY4UU2oJVkqwLFh8SCDgREVxoqIubyZICHI6fDab32b326xeu9Vvt/shPgQAaFFQAIC2hAVcHCtHsfLA3dGgpTEAIDQQQkpdpNSFMgIO8jhYIcYKUXl8SCXBSnGQ&#x2B;BDGSCLlSaS82ICDfj9jt/lttvJOBeykAcSHAADNBQoA0O5gmQDLBFSS8vIhaGkMAAgVPpoU2EiBrXp8SMX2MxZjtlmBUow4dcaHuFwqUsGPVFSND7lpK7shqdVnt/vtNogPdRQMA7UfaGZQAIBQQGGsFHOU4ioHoaUxACBEEJcX5XhJTq3xocrmZRIsFwa5iEDIiRJWjw85HBVtCip2H3K76SAXAQAABAUACGF8DhUjQzGywGPQ0hgAEBoux4eKLh/kcbBSjCPFWC2hFGKskmCVGAuCxYekUp5UykMaUeXBivhQ&#x2B;QZEbFUA8SEAQCAoAEBYwWI&#x2B;FvNRouLyogJoaQwACBU&#x2B;muTbSL4NnUdV40MSrBRTbDPjyKbEh9zuqs3LrD6Hwx&#x2B;i&#x2B;4AD0CYwbkxzkHYPCgAQ7iiMI0WcSBFKVl8&#x2B;CC2NAQAhoiI&#x2B;VHL5GT6FsVyI2Z5lCjGllmCFOHh8SCjkCIWcqOjA&#x2B;BBx2MvXGVutPjvEhwDoSKAAAB0Sj0NFS1G0FKHoymPQ0hgAEBqYivhQeo34UGXzMpUYK4PHh7BUxpPKeAhdjg/5fIzDzgaHKluY&#x2B;SE&#x2B;BED4gQIAgHJYyMPxkSg&#x2B;8nJ8CFoaAwBCRWV8COVfjg&#x2B;JK&#x2B;JDSjFWSSiFBCvEiFNnkoHHqy0&#x2B;5KJt5csJfA6b32aD&#x2B;BAAIQ8KAADqBi2NAQChjDi9yOkl2bXFh8p3H2KblwmCXEQo4ghF1eNDdrvfHhAfstl8HogPARA6oAAAoJGgpTEAIHTVGh/ic7BCjJVirKyMD0mwoM47BIyxTMaT1YgP2e0&#x2B;m9VvZxNEdr/N5qP9MFEAwgQsAgYAVActjQEAIcwbND6kkmClhFKI640PKRQChaLKZILL5bfZaLvVZ7OXTxQ4IT4EQDsABQAALQVaGgMAQlft8aEIIVZKsUrcwPiQSMQVibjRAfEhhiEOh5/ddMhq89mtfpvN5/FAfAiAVgUFAACtCFoaAwBCF0NIiYuUuFB6wEE&#x2B;u/uQBKsklKK8hRmqOz5EUXXEhyp6lpVvQGSH&#x2B;BAALQgKAADaGrQ0BgCELi9NzDZitiEU0LxMIkBK8eX4kFKMI&#x2B;uLDykFCmXN&#x2B;JDfZvXZbT67nbbZfE6HD9JDADQLKAAAaI&#x2B;gpTEAIHQRhwc5PLXEh1RStlkBpZZgRQPjQ5cbnDFMRfMyNj5k89tsPm8HiA&#x2B;F2fJT0B5AAQBAiICWxgCA0FUZHwrE52KlCCsrZglUDYgPyXkyeZX4kNfL2O0&#x2B;u9Vvt/tsNp/N5rfZfUx4xYdg2TRodlAAABDKoKUxACB0ef21x4dUEkopwioJVkgopQQrRIiq8xE4n08plQJl3fEhdsbA6fTDXTS4EmE2DwMFAADhBloaAwBCFxsforMCDlEYR4iwSoKVYqyUUGybAmmj40OVawnK1xlbfV5v&#x2B;MeHAKgVFAAAdADQ0hgAELoYQkqcpMRZ5aCAW9G8TEIpJVgtpiLriQ/JI/jyCFQ9PsROEdh9Nmt58zKGhicjIPxBAQBARwUtjQHo2Apdrk&#x2B;OHzlrsWhl8vu79eihUtX/HoQQQi/s2aWTy3XyCJ1crpXJxdy2uJfw&#x2B;InZSsxWFBgfkgpQ&#x2B;XICMVZIKJUER9YXH1IJlKqq8SGn32bzW60&#x2B;u91nh/gQCFM4RFeWlJaWtPUQAOgooKUxAOGHIWTS2r8vVvxjyqWoL0ePuUoT15D3dvvlp8BfxkjE2ybd3vxDbBYUxpHlywmwUtyQ&#x2B;FBNAfEhr83mt1v9NpvX622lhVVyeeT465Uul6v&#x2B;U0FLUqvVHA6n/vNCBMwAAADqAS2NAQg/50tLLgY8SvMzzKv79266&#x2B;VYuRTX2UvkOZ/0ntRWGEHaHNFR4&#x2B;SAbH1KJKaUEKyVYJaYUYsRvdHyITQ0FNi&#x2B;D&#x2B;BAIFVAAAAAaD1oaAxB2zA7H&#x2B;dKS7sqGBoFCWEV8KPAZfnl8SBWwrqC&#x2B;&#x2B;JBKLVCpq0wmOJ1&#x2B;Oxsfqlha4IL4EGiXoAAAADQTaGkMQOjoHKlIlMqy7bbAg/zGP/4PG8TuQXYPnWW5fIhTsfuQQoJVYkpZf3xILOaKxdzomIDdh2hit5dvRVrepsDq8/ngZyBoY1AAAABaUD0tjS1OptgJLY0BaH0Uxu9fNeLBLZtc/vJpur5RUamRirYdVftCB4kPScrrAZWEUoiCxYc4bHyIH3iQjQ&#x2B;xUwR2m89u81vtPgLxIdCKoAAAALSuOlsaO0mJC1oaA9Bq&#x2B;kZFrbrhpiXnzmZZbWmRkQ/16BlWjY5aSK3xIVnl7kMSrBBTKgmOaHx8yOG32wPiQzaf0wkRStBSoAAAALQDPA4VLUPRMmhpDEAQfoYxOZ2EECGXGyUSXfn9eqJU9vKAQc0wso6N2DzI5qEzq8aHIkVYycaHKpYWSILGhyRcsaRKfIimid3mI0SCEPzcA80MCgAAQDtVe0tjq7t8T9ISByl2Egu0NAYdwomiwh/OntmZm1OZ2BHzuINjNDcnp4xNTKIwPLtvZ2hCip2kuLb4kFpCKcRYJcEqCRUpRvw6d5bkcHBEJF8sFrndjtYYM&#x2B;hIoAAAAIQOjHCEEEfU2tKYXVHgIBYnKnYQp7ftRglAc/IxzPuHDy49f77acafPvy0ne1tOdmqk4u0hQ3upo2p9O2hHgsSHVBKsFGOFmFJJcYQwMD7EZeDxf7uAw6vMhgIAABDiLrc0vqxKS&#x2B;NiBymBlsYgJBGEXtiza0OmMcg5l0pLpm7a8NqgIZNT0xpyzUOFBf9mGU8VFRU4XQQRCY&#x2B;fHBHRW60enZColcmbZ9ygweqID11uZszERTNR/LovAFoJFAAAANDeYQEXx8pRrDxwcp3YPMTiYBcZQ0tjEBJ&#x2B;O38u&#x2B;N0/y88wr&#x2B;3fK&#x2B;RwbtAnBzntUlnp3P17jxYWVj3suFhasjHTOP/woUGxsc/26dcTJhPaFk1IsYMUOxAqpBHyRuSQRwa39ZhAuIECAADQUZS3NNbW1tK4pGJPUmhpDNoNq9f7yfEjDT//1f37eqmjkmSyWl89WVQ4Y8smpy/YPNhBs/nODetm9ez1eO&#x2B;&#x2B;YfW0EwBQFRQAAIAO7HJL44BHnl4/U&#x2B;K63NK4yIFKndDSGLS&#x2B;FZcu2r3VN8ONl0indu0q4fL2mPI2Vp0c8ND&#x2B;hceOLBwxsualvDT97O5dwe/&#x2B;WQShr06ecPh9L/UP4d2B/Ayz32w6XlRo9XmVAmEPlXpwTCy3A7c5A6AaKAAAAKAqPrdhLY2dCBr3gJa0zphR7UhKROSv4yfI&#x2B;QKE0OTUtHVJSc/t2hn4p3BzVmauwxEvkVR74ypDek7Vpr/BLTl7dmhs3Kj4hKaNvG2dKi5&#x2B;fs9Oo9UaeDBGIn68V99JKakwswEAggIAAAAaAloag1Zm9XrOWCzVDr41ZBh798&#x2B;6XqvfkZPzt&#x2B;FynUATsiM3&#x2B;&#x2B;5OXaq9cfnFC4G/VAoFE/XJvdVRSqGoxO0&#x2B;Y7GsTL9Q4q4SfvvixLFQLADOWIrv37zR7qs&#x2B;c5LvcM7Zt2dXXu78q0bwYCoAdHhQAAAAQJNAS2PQkrbl5FQ70lOt7hNVfXnuTckpgQUAQuhoQUG1AoAmpNrj/wi&#x2B;8Jk&#x2B;/QWc8nr2Oq3uns5dJq1dXea5vH/uqeJis9MZKxZf4TfSmrw0/cyuHTXv/ittzDQKOZz3hg1vzVEB0A5BAQAAAM0HWhqDK&#x2B;NjmD/TL/567mx6WVm1l0bW9jw&#x2B;Vlw97ZPvclY7wsF4zsDBz&#x2B;3eVXnEYC379PjR5/oNCLiOeGhsXLUdh3Id9mYvAApcrhNFhTavT8Ch4iXS7ipVM0bzl1&#x2B;6kGWrJ&#x2B;m0OiP96viE67S65vpQAEIRFAAAANCyoKUxaKCTRYXP7t5VV1jf5vURhKpF2K3e6j3vbDXWDSOEJuqSt2Znrw&#x2B;4v//p7JnxSdrA9mGFble1dwmaNSpzsbRkwZEjO/OqzGyIedzrtPoZ3bonyyOu/COWnDtb7UhapEIrl&#x2B;/MzfHSdOXBD44cGpuYBEEg0JFBAQAAAK0OWhqDGo4XFt63eZOHrnOjnp/Onj5lKXqub//Au/YdudWTQkwdZeRrg4ccKswvdLoqT3tp754V198g4nIRQrkOx7GCgsDzRVxup0hF076XmtYZDS/t3e2r0dTW6fP/eeni6oz0WT16PtKzN3UFvZZOW4qrPf4fGBv7/ZhrORgfLyycumk9XfE7Y3Y4/jEYJqWkNPmzAAh1UAAAAED7AC2NOzCX3//07h1B7v5Zh/Pz79ywrpdaPSYxSSeTHy8q&#x2B;uns6WrnXCwt2Wc2DY3VVDsewRe8O3T4Q1v&#x2B;rTxisJZ9cOTQa4OGIIQWHDlEV60crtPp&#x2B;BwOag7bc3Oe37OrrsoEIeRnmEUnjhtt1veHjeA0tQbYVaMWerp3P/ZqvaOibktL&#x2B;&#x2B;PC5ZXQK9MvQAEAOrIwLwD&#x2B;O3xeIhHqtbEikaD&#x2B;swEAoJ2BlsYdxIpLF80ORwNPPlFUdKKoKMgJj27bOmfg4JuTk6vF66/SxN3Tpcuv585VHll24XxnhfJCqaVa&#x2B;p9HUQ9179nQ0QeV53A8v2dnkLv/SmsNhjiJ9Ok&#x2B;/Zr2QUeqdjhWi0SBa6Yn6VMDC4AjBQVFbrdaKGzaZ4EOCF/B9FQ7FOYFwMHD5w4dPmcwmmmGSUiIStFp9DqNLkmTrNckJETxuM3zbAMAAFoTtDQOPxuzjDUPcinq5uQUjUTy9ckTNcMzQXho/6v797y2f0&#x2B;kUDBME6eTybUyeZxUGiUSPdi95/bsnFyHvfLkNw7sq3mFJ/r01crkjf8&#x2B;ajH/8KGa7czqsvj0qQlaXVeFsv5TazhXWmXX1F6qKjsm9VCrxTxuZSs0gtA&#x2B;U&#x2B;6NepgEAB1UmBcAs2fejNDNCCGvz5&#x2B;VXWA0mgyZps3bDxl&#x2B;NGfnFvB5vJTkOG1SbLJOk6yL1WljY2OUYVbhAQA6BGhpHMpsPu&#x2B;xqk&#x2B;vEUJSHu/7seN7qFQIoWsSEp/bvSu9rLRRlyUIlbg9aw2Gxo7njk6d7&#x2B;/Wo7HvqtWlstJNNWobjUTyzrDhA6KiDxbkv75/X&#x2B;CiZ4aQr0&#x2B;e/PjqWpoZB&#x2B;fy&#x2B;4ucVRYxJ8mq9PLjYNxFoTwSsM7hUEEBFACgwwrzAqASn8dNTY5LTY4LPOhwuI2ZpnSjyWA0Hz5yPt2QZy4oUSnlel1sslaj18bqdJpkfVxkRPVN1gAAIARAS&#x2B;MQkWm11UzIPN2vP3v3jxDqolD&#x2B;NfHG3y&#x2B;eX3TieKmnzomdEXHxY5KSXt9fyxP9hhuTmDSrR68gT8LctS1UcNN&#x2B;IaeWO4ofzlRfoiDl834cNz5RKkMIDYvVfD/u2pv/Xu3yX77mv1nGAtegaJGoUcM2OasHqKLF1a&#x2B;QKJUFFgDnSqr3WWu3COwPBppbRykAaiWRCLt303fvpg88WFxszTCajJnmS4a8jVsPZ2bll5TaEuOjtNqYZF1csk6j08botbFCISwqAACEHmhp3A5l19j3k8fhTEqu8nCaS1H3dO56a0rahszM1YZLRwsLfQH7WiZKZQ/26HlbSiqF8ZGC/DUZGaiptmRnbcnOEvO4SVK5Xi6X8fkiLnd4XHwvlVrG5yOEDpjNNd&#x2B;VY7OnRkZWO2hyOqo1KUMIze7Vh737ZyVIpDfokwMbFROEduXm3paa2qhhB7YwYwm51e9woqv2NMho5IxKG4JsAmh2HboAqJVKJVep5AP7d648wjAkz1xkMJoyDKaDh879vmKbwWhiCElKiknWxuq1Gq02NjU5Lj5OzYVFBQCAkAMtjduazVf95rWXSlXrA3URlzspJWVSSoqPYS6UlhS5XBTGWpk8MO7y7tDhOnnE58ePNWTdbV2cPv&#x2B;5EkvlM/Kfzp5BCEUKBBIur&#x2B;azdoTQ4jOn3h02vNpd6vdnTvurLl2QC/hTUjtVe293lWr5xSpHMqyljR2w1Vt9YkRAVf8NjOBXeXLn8PmtXq&#x2B;cz2/sZwEQBqAAqB9F4YS4qIS4qBHDelUe9Pr8mZlmY6bZkGXetOW/b3/Iz8opEAn5ep1Gr9XoAxYVtOHIAQCgiaClcSty&#x2B;6uHahKr5tdr4lFUd6Wq1pcojB/u0evWlLQVF89bPB6n35dlsxmtZRb35VtkLkXFisVpkYpEmez3Cxfq3X6UVerx1BVAWp2RnuOw35Ga1kmhTItUEELWZGQsPX&#x2B;u2mnjErWiGg/mlYLqW/EU12hJVq&#x2B;ai6SlvOofVPNev9DlggIAdExQADQRn8dNS01IS63SmN1md2VmmS9l5Bkzzf8dOnvJkFdQWBqljtAlxSbrNHpdrF4Xp9fFRshhUQEAIPRAS&#x2B;MW4vRVn1qRXfFdabRI9GivPoFHfAxj8bh9DCPh8iL4/MqWW1PSOn1w&#x2B;FDNhmKNdTg//3B&#x2B;PkIII8zncjw1qhqEkMXttvt8Uh4v8GBewJZELC/d6KqSJtXfUjM2w8HVW//W7KMMQAcBBUBzkklFPbrpe1RdVFBYVGowmo1Z5vMXszdsPmQwmsqsjsSEKL1Wo9fGJus1Om2sXhsrEMBDCABAqIGWxs2BbpV6iUdRMSJxzePJ8ogvR485YyleY8jYazJllJVeSXYIIUQQqfXuHyG0LSd74t9/Pd6r7w16PZtxcvn9f166VO20CEGjV9nVvLn3N2DjVKe/Qam2S2Wlbr&#x2B;/h0pd/6kAhAgoAFpclDoySh05aECXyiM0zeSZizMMeQajef/Bs7/9vjUzy0wISUqKTdFpdLpYnTY2WR8Xr1HBogIAQOiBlsYhqJtS1U2pQgj5GCbTZjVarZk2q8FadsBkNjkddZUEGKGZPXr9mXGx2hacQRQ6Xa/t3zvv8MG&#x2B;UTGRAv7hggJTjQ5oSfUloGoS1GhaXFQjR&#x2B;Rmqv95c9VRqATanJ314t5dAg5n2YSJgcuXAQhpUAC0AQ6HSoyPSoyPGjm8d&#x2B;VBj9eXmWk2ZuVnGE3rNx0wZuZn5xZKxAK9TqNLik1JjtNrY3XamJhoWFQAAAg90NI4VPAoKjUiMjUiMvCgzevNtFkzysqy7TaT01Hq9gq5VJxENkGr7aZUXZOQMGvbliD7k9bk8Pl35&#x2B;XW9eqAqOi6XqpLVI1tQy&#x2B;UllQ7UuBwNuqaDCGfnzj21ckTCCGnzz9zy&#x2B;al110fyYc9AEE4gAKgvRDweZ3SEjulJQYetNldBmNeusGUmWnet/90RqapoLA0Wh3JZoe0STEpyXE6rUYuq2VWFwAA2jloaRwqZHx&#x2B;D5W6rgxMT3XUmhtvXnz69LKL52sN//SLjrZ6fZdq3JHXKiUiooc6qv7zqkqWR3ApKjD2sysv188wXOpyNOhEcfVua4GvVmPzep/fsytwaUSmzfrY9q2Lx1xbc7ahIRw&#x2B;n6Tq4gcA2hAUAO2aTCrq1SOlV48qu0EXFJYaMk3GzPyz57PWbTpozDTb7K6khGhtUkyyPo7dfUinjRXw4QcNACDUQEvj0KQWil7oP&#x2B;CF/gP&#x2B;K8g3Wq12nzfHbitxeyQ83pCY2Ak6vZ9h5h/5b9n58/XO7zzff2ATNr3nczh9oqIO5edXHsl3OFekX7wzrXxT71yH47&#x2B;AV1mKOh7nm53OBzZvMljLqh0/UlDwwp7dC68e2dgR7jOb/rd7x2uDhoxP0jXyrQC0CCgAQk90VGR0VOTgAV0rj9A0k5NXZDDmGYzmvftP/7Jsc2amGWOclBSToo/TJsUk6zV6nSZeo&#x2B;Zw6nzaAQAA7RS0NA4dA6NjBkbH1DzO4XBeHTjktpS0hceO7MnLq/W9HIxfGTR4RFx80z76Rn3Koaq3&#x2B;O/&#x2B;d9Du9d6YnGL1eF7dv7fmsuAkubzWS6mEwhiJuGYBgBDalGX84LDk&#x2B;f4DGj6wH86eXnDkMEPIi3v2RIskfaMaPb8BQLPDIdpfurRhM4kdmcfjNWblG4wmg9GcYTQZs8zZOYUyqUinjU3WaZL1cTptTLJOE6WObOuRAgBAcwjZlsaLThxbdOJ44JFpXbu&#x2B;1H9QW42npWXb7euMGYcK8s9ZLCUeD0OIWiQaptHc17V7F0XT17m5af&#x2B;1q1c2fDmyViZff/Okul61eb13b1yfXlu3YA7Gf91wU7VlEnUN6bX9e/8xGCqPKISC38Zfr5XVXnjUSh4R4XlksBd2LG1rMTG1VLahC2YAwpZAwO&#x2B;clti56qKCMqvDmGnOMOQZM/P37D2ZkWkqLCqLjopM0cXptDE6nSZFr9FpNTJp9dVUAADQ3kFL4xCRKJXO6tFrVsUvqyX1m0zI4b4yYNDTO3c08Pwb9Pogr8r4/K&#x2B;vGXvnhrVFrioVhYTHXThiVEPu/nMdjid3bD1jsQQeLHF7Zm3dvHTCREXjtzoFoBlBAdCxRMglvXum9O5ZZVFBfoHFYDQbMs2nzxjXbthnMJodTk9ifJReF5us17D9CpKSYmBRAQAg9EBL43avWe7&#x2B;WeOTdDN7lHxz6kS9ZyqEgqldugY/J04i&#x2B;XL0mOmbNlTuFhojEX81amxnhaIhg9mQaah298/Kstke275l8dhr2U4IALQJ&#x2B;MMHUEy0MiZaOWRQt8ojfj&#x2B;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&#x2B;t08Ym6zXJWo1WG6tNiuHzYAIKABAOrrClMUNIrsORZbMarGWZNqvBah0UHTuzR88WHTNoNSan444Na9ntiVIiIr&#x2B;6Zmy8RNLwt0MB0E5AAdAuXEkB8MU3qz/85A/2665dtGv/fLeZBgXq5PfTObmFbEvjDGNeRqY5O7uAQ1E6baxer9ElxaQkx&#x2B;m1sZpYNUU17SELAAC0J9DSGAQ4Yyme/u&#x2B;G3uqoj0eMkvH5jXovFADtBBQA7UKTC4DiYuuQ0bNpmundM1kuk&#x2B;YXlmxY9T77UkFhabGlrGtn7RWObeuOo2&#x2B;9v2T82AEvPnv32fOZpaX2TmmJKmUjNv3tIFwujzHLzLYpMGSajEZzrqk4MkLKNihI1mm0SbHJeg381gEAwgS0NO7AzpZYUiMieY3f8ggKgHYizAqA8M9gzHpiIU3TLz17d0pyHEIow2iiaUajUa5c&#x2B;ibGmKbLV9b/u&#x2B;XQY89&#x2B;lhCv3rh6Ppd7eWcIr8/f2KQK7aczs/KPn8xACG3cfOjTL1beN23Cay9Oa77vKUyIRIKunbXVKq6SUnuGwZSZacrING/decyYaS62WGOjFSnJ8WxL42SdRpcUK5EI22rYAADQRNDSuAPregU9zkCbw41fN9LOhX8BkJNbePZc5kP3TWQLAL0ulsflmEyWn3/bdO894yt3sRw2pIdKJTcYzb8s23zf1PGVbx97/bMMIj9/81KyXoMQ2r3vZGJCTGJ8FCRVWogiUtq/b1r/vmmVRwgh5nyLwWjKyDQfO5G&#x2B;6u/dGQaTz&#x2B;9PjI/WaWNS9HG6pFi9TpOYGA2LCgAAIQeL&#x2B;VjMR4mKy0&#x2B;eQralMQDhimq&#x2B;bhXtREe5YapMOqlVEXNfue&#x2B;1t75/492fDxw69/H82exdo0QifOPle2c9sfDTL/6cdNPwCHn5Ah2CUF5esdtTvu/b7Kc&#x2B;sdldO//9OCEuympzfr14zcX0PL02dupd4xLjo5prtIt/WmcwmiZPGtWnV0r9Z4c7jLEmVqWJVQ0b0qPyoM9PZ2cXGIxmQ2betl3HFi9Zn5NTyKGoZL1Gp9PotbEpeo02KSZOow6/qh0AEOagpTEAoIWFfwEQpYo4i1BObmHlkbunXNOlU&#x2B;LsZz7dsOngpzrN4w/f4vczEolw3JgBI4f32rH7xMeL/pz70vR6rzzriY8OHDzLfr1s&#x2B;dY/l76ZmhzXLGM&#x2B;eyFr5apdKfo4KADqwuNykvWaZL0Gob6VB10uT4bRZMw0ZxhNK1bvMhjy8swWpUKm08Ym6zR6baxOq0nWa5QKWZArAwBAewQtjQEAzSf8C4Dx4wbu3HPiky9Wdu6U2LN7MnuwX5&#x2B;06Xdf&#x2B;8HCZecvZh87kX7XfW9HRyv02tj8ghKE0C9L/&#x2B;3VI3nihCFBIiVZOQUHDp7l8bg/fPXc2o0Hlv6x9dNFf3664PFW&#x2B;q5AbUQiQfeuuu5ddYEHLSW2DIPJmGkyZJq37DhqzDRbSmxxsUq9Pk6vjU3WadjyQCSqvyUkAAC0K9DSGADQNOFfANw5efR/R86vWrP75imvJus1XTtrVUp5SYlt07ZDCKFB/TsrIqX9&#x2B;qYZDKYD/51FCKlVEUXFZc&#x2B;&#x2B;&#x2B;OVzL3&#x2B;dEKcuKCyt9bJ2uwshFB&#x2B;nHjakR0JC9NI/th48cr4Vvy20bMW2uW/98P7bMyfdOLw1PzfkKBUypUI2oF&#x2B;nyiOEkDxTEdup4PCxi3&#x2B;u2plhMNEMk5AQxU4U6LVxel1sYmI0L2A5OAAAhABoaQwAaIDwLwAwxh&#x2B;998j14wb9/Nu/Bw6dzTCY2OMUhSdPuvreqRP4PO6KX15HCFltTofDFaWOXLL039/&#x2B;2IIQyjMX&#x2B;2p0EWdpE2N4XE5ubuGhIxc6pSUghCwWaxOGd&#x2B;jI&#x2B;UVfryoqtvbqmTx75s1xGnX970EIISQQ8Hx&#x2B;&#x2B;ujRi4EFwGtv/rBm3d5vF/1v7Yb9w4f2GHtN/yYMKexhjOPjouLjogIXFXh9/uzsAoPRZMwyb95&#x2B;yJiZn51bwONyk/UanVaj18Uma2P1Ok1sjBIWFQAAQgyHwmoJR12l&#x2B;VRLtDQGAISK8C8AWGOv6d&#x2B;vbyev1&#x2B;d0ekrL7FwupdfFyaSiwHPkMrFcJkYIzZg2Yca0CezB/AKLwWhOTCjPXFZOokokwgdnTPzy2zVTpr0hlggQQn4//cKr36Qlx/uZhuYvs3MLp8983&#x2B;3yIoROnzVu/Pe/NcvfrlkDuFyeZcu3ajSqCeMud4afdOPwfr3TYmMUgWdyuByrzfnPun1Llv37z/p9h6AAaDA&#x2B;j5uSHJdSdRWHw&#x2B;E2ZpkzjKYMg&#x2B;nI0YvpGbnmghKVUs6mhpK1sVqtJlmvUURK22rYAADQNFjAxbFyFCsPnOi8wpbGAIBQ0VEKAITQ5HteN&#x2B;UXL3z/0a8X/z3z/ht79Qi2vtbr87/65vddOiXddP0wr88vFgkQQnaHy&#x2B;5wIYS4HA5C6Lmn7ujSOWnthv3HT2Y4HR6E0PKVOxo1pGXLt7pd3sEDu3747qwPP/5j9dq9X3675q3X7q922tI/tr49/5foaMWoEb2FQgFCaMv2oyvX7ORxuN3&#x2B;3959BjZV9WEAPzd7NKMzoyNJy957iICiiIggqKggoCIve8gQAZkyZE8ZslERB3sKCiJLpmzKapN0Jd27JU1u7vshUEJbZkfa3uf34X3Tk5t7T0DgPPee/zm1dF07tQoIuB8DJo3r3fODdlXCAqtUCRQJn2&#x2B;vQXd37sZkZOZWqxpUICOxjVQqKlxUkJySEWm0mKOsd41xh/6&#x2B;YDLHp6VnBWp89Xq1QacJ1WsMerU&#x2B;RI2iAgCocCiZkJIJOTq3FeuxpTFAZcSiANCiWc3tu0/cvht7&#x2B;Wrk&#x2B;h8PdHyj2RMOTk/P2rbzmNPJXL1u3LnnxPgxPaKjE4&#x2B;dvEIIEUuEfr4K12GdO7bs3LHlT7/&#x2B;NfmbDVqt7&#x2B;e9O8bEJWVk5piirMon3hW22fJWb9i3&#x2B;Ze/CCFdOr0UqPV/p3OrXftOXbkWWfjg3h&#x2B;/8duOf27fiV61bu8XQ94jhFy9Hnng4FlCyO79pxYu2zp3Rv8ub71ECOFwKF9fhTkqvkf3drxizF/fd/CM&#x2B;/5l/565fv7i7VYt6jRqUPWpn630fH3kvj7ypo2r57c4nUycNclktkZExp3779Zv246azFba6QwODgjVqUP1Wp1OHWbQBAX6F&#x2B;c3BQDAAzgU5SPh&#x2B;kgIcVvqGlsaA1RwLAoAs6b2mzW1HyGkdg19SEjAkw/291N&#x2B;v2x0SkpGUKDflWsRQYEBR/65FBWTQAgZ2r&#x2B;raxi3dcc/P/922JbnCL9pJoS81qbRZ306FjhP925tdMEBAf7eBdqnzNz027ajrtfTvv3hwqXbkZFxhBBvZRErVPJ53BmT&#x2B;37Qe9rqDXt7dH9VFeDzfrc2bVrVS03L2n/o9I5dJ0Z9tSJUr6lTy0AIufDfrQHDFzVvVnPLhonP9euz8aeDV65FvvdO61Yt6xR46&#x2B;atqEXLtpqj4xEAisThUEFa/yCt/8st6&#x2B;Y35tkd5qh4s9kaabb8eeT8GrM1OjZBKBCEGjR6ndqg07h2KtCofZ9wZgCA8ghbGgNUcCwKAPlee7Xh0w8i5LVX7h/21975hJAG9cLiE9IC/BX5c/QzM3MuXYlwva5fN3TY4G6FTxKo9e/WpeAGYQzD7Nx7khDSv2&#x2B;nhvWrTp/z4/adxwkhHA7Vu0d79yPN0QmXrtwNM2iqVwt&#x2B;tW2Dv/&#x2B;5NHv&#x2B;lkVzh7iGm65O&#x2B;nrL127cv2rtnu8WDne7xv3/jzRavv5mXaP6Vb784iOHg46OSQwK8ufzuHYHffVapEH/cP56VEzCzj0nQoIDCgcAeAECPq9qWGDVsED3xqzsXJPZGmG0mMzW8xduRhjj4hPT/HwV&#x2B;QuSGvSaUIMmfx86AICKAlsaA1QgbAwAL8a1Ga17y8c92rd7pVF2zj2ZTPJc2wCnpGbm2eyEkOGD3pNIhO1eafTvmevW&#x2B;JS6tQ01q&#x2B;sIITIviWupmdu3o0aOXe7&#x2B;2V37TqWkZn34/itVwwJDQlRCAf/jD19fu3H/qdPXirzWPVvembPhMTGJX37xUU6u7bVOo7lczp0rP&#x2B;bm2t7/eCohJPL65uf7hYBi8JKK69QyuJ7V5EtKTjearEaz5U5EzMHD540mS3pGdnCQv/uDglC9RliMog4AAA/AlsblzM3bUef/u8Xn8d5s30yhwJ0mVkMAeHECPk8XonqBD&#x2B;besxFCJFKhRCIkhPB53Dat6rkfMGV8n3Gje9jtjoyM7LGjPjKaLCaz1W53hIZqt&#x2B;88fvzUleOnrhBCOBxKq/YNCVETQtLSs3/b/k/DemHWxFRCiKtYuUg0jU0iyxc/X4Wfr8K9qICmnXHWZKPJYjRZTp8N3/Lb3yazhWGY4BBVFb1Wr1PpdOqw0MBAjS&#x2B;KCgCggsGWxp6QZ7dPm/XDnn2nXn6pToTR6ucrf&#x2B;1VrBPIaggAHsOlOE94VyjgCwV8L6l44Oed3dsHfd7l953/8LncmNjEu8Y4szk&#x2B;5sG9/3GTVucfdv2Gqe/AuXVqG1y3jROT07Oycx0OuhS&#x2B;B5Q8LpcTHOgfHOjvngxtefaoqHij2Wo0Ww7&#x2B;dc5o2hMdmyiVCA16tT5EE2rQGHRqg16tCvB5wpkBAMohbGlc2r78&#x2B;nutytfbWzZtYl9fH3l2zj1P9wg8DAGgggkL1Y4b1cO9JTEpzWiymqKshw6fz8zKzcm5JxTygzT&#x2B;u/efOnr8suuYPJv9jS5j1Q9WC92&#x2B;81jzZjXLuutQPEIBv2qVoKpVgtwbM7NyTWZLhNFiMlnOnA2PMMUlJqX7&#x2B;cpDdRqDXqPXqUINWr1OjaICAKhgsKVxydl/6EzjBtX69Hzj1t1omZeYw6FYvsY3EASASsDfT&#x2B;nvp2zWpMYH777i3v7mG82u3TA6HA4&#x2B;j1evTuiseZtdJcu&#x2B;vvIxX3/vfuT2nce8ZJKkxLQCZ6bxxKDck3mJ69YOrVs71L0xMSkt0mQxmeNv3o7ef&#x2B;isyWzNzMoNDvLXh6hd2xQY9Bp9iApFBQBQwWBL4xeyZ9&#x2B;ppQuGR8cm&#x2B;ChlIhH&#x2B;5gdCEAA8wkcpnzi2V3xiaqle5c32Td9s3zT/x9fbNTZHxWdkZlevFvLL70cOHj5/925sUnI6IWTdj3&#x2B;4VjIlhPy05c8LF2/fjYwjhJw6c/3SlYg6tfSl2k8oca5M2LzJw4c8NO2MtSQZTZZIo&#x2B;X02fDNvx6OiopnGEb3cPUhtUGvDdL6cblPmpkGAFDeYEvjJ2MY5m5k3O070TPn/TRnen9PdwfKC4qpmNPp0tJKd/TMElnZuV5S8eGjF6/dMJpMlghjnMkcn19ALJWKsrPvcbkcL6k4PSP73a6t588c6NkOQwmy5dlNZqvJbI00WSONceao&#x2B;KiYBJmXWK9TG3TqsNBAvU5l0GkC/JWe7ikAQLFV2C2N5QpFTv8mNP3iz&#x2B;Tbvz3mni1v&#x2B;cIRdWqHnv/v1s69Jzp3bNmyee0S7GSlx&#x2B;Vy/fz8nn5cxYEAAAUlJafHxiX5&#x2B;ynSM7JHjVuVnZ0Tn5BmtzsQANggIzPHZLZERMaZo&#x2B;IjjRaj2ZqQlBbgrwzVaQx6tWtLY4Nei/mjAFAZVIQtjYsfAHJzbXFxybv/OLV3/78cDufN9k0/7dXB10dRgp2s9BAAygsEgLLkdDJx1iR7Hm3Qqz3dF/CA&#x2B;IQUkzneaLZGRMaZoqxGkyU7xxYc6O8qMg7Va/QhKp1OLRTwPd1TAIDiKm9bGhc/AAwaseh6uKlThxYd32hWr25YCfaNPRAAygsEAAAPcjjoWEtypDHOZLaaTNa7prjoqHiKonQh6lDD/aKCUINWq/ZFUQEAVHge3dK4&#x2B;AGgS/evd/46g8OhSrBXbFP5AgCKgAHgufF4XF1wgC44wL3RZsszuooKjJa9B04bzZbomESFXGrQawyuBUlD1Aa92t9P6aFeAwC8kAq&#x2B;pTGHy3Ef/UfHJkjEQkwBYjkEAAAoGUKhoEa1kBrVQtwb0zOyjSar0RRnNFmPnbhiirImJqUH&#x2B;CurGLQ6nVqvU1cJ1ep1ai8pigoAoEIpwy2NS2SyRmZW7oGDp3ftO3U93Lh5/UQEAJbDFCAAKGvW&#x2B;BTX6kNGk8VothhNltx7eSFBAboQVVio1hCi1uvUOp1awMcdCgCo4Iq9pbFcocj8vGFxujB6/ArayZw4ebVp4&#x2B;qd3mzZrm1DLpcjFKJq6znw&#x2B;XwfHx9P96IkIQAAgOc5HHRsXNLdyDiz2Wo0WyLN1qioeA5FGfT5WxprDHqNVu2HaawAUOE9z5bGxQ8A7d4aNbj/O2&#x2B;81lQukxBC1mzcW79OlWZNahTnnGwjEAi8vb093YuShBtsAOB5PB5XF6LShajcG&#x2B;/dsxnNVpM5PtJk2bn3pNkcHx2b6K2U6UJUYQaNQafR69Sheo2vr9xT3QYAeBFlu6WxXC59v2vb/B8Tk9KLf06o6BAAAKCcEomENavralbXuTempWdHGuNMJovRbD164pLRZE1OyVAHeIcZtDqdOtSgCdWp9TqNVCryVLcBAF7AY7Y0viekBZmkBGKA3e5Iz8j288XUfyAEAQAAKhalQtqoQdVGDarmtzAMk19UcOlKxK69JyMi4/Ls9uDAAINeHarXGHQavV4TEhyAogIAqFgomYijUJKEhOKchM/jHT1&#x2B;efzk1alpWVqNr1AoeP2VxiXVQ6igUAMAAJWQ3UHHxCRGGi2mKIvRZIkwWWJiErkcjkGv1us1oXpNqF6j16k0KCoAgPJNoVAmFC8AHD91deOPf0yb9KlIKDj577Xz/90aNby7t1JWUj1kg8pXA4AAAABskZvrKiqwRhjjTFFWo9ESa0n2VsoMenWoXu0qKjDoNb4&#x2B;KCoAgPKi&#x2B;AFg1LgVE8f28sHfbMVQ&#x2B;QIAHogDAFuIxcJaNXS1ajxSVJCalhURGWeOshjN8Yf/uWiOik9OydCqfQx6rUGvNug1Bp3aoNNIJEJPdRsA4IUxDBMTm8gQ5ka4KThY9f3a3Rcu3Z4zvX9IsOrpH4bKC08AAAAewTCMxZpsMlsjTBajyWo2WyIiLQ4nHRwUYNA9KCrQqUNCVHwe9&#x2B;mnAwAohmI&#x2B;AXA46CatB3grZZPG95m36NdXXq5/&#x2B;25Mty6t3&#x2B;7YogQ7WelVvicACAAAAE9nd9BRUfEm1zYFJovRbI2OSeBzuaEGjV6v1etUYXqNXqfWqH0pCkUFAFBiij8F6G5EbFZ27pQZG&#x2B;bNGlStStCs&#x2B;Zu7dmpVq6a&#x2B;hDrICpUvAGAKEADA0/F53LBQbVio1r0xJ8d2Pw&#x2B;YrFsvHY80xlniU3x95LoQVZhBa9Cp9DptqEHjrfTyVLcBANRqnwHDFn6/bIxa5Z2ekW00WTD6BzwBAAAoSckpGUaT5cGzAqvRZE1Lz9KqfQwGjT5EHWbQ6nVqg04tFqOoAACervhPAJZ/v7NJw2rNm9Wy2x3DRi8dOrBbnVqGkuoeS&#x2B;AJAKsxDLP4u22BgX4fvPuKp/sCAOWUr4/c10fepFH1/Bank7FYk4xma6TRcu6/W79vP2o0WWmnMyjIP0yvMeg1&#x2B;hBNWKgmMNAfRQUAUOLOnA8fMqBrSmrGqHEr3&#x2B;/aFqN/IHgC8OxstryxX6/ec&#x2B;Bfg159YOcc7CgEAMWRZ3dERSeYTJb8SUTRsQkCPj8sVKsLUYfqNaF6tV6nVqt8UFQAwGYKhTIxMfGFR2u5uba2Hb74qPurBw6eHTW8e5wl&#x2B;eLlu5PG9VYFVKr72aVNKBQqlUpP96IkYRT7TJKTM/oPW3Dx8t0mjap/v2wURv8AUEwCPq9KqLbKo0UF2dn38vPAhf9uRRjjrAmpvj5yg14dptfqQ1QGg9ag1ygVUk91GwDKXnHu1YrFwg6vN83MzJk9Y8CMOT9UCwtKTkn/79Ltjm80L8EeQoWDJwBPdycitu/AubFxSV27vDz7m/9h9A8AZSk5OSPyQVFBhNFiMlvT0rOCA/11OlWoXuva0tigU4tEKCoAqISKXwNACImKSRjx5bKJX/Vu3KDa7AU/d&#x2B;rQom6d0BLpHkvgCQDrXLx895P/zc7Kzh094oMh/d/xdHcAgHV8feW&#x2B;vvKmjR8pKoi1JJnMlkij5ez5m79u/dtosjAMExyiCtNp9Dq1Xq8OM2gDtX48FBUAsJ7NZp8wZc2SuUNDglW5uTZzVDxG/4AA8BS79p7Mys5dPG9Il7deKvDWqdPXqlcL8cXe2gBQtjgcKjjQPzjQv/VL9fIb8&#x2B;wOs9lqMlsjzZaDf50zma3RsYlikcCg1xh0GoNbUYEHew4AZW/dD/v79ukUEqyiaee4KWs&#x2B;69PR0z0Cz0MAeIqmjav/8POhS1ciCgSAn387MmXGhkYNqv76w2RP9Q0AIJ&#x2B;Az6taJahqlSD3xsysXHOU9W5knMlsPXc&#x2B;/K4xLjEp3c9XbtBpDDq1Qa826LUGvVohR1EBQKV16vS1wf97Jys796uJq1s2r1W9SrA1PlWtQhEwqyEA3JeWnv33P/81bVIjSOvv3t7pzRZnz9/c&#x2B;OMfQRq/vp90JIQ4ncychVvWbNjn6yP/alQPD/UXAODpZF7iOrUMBVb9S0xKM5qspijrzdvRB/48ZzJb0zOyg4P8Xakg1OBamVQlFAo81W0AKClZ2bnmqPj1P&#x2B;z/fcexfp&#x2B;&#x2B;VaeWoU//bxfPGeLpfoGHIQAQQkik0fJJ/9mxcUlSqWjLxonu/1jeu2dLSc0khMyct1mj8X21Tf0vvlpx6K/zYaHa9avGBgf6P/6sAADlkb&#x2B;f0t9P2axJjfwWmnbGWZMjjXFGk/X02fCffz0SFR3vdDpDQtRheo1er9br1KEGbaDGF0UFABWLl1Rcv26VS1cilswbevtuzPgpaxZ&#x2B;O9ig13i6X&#x2B;BhWAWIEEL6DZl/5OjFQf/rsnPvCXsevW3LNNfIPiExrf/QBVeuRTZvWtNmy7tx06zXaW7fiW7Vss6KxV/IvMQl2AcAgHLFlmc3ma3mqPgIo8VoijOZ46NjE6USoUGv0Yeow0K1Br3aEKIOwGriAKWpRFYBomnn/MW/mqOtc2cO9JJi9PLcsApQJZGQmHbthrFZkxquPwYGnYaiLtWpZej6dqv3ek79bMCcrZunxcYl9h&#x2B;2wGJJ&#x2B;eC9V76Z9FlmZs6wMcvOnA3v3aP9xHG9sWEnAFRuQgG/etXg6lWD3Rszs3KNprgIo8Vstv57&#x2B;nqkyZKQlBbgp3TNHdKFqMJCtXqdRi6TeKrbAFBAalrm6PErG9WvunzRF6lpmaevRTZvVgs7DLIcG58A/HXkwoivlufm2LRa308/7uCgnZ9&#x2B;/EbPz2beuBX109rxNO3s0&#x2B;/bsLBAc3S87V7elyM/HNC3cwn2HACgkklISDVGWY0ma6Qxzmi2mszWzKzckKAAvU5l0GvDDBpdiEqvUwsFfE/3FKDiKf4TgJ6fTU9MTD&#x2B;0Z94PPx9a/v1Om82&#x2B;YsmIVi3qllQP2aDyPQFgXQBYvWHv3IW/CEWCLwa/u&#x2B;6HPxISUgVC/l9754lFwvd7TknPyN66edqV65GjvlpBCPl&#x2B;6cj2rzUp0Y4DAFR&#x2B;NO2MiUsymuKMJqvJbI0wWqKirBRFhYSowgxaXYjKVWocqPHjcjme7ixAuVb8AJCTY9vy&#x2B;&#x2B;E7kbGMkxk/pufajftbNq&#x2B;JAPBcEADKixcIAHl2x&#x2B;TpG37bdlSt9lnz3ejaNfW2PPvVa8aQ4IAAfyUhxGS2vv/xVKlEtG3LtN93HJu36Je&#x2B;n3ScOLZXyfceAIB9bLY8U1S80WQxmqyRJospyhodkyjzEhv0GoNOHRaq1YWoQvUafz&#x2B;lp3sKUI6USA3AjLk/qQO8&#x2B;33aiRAyZOSS&#x2B;bMGisXYO/w5iMViubxS7fvElhqAtPTsQSMWnTkXXre2Yc3yMa4Rv1DAb9KoWv4xep36&#x2B;2Wje/Wb2Xfg3N9&#x2B;nBwbm7B&#x2B;04Egrf&#x2B;nvTp4rN8AAJWFUCgoXFSQnpFtMltdCxAdP3nVaLYkJqUH&#x2B;CvD9Fq9TqXXa8IMGr1Og0UXAF7Yv2eucziUa/S/e9&#x2B;punVCMfoHVjwBiDRaPh88zxwV/1aH5vNnDRCJivjv/sy58DkLt6xd8eX5/24N/mJx25frrVw6avAXi48eu/TdwuFvtm9Wcn0HAIAniU9IMZqsRrM10mgxRVmMJmtOri040F/v2qZApzHo1CEhKhQVABsU/wnA0FFL584YIJEI/zpy4dftf69YPJLL4XA4KAJ&#x2B;DngCUPGcOn1t8BdLMjJzhvR/Z9Tw7kWWvf&#x2B;67ejkb9YTQq5ci3jjtSaTxvWeNuuHb2Zt&#x2B;m7BsA96fzN6wqrmTWt5K73KvO8AAGykCvBRBfi0aFYrv8XhoGMtyRGRsSaT9cTJq5t&#x2B;PhQdFU9RlF6nMejVBr061KDR6zSBGj8Ma6CSKeaN2nv38qzxKU7GufC73y9durtswfAl321t26ZB00bVS6qHUBFV8gBw&#x2B;O&#x2B;Lg75YRFHUwjmDu77dqvABNO2ct/iX1ev3eSu9Vi0d1bRxdULIJx93iI1LWrtxP4/HS0vLys2xJadkIAAAAHgKj8fVBQfoggNI24eNNltepMni2qlg175TJrM1OiZRqfDS69SherVBrzHoNAa92s9X4bmOA3gYRVF3ImJavTas14ftF8wePHr8ynp1Qhs3qPb0T0KlVsmnALXv/GV0bOJPaye4z/XPl5NjGzH2u8N//xdq0KxbOVYXHOBqz821iUSCL75cvufAv4SQMSM&#x2B;GNz/nRLsPAAAlJK09GyjyWI0xpmi4iNMcSZzfFJyuspfGWbQ6vUag14dqtcYdBqpVOTpngI8E7lckZiYWJwzREXHS6WihMT0cZO&#x2B;HzHk/XZtG5ZU39ij8k0BquQBoHbTvq1a1Fm9bFTht&#x2B;IsSf2HLbwRbn6pRZ0Vi0fkb1vjdDLv9pjc7pVGQwd0/fvYpQB/Rd3aoSXZdQAAKFsWa/L9LY3NFpPZGmm02PLyggMDXEUFoTqNTqfWhagE/Er&#x2B;VBwqouIHAELInv3/bvjpj/kzBwYF&#x2B;d2&#x2B;E1OnlqFE&#x2B;sYelS8AVPK/7GrV0F26EpGVnVtg4&#x2B;vLVyP&#x2B;N3RhUlJazw/aTf36U57btr6xlqQr1yKDgwI4HOq1V5CSAQAqPI3aV6P2dS8qsDvo2NjEiEiLOcp69PilyJ&#x2B;s0dEJXA7HoFfr9RrD/WpjtUaNogKo8GbN37x3/79/7pmfnJLe&#x2B;f2J5ijrL5smNahXxdP9qkgq6O3yJ6jkAWDM8A8&#x2B;7jtz6Mila1aM4T8Y5e/74/SYr1fZ8xwTx/bq&#x2B;0nHAh8J8Fd6K72sCSll3lkAACgjfB5Xr1PrdWr3xtxcm8m1pbHJsmPPCaPREmtJ9lbK9DpVqF4TqtfoQtShBo2vT6W6EQiVXo1qITdvRlEUNX7K2sVzh&#x2B;zYczw7J7e0Lzrpm/XTJ/ct7avAC6vkU4AIIZt/PTzpm/Xvd2szd8YAQsimzQd37D5h0Knf6dzqldYNivzIyLHLd&#x2B;079e/fy1QBPiXVYQAAqIhS07IijRaz2RJptkaaLCazNTklQ6PyCTVo9Tq1q6hAH6JGUQGUkhKZApSRmfPTL3/WqWVo06reiLHffTPxM4VcWiLdK1Ke3X7wz/Od32pZepcoYyKRSKGoVMsJVPInAISQjz98Lc6StHLNbq3G74sh733ycYdPPn7sxl52Bz1lxoZd&#x2B;04Faf18fCrV7zQAALwAb6VX44ZVGzesmt/CMIw1PsVoskSYLJeuROzcfTzSaLHTdHBggF6nCjNo9SFqg14TEqLiu80vBfCUq9cj69YOPXX62qB&#x2B;XS5evuvrIy&#x2B;90b/d7uDzeQI&#x2B;vzKN/iulyh8ACCFjRnxgsSQvXbE9SOv3fre2jzssPSN70BeLT5&#x2B;5UbuWft3yMfiLGwAACqMoylVU8FKLOvmNdgcdHZ1gNFmN5ri/j19a9&#x2B;OBmJhELocTFqrR6TQGnTrMoNGFqLQavyK3owEoPZNnbNixZXp0TOLZc&#x2B;Gp6VmjhnUvpQvt3ncqKzu35wevldL5Pajy/bFlRQCgKGr2jP7WxNQJU9cFBHi3aVWv8DEms/XzwfOMJmuH9k0XzR5U5G7BAAAAReLzuKEGTahBQ8jD1SNyc22RJovRbDWaLFt3Hjea4uKsKT7eMr3OtRqpWq/ThIVqsc8MlCqGITFxiUKRINaa7LA7&#x2B;g2et2zBCH&#x2B;/kp/mULNGiD5ETQix2x1JyRkadeWZR135AkDlrwHIl5mV&#x2B;/7HU&#x2B;MsSb9smlS7pt79rTPnwgcOX5SekT3of13GjPig8v02AwBAOZGSmhlptJjMFuODooKU1MxAje/91Yf0Glc8EItxHwoIKYkagCYvDwwO9v96bO/omPgTJ69aE1IHfN65yJuhJeJGuCktI2vsxNUn/lxaSpcoexKJRCaTeboXJYkVTwBcZF7ijd&#x2B;P7dZjSt9B83ZsmabV&#x2B;Lnaf912dPI36wkhC74d2K1La4/2EQAAKjkfb5mPt8x9e0qnk7FYk0zm&#x2B;EiT5fzF29t2Hos0WminMyjI37X6kD5EE2rQBAX5Y24qvIB3Orf6Ysj7kca4o8cvL54zZPaCLaoA71K61vmLt0eO/e74n0tD9ZpSugSUCBYFAEKIRu27YdWXH/ae/kn/OWtXfKlR&#x2B;8xf/Ovajfu9lV7fLxvVpFF1T3cQAABYh8OhArX&#x2B;gVr/Vi0fFhXk2R3R0QlGk8UUZf3r6HnTpviomHgBnx9q0Oh1GoNeHapTG/QatcoHT63hycZ&#x2B;8VHfQXPDb5mnjP/E7nBEGOOqVQkqjQvl5Ng2/vhHtSrBOTk2rdavNC4BJYVFU4Dy/Xvm&#x2B;udD5tvu2QVCnu2ePSxUu37V2OBA/xLsHgAAQInLzr5nci1IarSYo&#x2B;IjImOtCam&#x2B;PnKDXh2q0xh0ar1eY9BrUFRQmRR/CtCSFdtqVAuxWJOjYxMTE9M6vdmiZfPacpmkOOd0OGhzVHxYqNa98detf&#x2B;tDVD9s&#x2B;VOl8u7aqVW9umHFuUS5gilAlUHL5rX/2Dnnh58PRcck1qwW/L/P3sb6zQAAUP5JpaLatQy1axncG5NTMiKNFnOU9a4x7uCRC&#x2B;ao&#x2B;NS0zCCtn16vNug0oXqNQa/Wh6hRVFBBFf9G7cXLd0cMfu&#x2B;rSasjIuP69Gh/&#x2B;uz1kGCVvHpIcc65fdcxLo9bIABcu2GUyyUms6VRg6pbtv5dmQJA5cPGAEAICQkKmDi2l6d7AQAAUFy&#x2B;PnJfH3nTxg9nsTqdTJw1yWS2RkTGnfvv1m/bjprMVtrpDAlRherUBp1Gp1OHGTRBgf48FBVUdmnpWeYo6/Q5P9avGzZnen9CyKlzN4p/2m5dWvP5BceQNWvo5i3&#x2B;ddigbm93fGnEmMpTAVwpsTQAAAAAVFYcDhWk9Q/S&#x2B;r/csm5&#x2B;Y57dYY6KN5utkWbLocPnzFHxUTEJIqEg1KDR69QGnSbMoNHr1GpV5Vm6EQghcpk0KNDf11veommtM&#x2B;fCa9fSF&#x2B;dsBw6dadOqvlQqKjz6J4T0/OC17u&#x2B;&#x2B;QjvocRO/7/nh68W5EJQ2BAAAAIDKT8DnVQ0LrBoW6N6YlZ1rMlsjjBaT2Xr&#x2B;ws0IY1x8Ypq/n0Ifcn9BUoNeE2rQlN7GsVDaOBzqx7UTlqzY1vt/sxx2OjfXJpEIP&#x2B;nZ4cXOdu78zTfbN3vcuxt&#x2B;PBAU6L9u0/5PPu5Qq4buRbsMZYGNRcAAAADwOEnJ6ZFGiynKGmmMM5rjjSZLekZ2cJC/&#x2B;4MCg04tFAo83VNWkMnkSUlJxTnDocPnzv1366uRPbhcztVrkeG3ot7t2qaYS8pu2nywZg1ds8Y13Bunztx45vzNRXMGJySm/fzrX6uWjirOJcoVFAEDAABAZebnq/DzVTRr8nBsR9POOGuy0WQxmiynz4Zv&#x2B;e1vk9nCMExwiKqKXqvXqXQ6dVhoYKDGF0UF5dDvO/5ZuXik67fG20cmlYq5HM4Ln&#x2B;3q9cir1415dvuhw&#x2B;fdA8Dq9Xt37Tu59adpBw&#x2B;f27X3lJ&#x2B;vvAS6DqUGAQAAAACehMvlBAf6Bwf6u28fa8uzm81WU1R8pMly8K9zRtOe6NhEqURo0Kv1IZqwUK1Bp9brVKoAFBV4UkZmTmpq1qkz15VyaW6ubdyUNekZ2RqNT&#x2B;MG1Z7&#x2B;4UISk9K/&#x2B;fbHti/Xa9a05s1bUe5v5d6z/bTu659/P/zfpdsHdsz&#x2B;bOCcEvoG5ULl220DAQAAAACem1DAr1Y1uFrVYPfGzKxck9kSYbSYTJbTZ25EmOISEtP8/RShOo1Br9HrVKEGrV6nRlFBmRGJ&#x2B;OYo68af/pg4tvf8pb/t/HXGkhXbBEWV8D6LVet2jx310ZmzN7bvOvblFx&#x2B;6vzVi8Htnz99UyqVisfDSlbvBQQEl0f3yAgEAAAAAoGgyL3Hd2qF1a4e6NyYkphnNFpM5/ubt6P2HzprM1sys3OAgf32IOtSgDdWr9Tq1PkSFooLSIODzTx35js/nzV/866hh3RVyqdWaUrP60yt04xNSZV4SieSR7SOs1hStxnfPgdPdu7UxRyX4&#x2B;ijc3/3j0Jm&#x2B;n74VYbJ8PW3dptXjSvibQIlCAAAAAIBSFOCvDPBXNm9SM7&#x2B;Fpp2xliSjyRJptJw6ff2nX/4ym62EEJ0uf/UhtUGvDdL6cbkvPlsdXFxLdp46e33ksO6bNh9s06res5RqTPxm3dwZA9wDgN1Bn7twc&#x2B;TY5e3aNGjWuMbhYxcbNajq/pH0jOxTp6/PnzmQoij8xpVzWAUIAAAAPM9myzNFxZvM1kiTNdIY59qpQOYl1uvUoXpNqEGr16kMOk2Av9LTPS1TxV8F6MChM61b1es3eF56Rk6dmrq5Mwc&#x2B;y4SW9PRsuVxS4MiTp696SSX16oRO/GZ9r4/a13x0O&#x2B;ErVyPsDnrnnhO79p78tM&#x2B;bo4Z2L063yxWpVOrl5eXpXpQkBAAAAAAopzIyc0xmS0RknMkcbzRZIs2WxKT0AH9lqE5j0Kt1OnWVUK1ep5F5iT3d09JS/ADQsFX/3Bybr4&#x2B;8f9&#x2B;3Qw3aW7ej&#x2B;nz8hoDPL3yk3UH/eeT8W280J4SMGb9y9IgPNepHarj/PXO9Xp2wcZNXN21co0/PNwp8PCExbeCIhe3bNQkODFj/44HtP08rTrfLlcoXADAF6D6T2RoVk&#x2B;C&#x2B;vgEAAAB4llwmqVcnrF6dMPfG&#x2B;IQUkzneaLbeCDfvP3jGaLLk5NqCtP4Gvdqg14TqNfoQlU6nFgqKGOOy0Nl/Vubk3GMYZsKUNTv3nkhMSq9XJ8x9mdd8Fy/fyc6&#x2B;53rdp&#x2B;cbBUb/hJCFy7YyDDPw884Gvebo8cuvtK6f/1Zenn3MhJUTx/Zu1KCq08ms3bSv9L4RFB&#x2B;7AsD1G8bq1UKKnPp24eKtb7798fKZtWXfKwAAAHh2qgAfVYBP86YPiwocDjrWkhwRGWs2W0&#x2B;eurbp50PRUfEURelC1KEGjV6nDjVoDHqNVu3LwrnpfB6XpumBwxf1/OC1rp1fnjJjo0JR9CpMzRrXcC3tf&#x2B;9enlJZ8Ib3X0cuJCWnrVsxNsIY&#x2B;0GfaSsXj3R/d9XaPT26t3NVBSQlp5fOV4ESw6IAkJKa2bn7xM8/eWvn3hNL5g55qUWd5z3D6Akre3/0RoN6YU8/FAAAAMoKj8fVBQfogh9ZetJmyzOarSazNdJo2bP/X6PZEhObJJdJDHqNwbUgaYjaoFf7&#x2B;yk91OtnUvyp2g4HPWbCqvFjPm5Yv0penj02LqlalaAnHH/2/M3R41ekpGYe2jMvUOPnajx28squfSff7tjyjz/PXr52d0DfzsdOXsl/jJBnt1&#x2B;8cnf44HcJIRcu3Z42c9PXY3sVs9tQqlgUAHy8ZZvWfKXXaex2h0wmeYEz/HX4wkvNaiEAAAAAlH9CoaBGtZAa1R4pVE3PyI40Wowmi8lsPXbiiinK6ioqqGLQ6vUavU4dZtDodWovaXkpKih&#x2B;APjh54PvdmnTsH4VQsi38zf37vnGE4qA70TEfPf9jt9&#x2B;mLJizS6H3ZHfXqemvvX8YTv3ntix&#x2B;0SnDi0CArwt1uT8dy9djqhTS08I&#x2B;emXP/f9cfr7ZaMLTx&#x2B;CcqWSB4Bbd6Jttrz8uYOtX6pHCJn69Sf5BzAMU/k2dwAAAIAiKeTShvWruEbD&#x2B;azxKa7Vh65dN&#x2B;7ZfyrSaLlnywsJCtCFqMJCtYYQtV6n1unUL7Z/lv3u3bxTJ5l7ObygYEHrNhyZvIS&#x2B;yjNhGObo8cubVo9zOOhZ8zd7K&#x2B;VtX35SueOylTuWzR&#x2B;uUEgzs3ODAh8&#x2B;UfHxkRNCDv55bszwDyZMXatQeK1aOir/3ThLksxL8tWk1Twed9PqcQJUX5R7lTwAHDh09s8jF/Ztm/W4AwaPXKJR&#x2B;04e17ukruh0Mtb4ZO2DR2YAAABQzqlVPmqVT4tmtfJbHA46JjYxwmgxm63HTl7Z&#x2B;POhqKh4DkUZ9BqDQaMPUYWFavU6tVbtx&#x2B;E86TbivT8PZm3amP8jtWOHbPBQQcOGpfddCkhITEvPyD528urKNTtbv1RvyICuTzj4eripTi2DQiHdve9U4wbVCtRL5ObaklMy69QO7dr55TffaOa&#x2B;8hJDmFXrdn81sseH77/qatm992SXt1uVwheCklHJAwAhxO72AKswmnZmZGYXaGzcakBqWpYuRNW5Y8uB/boU2AbvyQ4dPjdk5NL9O76t/uju6AAAAFBR8HhcvU6t16ndG&#x2B;/dsxnNVpM5PsIYt2PPCZPJGhOX5K2U6UJUYQaNQadxbVng63v/Hr8zIyP7583uZ2ByczIWL1ROncYzPLJZcunxVnplZGQv&#x2B;u73L7/4oFWLuoSQ23djvJUyfz9F4YPDb5nT0rJWb9h77bpx/OiP8&#x2B;x299VChUJBdk5ualpGUKD/9p3HB/brnH&#x2B;n399PuWHVV/Xr3p9wYbEkG6Ospf/lyk7lmy1SyQOAr488KiYhNi4xUOv/7J9avmiELc9&#x2B;5Vrkj1v&#x2B;&#x2B;vPvC79smqSQP1IvbzJbb96OknlJGtSrIpWK3N96tU2DGVP6hgQFPHpKkp6R/dWk1XcjYrt2fnlI/3cq339JAAAAlZtIJKxZXVezus69MTUty2iymEwWo9l69MQlo8makprZvWub0SM&#x2B;sN&#x2B;&#x2B;ydjtBc9CO3J&#x2B;&#x2B;1X&#x2B;1fiy6bNAwP/7wCL3ltXr9kwa16fIg8MMgYu&#x2B;29a1U6se3dv1HzZ/25ZHFvLncKifN0wcM2FVVlZOdGxSWFhgpw7NXW&#x2B;93LKu&#x2B;5Eaje&#x2B;Iwe&#x2B;V6PeAElbJA8AbrzVetmpnu46jG9SvUqNqiF6v1uvUoQZtoMb3Cftgux4Ctn25fs8PXnu/55TZC37&#x2B;dtr/3A/Y&#x2B;8fpNev3ZmblCkX8fn3e&#x2B;mLo&#x2B;/mPyYRCQY/u7Qqfc87CLRcu3h7Q9&#x2B;2Va3bz&#x2B;dwBfTuX6BcFAAAAD/BWenk3qOpa/tKFYZjc3LwnfCTv&#x2B;jXicBCeZ8Zg878d9Li3GtavcvKvpZs2H&#x2B;w3ZP6sqf0KbBaWm2sbMnJJj&#x2B;6vvd2xxYYfDyQlpRV5ksSk9GUrt/v5KlyLAlUOle&#x2B;&#x2B;bSVfDVcV4PP3/gXzZw&#x2B;qXctgjo7f&#x2B;OMf/xsy/9U3R9Zq/NlrnUb3GzL/xk2T60iJRJyTa8vf/8LF10c&#x2B;asQHO3afyMmxubcPHdD18pm1l8&#x2B;snTyuz6bNhyZNX5//1plz4c3aDilwHpp27jtwetjAbv0&#x2B;7TRudM91Gw84nRVyA2YAAAB4MoqiXJOH&#x2B;aFVSJEDR6eTcTxpfnKJy8uzr/9h/1MPu3cv78sJK8//d6v1S3W7dHqpwLuzF2zp92mntzu2IIQU3iXAJSo6fsDwBQH&#x2B;yj/&#x2B;OksIiYlLLHbfoVRU8icAhBCpVNS5Y8vOHVu6fsyzO6KjE4wmiynKGmmyZOfc8/dVEEKaNKrmJRW/1G6oXqd&#x2B;&#x2B;aW6Bp3atXtI88Y18vIct&#x2B;5Eu1YMcDofnlnmJe7RvZ0uOKDX59/26N6ubu378/mSktJo9&#x2B;MIibMmZ2bltm3dgBDS7pWGX01afftudIGFyQAAAKAy4fj4iNq0uffPPwXauX5&#x2B;lEhU5EdKidFsDQp8ylzo6NiEMeNX9fqo/eF//vvyiw8pinJfKTHCaLHZ7a&#x2B;2aUAIiYlL3PLbkRFDCt7gt9sd0&#x2B;f8uGzBcI3KNyo6fua8n/z9lP0/e7sUvhAUV&#x2B;UPAAUI&#x2B;LywUG1YqLZAu7&#x2B;fcv&#x2B;Ob5ev3mU0Wc6cD9/y2&#x2B;G09GxCiEQqJISkpGQSQgICvE&#x2B;cuvpKmwbupTMvtahTu5Z&#x2B;3x&#x2B;n8wNAYUlJ6YQQdYCSEOLrI/fzU0YaLQgAAAAAlZu096d0QqI9/IZ7o&#x2B;TDHmXcjepVg5&#x2B;8NklqWuYXXy6fOfXz6JiEGtVCVAE&#x2B;X038fuK4PvlL/ezef7J7t7aEkJOnr85Z8MuMyX3r1S24LdK&#x2B;P06/0&#x2B;nlQI3f3gOnT56&#x2B;PuDzzn16vlFK3wiKiXUB4Ak0at8Zk/vm/5iekW0yWyONceaoeLXamxAyfPC7Yyas2nPgXx9vWahBqwtRhRq0Bp3K11seYYx7wpnz8uwcDiUUClw/KuSSjMycUv0uAAAAUBpy9&#x2B;7h&#x2B;Ppy1WquRvvUG/mUSKQYN&#x2B;He30dsJ084U1M4ASrxm28JGjUqm64&#x2B;O6FAsH7lWC6PM3/xb5PG9fp0wOwP3nvFfaHP6zdMfXq0/37dnlNnrm/4fqyvTxGLCP19/NK0rz&#x2B;9Hm5auWbnnOn9X36pbuFjoJxAACjawb/OJSSm9e7Rvr5bwO3csWX7VxvtO3CaZhiT2RphtOzae9JktuTlOZo3rfmEs/n7KZ1Oxhyd4NqlPM9mt5ft5D8AAAAoETm7djK59&#x2B;/icRRKrkbDVau4Gi1HreWp1VyVqmB1L5crer296PX2HujrM5NIhIQIZ83fXL9u6MhxK6ZP6lu7pt79gDybfezXq8PCtOtWfOlaRiU31yYWP7JOOo/D6T90gUDAW7P8y5&#x2B;2/IkAUJ4hABTt1p2Y37cf7d2j4B9XkUj4Xre27i1OJ2OxJqVnPOmOvkGvrlY1&#x2B;MsJqwb26xxrSYqOTdQFq0q&#x2B;0wAAAFCGnOlpzvQ0&#x2B;83wh00UxfX346q1XLWGq1ZxtIFclZrr51d0NXB5cvVa5LadxxrUrbJ&#x2B;5VilomCNr0gs6Nzxpc5v3a&#x2B;o3LbrGO2g69YJq1n94XzmGjVCZDLJ12N7rf/hQJPG1cuu6/D8KIapkMvRpKWlerYD5uiEHp9OX75wRIHtxPcfPDN01NK7V38qsDXgnYjYISOX3I2IJYS0alln0&#x2B;pxT947EAAAAMqh5P99nv8E4BlRfD5Xpeaq1VyNhqvW8mrW4AY8631AqdQrJSXl&#x2B;btZBIZh9uw79d/lO&#x2B;NG9xSJBO5vORx0995TWzWvM3JYd9fK5tt2HevYvnn&#x2B;Xqjp6dkKxcM9kSKMlgMHT2/86eCG78fm10CazFa9Th1ptKzeuHf2o&#x2B;unV3QymUwikXi6FyUJTwBeUICf4uWWdYTCh0vkJidnXL9p2rbzH5XKp/DgvmpY4KHdc81R8Xl2R5hBi9E/AAAASzB2uyMm2hET7fpR8u57knffL&#x2B;s&#x2B;MMw3325KTs2Kjom/ftPUuEE193fT0rMGft6lw&#x2B;tNCSF2u2PWvJ/u2Rxd3345/wD30T8hRKmQRMckjB35YUJCKql9v/H4qatTZm6Mio5Xq3xmzd88YczHpf6t4EUhALwgsVg4d8YA9xaj2fJp/zl8Hnfi&#x2B;N6P&#x2B;5QuBDN/AAAA4FmV1EyNLb8f0YVopkzoMGPuT1qVb4F3/XwVrtF/ZlbukJGLO77RvMhdTV39SU3LvHrdVLOGLjvnXi23UoEG9cLOX7zVvEnN6lWDRI&#x2B;WB0B5U8k3AitLTRpVD7&#x2B;48er59b0/KteFPgAAAMAqeXb7&#x2B;f9ufdqrQ1Z2bnJKhkZTMAC4MAwzfvKa4YPf69G93Z2ImLw8e4F3TWbrJ/1nt3trVG7uPULIxct33dc09/WRczicwf3fadm8zqbNB0v1G5Ux7AQMTyIU8AV8PFQBAACotCge19NdeG7//Xe7ft2wvDz7uElrnrAz1/mLt6uEaZs0rLb/0JmJ09aTRwe9N26au/WY9MWQ99u1bRQVnbB20/5uXVrz3H411v/4x9gRHxJCHDR9Lzev1L4NlAAEAAAAAIBnpZg0heLzn35ceZKanrX5t8PvfDjp3Xdanz57PT6h6JVUbt2OSk/PmjZr419HLqxY/IXg0a9ZrWrw6680qhIWeO7CzTt3Y44fWuLaGDjfp706HP7nv9L7FlCCcLsaAAAA4Fll/7CJsdsLNPJr1hK/3ZkXGkrx&#x2B;HRSouP2LdvxY/a7dz3Sw8Jead0gOSWjeZOaK9fuTkpO/7TXm0Ue1rB&#x2B;1flLfh0x&#x2B;L1Ob7bs0GXskQML5bKHS99kZGRduhIxaMSidSvHhhm0SckZ/n6PbAcWpPXfuvNYr4/aJyWll&#x2B;73gWKr5AHg8N//xVmTCy/nn&#x2B;/2nWilUhbgryyNq9&#x2B;&#x2B;E33s5JV&#x2B;n3YqjZMDAABAGaPj4/OuXS3QKGz5kmzQEMK5P6uCFxzCCw4Rvdbe9u&#x2B;prLWrGZvN/WB&#x2B;lSocqZSULbFY2KZVvbETvzeZrb9smlzkjPar1yOnzNz4/dLRrr1NmzetmZtrcw8Avj6Kjz96vXWr&#x2B;n4&#x2B;8iEjF/fq0d7f7/5WX2fP30xJzXizfTNCyJ2ImC&#x2B;//n5o/65l8cXgRVXyKUBXbxh/2fr3Ew6Yv/T3uYt/yf9x408Hz1249WLXYhhm/JQ15/&#x2B;7deDQ2fSMbEKIOSp&#x2B;1ryf8w/o8dmM/QfPvNjJAQAAwOMcN24UbKIoac9e&#x2B;aN/d8KWL8lHf1ngLX7NWqIOHUuvh0U6evzyqHEr27xcv0/PDnqduvABySnpsxdsWb7wi7&#x2B;OXnC1cDiUKsC7wGGhBq3dbu87aG7PD19/ueXDjX7Db5lz79kIIQzDjJ34/YJZg15v17jUvg2UgEoeADgcTk7OvWc//vcd/xz486zr9YWLd95&#x2B;f0JiUtozfpZhyM1bUcdOXPli7PLNv/xV&#x2B;ICYmMT4&#x2B;JLZywMAAADKHp2UUKCFI5NxvAsOlPPxa9UWtW3r3pKzb68zKalUOlcUhmFWrN7169Yjy&#x2B;YP&#x2B;&#x2B;/inX6fvRUVk5CRWXAjM5mXZMP3Yy3WZNeciB17jruP7wkhaelZhJApMzZMnblx8bwhNO08cvSR6f4Oh3P2gp8DNX4/rp0QFqot3W8FxVbJA0CQxjc6JmHn3pM222Or0Z0OZ5HtDofjRrjZ9mANrAOHzhb5cCD/AA6H2vHL9FHDu/&#x2B;1b/5nvYueXfcs7kTEPlfwAAAAgLLB3LMVbMm9R5xFDyRcBM1aPPKz03nvr0Ml3rHHyc6553DQyxd9sXHzwYH/63L6bPgXY5cXngIkEPAFfP71cJPD4Vz/w/6jxy/n3suLszwMKn0HzZs8fYO3t2zDqq927Tn569YjjRtVdz/DomW/y&#x2B;XS5YtGeEnFZfHFoHgqeQDo1LFFu1cajfpqRZ2mn7/&#x2B;9pj/DV0wc&#x2B;7mn387cvrsDYs12elkEhJSY&#x2B;KeKYjv2HPi1&#x2B;33ZxPNmrd5yvSNrtfv9piycs3u/MNO/HtVJOSLi7H/hd3&#x2B;SPB4HJp&#x2B;0l83AAAAUOIoScHRLWPPy7t65Qkf4chkBVryrlwu4W49npdUPHzwu&#x2B;G3zLm5trPnw3/65c8NK8fKvIoeo&#x2B;tCVOs27k9ITJs/c&#x2B;B/l277&#x2B;T6s8a1eNbhOLf3nn3QaNW6F08msWDxSIX9YyaBUeM2e3n/w/96pfOvlV1aVvAhYKBSsXjYqOTnj0tWICGOs0WS5dsO458C/CW4LYPF43E/7z2nWtGazxjXyCg2779172OJ03t&#x2B;NLyUtMzb2YWxwH6yPn7y2b&#x2B;83P&#x2B;tT6tP7Zs7bHH7LvGXDREJInt1x9Nill1rURuwGAAAoPdyAgMKN2Zt/4lerTomL/ieYjo0p0OKIiiI0TbhltJ8ATTtnzvuJQ1E&#x2B;PrKVi0dyuY&#x2B;9&#x2B;dumVb2zx1ZSFFmzcV&#x2B;N6iECwcNlQL&#x2B;d1u9ORMy4SWs&#x2B;//QtpUK6a9&#x2B;Jbp1b57/7ztutSvc7QEmr5AHAxddX/torDV97pWF&#x2B;S06OzWi2REUnEEKqVw0eMGzB8tW35ufYCCGtW9Vz/&#x2B;yqdbu/HPGhKsA7LS0rM6vgnDnPysi435979/IGDl&#x2B;0ZeNEV&#x2B;U&#x2B;AAAAlAZe9VqFG&#x2B;m42PTZM&#x2B;XDR3J8C&#x2B;6wy&#x2B;Tk5OzcUfgjzqxMjkJZGj0s7Mcth27djp7zTX9XYS7DMDTt5BW1ndmZc&#x2B;Ems/X0&#x2B;fBAjd/Azzu7v3Xg0JkJU9d6K2XTZm6y5eXNmva/suk8lBJWBIB8ySkZA4YtnDSud/26YbVr6mvX1Lva/9w7nxCSnpEdabQIhY9se3H23M2Wrw7l83l2u0Mo4k&#x2B;YurZp4xqXr0SkpmYmp2T4&#x2B;sjTM7LS0rLcP&#x2B;JkmLL6QgAAAFB2uAH&#x2B;/CpVCi/w74iISP1ylKjNK/wmTXg6PUcmc6an2a9dzdm2jU6IL&#x2B;JEZTVUsNnsew&#x2B;c/v3HqaEGDSEkIzNn3KTV0yd/5uujKHywOcq6ZMW2SeN616gW0n/4gp/XT8x/658Tl3v3aN&#x2B;qeZ17eY4T/15p1rjG9XBT/jiqMKeT2brznw/efaXkvxKUBHYFAKlEKPMSu9boLCD8lvnoscsfvv9qQuL92UF5djsh5M89c/YfPEdxKLFIUL1q8Iy5P309bR3DMM0a1XzlzZGBWv&#x2B;4uOTtu44HBChfbdNAqfBKTE6PNFlcZ3DQTkKILc8uFLzgloGXr0b8e/aGQi5t1rgGauoBAAA8TtS5q33R/MLtTF5e7l&#x2B;Hcp&#x2B;lwJfLLVwYUEq4XM6m1eOkUhEh5E5EzJBRS19uWafI0f/fxy4tWbF93OieQgG//7CFFIfKy7PnzwKa/U1/QkhCYtqUGRs&#x2B;69Ox/7AFc6b3f9xF0zOyx05cdTcirtIEAE5Ry7xWaOwKACKRcMP3XxX5VoTRsui7rdb4lJ9/O3zy8LKk5PT9B88Eav2EQmG3Li/nH7Z2&#x2B;RjXC4Zhjvxz6dyF8Lc6NFervCdOXT9/8W&#x2B;ut3bvO3XrdnTrVvWuXIsghBw6fL5zx5Yv1uEr1yP37P83ITE1OTmj05stZk3r97jCnaey5dnffOerYQO7XbkW2afnG647AQAAAPBchI0b2&#x2B;o1yLty6YXPwAvREe6zDsCY4j0r4PG4rtk&#x2B;Bw6dWbNxP4eiRg3rXuSRJrNl2YLhd&#x2B;5ET5/9w99/LJoyfUNaerb7TqkOB/3Ntz&#x2B;EGbTLVm5ftWTU4zZRtcan9vnfrKjohECtX3F6DqWKXQHgCd5&#x2B;s0X7do0ddvqN15okJae//d4ELpcza2q/xx1PUZR7XUHXt1&#x2B;OsySZo&#x2B;N9feR8Pq//0AWbf/kr5969dq80HDNh1fjJa15qUSclLbPASXJzbROnrx8x&#x2B;L2QoCKKigghvT9q3/uj9oSQf89cHztx9Ygxy9avGvtiX1Ao4L/SpgGPz/3z7/M1qocgAAAAALwYr4GD0iZNcCYnv9jHhc1bPP2gkkPTzgVLfrMmpLRqUbtendDHrRfyWe&#x2B;OySnpm3/5s3HDalZrSk6urcAQf8mKbRev3AnwV65fOZbPf&#x2B;wAMio63lVjyedhkFl&#x2B;4ffmIaGALxTwW7WsQ9POk4eXSiQi9yWunkwg4Ol16vzd9f45uDj/rWs3jGvW7xOJBXVrGWRuW2oTQuwOeseuEx90e&#x2B;VxASBfy&#x2B;a1164Y81a38Sf&#x2B;vVpgb45nN2V8H0JIl7deerGPAwAAACGEI5crxn2d/u0MZ8pz7&#x2B;/JkclFr71WGr0qkt1BDxy2sFXL2h&#x2B;&#x2B;/8riFdtHD//gwKEzTRvXcF/iM9/R45ffeL1phDHu474z164Y4/7W38cu/bjl0JQJn7gv/vMEISEqHr&#x2B;yTZupTBAAisDlcjTqgoX8L6xOLcOS&#x2B;UOfcICzqA1Ejhy9GKjxa9GslmveHiGketXgpo2r/3n4wosFgNS0rKUrtxuNltq19H37dPT1kb/ASQAAAIAQwtVoFJOnZi5Z7DBGPsfHKMpr0CBKLHn6kSWEdtD9P&#x2B;vUvFmtoaOWjv&#x2B;y59yFv8Rak157tVGRB6elZV0PN00c27tmdd2tO9F1a4fmv7Vj9/HN6yc&#x2B;ruo3OSV9z/5/P&#x2B;31JiGEYZiaNXQ3b0VpNSU2lIIShwDgSV5SsZdUHH4zqmXz2vmNNpudEDJz3mZ7noMQ4uerCDVodCGqUIPG6WRuR8S4qoqzs3OTktMZhnnGTTcGj1wcE5PYpVPLv49dOnDo7N6tsyQSISHk2g3j79v&#x2B;4fA4nTq0aNKoWul8UQAAgMqG6&#x2B;evnDotd&#x2B;/enN07GVvBHYILo4RCr0FDBPUalH7XHhKJBM2b1dq971SVMO3kbza0bF6r/&#x2B;dvO&#x2B;zOIlcneatDi5u3o/Ye&#x2B;Hfj5j/MUfHvd22b/9aCbwc9btrPlasRQ0cvrVs71BUA0jOyw2&#x2B;aS&#x2B;fbQIlBAPAkDod6953Wqzfua/96k&#x2B;BAf1dj&#x2B;K0oQsi/R77LyMyOT0g1meMjjXGmqPhtO4&#x2B;bo&#x2B;LtdkfNhp/6&#x2B;shTUjMZhhk8cslLLeo0qBta&#x2B;OSZWbl5eXbXnf7k5IwzZ8N/3vB1i2a1hvTv1uq1YTv3nuz5Qbs7d2Pe6zm1Yf0qUqnowz7fLJg9qOvbrQghazbsvXU3JsBP2a5tI6QCAACAonF54ne6Cl973fb3EdvJE46Y6MccxhU2bSb5sAfX379s&#x2B;0cIIenp2YuXb5XJJONG9VAovD7pP3vDqrGum4AFaNQ&#x2B;Mpl40vQNv/84teuHE93fetzo/&#x2B;TpqwOHLbI76PwWLocihHA41FOnN4MHIQB42JdffBh&#x2B;y9zhnbFvvt4sJDggN9f282&#x2B;HG9av4uMt8/GW6UPUzZs83NvL6WRiLUl/H7vIMMRmy2vepOaYr1cd&#x2B;ut8kUsEnD5zfcyEVZfPrCWEOGgHIcS1gpBEImzSuHr4TRMhZMeeE6EGzZaNEymKWrRs69xFv7gCwD2b3UkzJ05dXbV2z1sdmi&#x2B;cM1jw&#x2B;HIfAAAANuN4eYk7dxF37uJMSbbfueOMjaVTU0ienXAojlLJDdHx69ThyDw283bOoi1Kpey7BcPOXbg1f8lvS&#x2B;YO9fEuojN2u2PClDV//Hlu2cIRXC6HW9ROYYXdjYhzjf7diwpkXmKltywqJqGkvgKUOIzqPEwqFW3ZOGnvH//&#x2B;efjCocPnHQ66Q/umX474oMiDORwqONC/T4838lv&#x2B;3D3P7qCjoxOMJmvhhX3yc4EqwMegV89Z&#x2B;Ov8WQO8Xc8EUjMJIekZ2UGBfq5JRG&#x2B;&#x2B;0XTZqh2JSWn&#x2B;fsphA7u5PvjfpTsDhi&#x2B;c/u0P0yf3dbUsX72rXh1D65fqFbiW0WQNCvLnP9vfFwAAAJUPx8dX2Lx8TXzPzr7HMOTHtRMWLvstKTn9x7UTirz3TwhZvX5v44bVnU5GFeC994/Tzza/&#x2B;L4&#x2B;H7/x5RcfuV67hh7R0QkhIapidh5KDwKA53E4VJe3XnrhxXn4PG6oQVN49C&#x2B;VirKyc3NybK4/6kvnDxs6ckmLV&#x2B;&#x2B;XI7v2A29Uv8rX09b/c&#x2B;Jym1b1XCsUpaRm&#x2B;vsp80/SqEHVb6f2Gzhi0dCBXVUBPoSQ/QfPJKdkuAJAr8&#x2B;/rVE9eOLYXoSQ1zqNnjez/3tu8wUBAAAqMTo&#x2B;3n71ijMpkcm9R3lJOd7eHLWGq1Zzff3Icw2fS5NUKho9vPvA4Qvavlx/4theFEVFxSQoFV7yAssS2h0Xr9xdu3xMpNmydMU2Lpf749oJjzvn6TPXL16NGNSvCyFELBbOmzmw81sP9zuiCMnMyiWE&#x2B;HqX0WZn8AIQACqt2rUMAiH/x18ODejbmRBSu6b&#x2B;yIGFdyNi09KzV67ZJRULCSFdO7c&#x2B;efrGZwPmKuRSrdaPELJu04HgIP92bRsadBpXcni1bUOxWHjq9PVuXQqu/EXTdFp6VpFXN0cnjJu8OjzcXKuW/usxPWvXMpTutwUAACgrTG5u1ob1tlMninyX4vO5KjVXreZqNFy1lqNWcbVaT00BstnsfQfOnTCmZ4vmtQkhx05eWbD0tx/WjC9wWExsoq&#x2B;PPDkl/eKlu6&#x2B;/2qh/37eLXGKEYZh1m/YvXPZ7rx7tCSFXr0VarMkjBr9X&#x2B;MjqVYNseY5S&#x2B;EJQMipqAKAojtNJP&#x2B;MCOOykkEu/HPHBrHk/Wywpn/bqoNepKYqqWiXoTkTshYu3Rw3vTgjhcjkLZw/6Yuh7586HX7lmDL9p/ufklZTk9EXLthJCAgK89SEqg17NoaiTp6&#x2B;pVD5hBk1KamZiYlr&#x2B;VYosP3A46H6D5wkE/AljPz50&#x2B;HzPz2b&#x2B;uWdeQIB3WX11AACA0sLYbOmzZzoiIh57gN3uiIkuUBBMicWuPMBTq/mNGvH0ZXRfjOKQmVM&#x2B;r1snlGGYlWt3n7twa8OqsYW3Obpns0caLX0Hzh076qNWLR672vjSldtXrtlNCOFSnN&#x2B;2H50x&#x2B;8e3Ohbc1Ix2OmvW0IXfNNeoHlLiXwdKSkUNAAqFghDidNI07XQ6aaeTdjicDOOkaaSChz7/5K1Ard&#x2B;Cpb//8PMhH2&#x2B;ZSuXDMMztO9H164Z99P6r&#x2B;YeFBAWEBAXwBfyffvnrz91z5TKJNT7FZLaaouIjIuNMUdaAAO/de09t33X/VseZc&#x2B;GDRy6pVUN3/YYpOjYhITHN9awgISnDdcA/xy8bTZZ/Di4K1Pp37fxyq3bDdu07&#x2B;b/P3i77XwEAAICSlbt96xNG/4/D5OY6IiMdkZE2QiSEKbMAYM&#x2B;jFy/ftnje0K8mfq8LVq1dPobLLXp/LgftWLFkZKDG7wlns8Tf3/gsJS1jw/Q/Ch8QZ0nauftk5VsGtPKNLStqAHDhcLgcDpeQh4vZMgzjdDqdTidN0zRNM4zT4aAfVKSw0Zvtm73ZvtmduzGXr0bEJ6YxDDN6&#x2B;AdtX67He1CtO/mbDWnpWXkOx9Fjl9q90tA1KVCt8lGrfFo0q5V/Hpp23o2MzczMUcilUqlo8fJtO3YfDwkJqBoa&#x2B;FK7oSKxgBCybuO&#x2B;SGNsm1b1lq3aGRDgLZGICSECPs/bW5aaVvRMIQAAgAqEyc7KPXTQ0714DrTTGROX9En/b/t92umtN5ozDJOcku7rU3Ab4OAg/182ThYKi9odgJA8u13Av/&#x2B;WzEs8Z8bA0&#x2B;euu36sXiUo/7BTZ66N&#x2B;mqFq5JQJOIH&#x2B;CtL&#x2B;ttAianYAaAwiqK4XC6Xy&#x2B;XzC6YC18MCp5N2OGiGcRY5d6WyqlolqKrbH1F3Go1vcloGIWTE4Pc&#x2B;693hcWfgcjnVqwbn/zh3xoD815/0evPy1buqAG&#x2B;nkxk9fuW2nce1Wt/gQP/XO41&#x2B;9502DGHuRsQO6te55L4NAACAZ&#x2B;RdvcLY7Z7uxfPJys79buGwqmFB2dn3xk1efe7CzX8OLikw1veSiov8LE07l67abghRd&#x2B;38MiGkWljg4H5dQoJVp89dF4n433z9WZe3W7mOPHXmWr/B851Oxt9PqQ7wttPOBLcJw1DeVLYAUKT8VODe6HzIFQlop5NhVSpwGfS/LsU8Q4N6YQ3qhblev9WhuS3PzufxnE7nlq1Htu04lpKS0f3dtp06tnzySQAAAMo/Z5yljK9Y/JFJmF5TNSwoJTVjwLBFn3/SMSk53RRldb&#x2B;p9zjp6dmjx6888e/Vb7/p52rp2&#x2B;ct14vgwIBfNk2uUe3hLP/4hFSnkyGEBAR4m8xWu4P29yv4nAHKD1YEgCJxOBwOp&#x2B;A0uEenD9EOhxOlxs9LKOATQjgcbu&#x2B;P2vf&#x2B;qL2nuwMAAFBinNnZnu7Cc3Nt4hufkBYWpn2zfbM//jon95I89VOEkC8nrjrx79Ui3&#x2B;rd4/6/7w4HnT&#x2B;pmKKooQO6Vq8afPLfa4QQpdyrBHoPpYO9AaBIrlTA4z3yy5I/dwilxgAAAGzG8SpiUMsNCJD27ccNCHCmZzjjrXS8lbZYaIuFtloYm63sO&#x2B;lOJOJ/2vvNv45cCAz0F/B4TieTnp6t0TzTbmX3cvMIIb6&#x2B;8lo19EUecOjwufBbUa5lQBUy6colI19pXf/w3xcIIbVq6tIyMkvsa0BJQwB4ugfTh1BqDAAAwGqc4CKWtpS8976gTl1CCDdARapWdX/LmZpKx1udFovDYqHjLbTFSsfHl1FfCSGECPj87buPTxjzsUDAGzvqo31/nH6ldf0nHG&#x2B;3O3JybfnrhNarE7p0/nC1quBC3jTtXLx865oN&#x2B;/p8/Iarpd0rjVwv8uyOsFDNjfBKtQxo5ZsijgDwIh5favzgaQErS40BAAAqN0Ht2pRQwNjyHmkVih53PMfbm&#x2B;PtTWrUFOY3OZ1lWUack2Oz3bO5puNHRcf/vv3oulVjH3dwYlL6iC&#x2B;Xjhr&#x2B;YZOG1Wja2aF90&#x2B;7vthXwi1gaaMXqnWs27CvcfuVqxJbfjkREWkjlGjRXvnkfRa8FCy&#x2B;AoigulycQCEQikUQilcvlCoVSLld4eckkEqlIJOLx&#x2B;Fwup/L9NwQAAMASlFgsavd6gca8f089xyk4HEoofPphJSTWkugah5&#x2B;9cHPE2O9mTP2cz&#x2B;MWeeSFS7e79Zj036W7UokoPT174IiF6gBv1&#x2B;g/Lb3gWt6Z2bmEEB6X676a0G/bj/b6fFZqeiYhxMdH5q2Ulc53ghKAJwCl6/GlxjRNO1FqDAAAULFI3n0v78I5OiExv8V25jRHrpB0/4CSPFNxbVny9ZYfO3mlY7dxQiF/ydwhIUEBjztyyBeL09KzCSFGk2X46KXRsYkfvfdqTo7t62/WtWlVt1vn1gWO91Z6ScRCm&#x2B;3&#x2B;04xde09Onr6BEMLn80INGos1uXBsqLgKrCRZCSAAeMCDUuNHGlFqDAAAUP5RYon8q6/TZ37jTEnJb8z98&#x2B;C9o3/za9fiBQVz1VqOWsXVaDgKpee6eZ&#x2B;Pj3zTmvGZmTmtX6rLe8y9fxeadhJCWjSrtXDZbzGxSYSQhMS0D/tMuxMR26ZV3QIHU4S6l5fnvstn/nBfJBTcCK88OwHzeDylUokAAKXl8aXG&#x2B;c8KnA6Hw4M9BAAAAEJI3vlzzrS0Ao2MPS/v0qW8S5fyWyixmKtSczUartr1vxquRkOJy/opQZOG1R73VkxcYoC/0jXPh6Koz/u8NWp49ze6fEkI0YWoN20&#x2B;ZIqyFvgITTuXrNh6&#x2B;erd3Jw8QojA7XamWMTXav3uPSiQ0Kh8Svy7lDGRSCSXyyvl3VgEgPLLrdT4YaNbqTHtdDpRagwAAFCWbMePZW/Z/CxHMrm5DpPRYTK6N3Jkcmn3D4TtXiud3j2H46eujhm/8s&#x2B;98wV8flJy&#x2B;owpfd94rSkhhDBMzZq68HBzSLCKEFIlVNusSU3XR9LSs0aNW3Hq9PX6dcMIIZ07thgyoKvrLYfdIZFKIiIttWrqeDxumEGbnX3PI9&#x2B;rRDAMI5PJpFKppztSWhAAKhhXqXGBJ1EP9zR&#x2B;sCyp04lUAAAAUMIYe172L1uKcwZnZgadllpS/XkxDMOsWrdn2crtrr17/7t0Z/iXy379YbLrXZXa57&#x2B;Ld1yvO7Rv&#x2B;u3U/0kkQkLI9XDT/CW//XvmOiGEy6HGj&#x2B;n5yccdXIf9tv3oX0f/S05OJ4RwCOXnq7h1J7pZ4xpl/9VKBIfDUSgUAoHA0x0pRQgAlcEzlBo7HQ4apcYAAADFkXflqjM9zdO9KK7MrNwly7e5Xv&#x2B;&#x2B;/eji77baHXT&#x2B;u/HxqYQQDofq2uXlQZ93do0ctu8&#x2B;Pm3mpupVgwkh3kqvls3ruEb/eXn2ad/&#x2B;sG3nsbp1QgkhjRtW6/B601nzNhNCSMUccfD5fIVCUfkm/ReAAFBpPWOpsdPp9FAHAQAAKhjabHz6QRUEh0MNH/zevMW/Fn5LIZfKZJImDapRFGW3O&#x2B;Yu/uXHn/8khDCEMeg01sTk/NuJ63/8Y9vOY67XvXu2Hzuyx94DpwghwUEBAkERGwiUc2KxWCaTseFuKfYBYBfX5mVCoUgslspkMrlcoVAoZTK5VCoVicR8voDHQyYEAAAoGpOT6&#x2B;kuvLh/TlzJf62QS1d/N3rg551dP9aqqcu/IahSeTtoOiY2kRASn5Da6/NZp8/ecL3lJRUbzRZX&#x2B;a&#x2B;Lw&#x2B;4ghIhF/JrVdF9/2YvP4zIMqVlDFxuXmGcru/3Oio&#x2B;iKLlcXllLfgvDaI/tHldq7PasAKXGAAAAhBDCkRW9uRU3QMXx82Oys2mrhbHZSvCKJfKgnqadC5f&#x2B;/vuOo2ePrSSEiET8bVumBWn9CSFisUCj8r0Rbs6fSxwfn&#x2B;qq3715O2rkuOXJyRlVqwQKhfxpX3/655ELrmPcR8nqAG877cxz3B/u005n&#x2B;M0Ktgwol8tVKBT8ovY8rqwQAKAIFEUVfhSAUmMAAGA5TmBg4UZR6zZe/QeSB2NiZ1oqbbU6rfG0JZa2WhxWKx0fT158Ie/i/jublZ07dNTS02dvyLzErhYBn&#x2B;8a/RNCxCJhpMlS&#x2B;FMd2jfdtvOf5OQMQoivt3zO9AG1auj&#x2B;PHKBx&#x2B;WGhWmlUpHrMB6fl5KamWd/&#x2B;O14XA4hhMOhfP0Uxex52RAIBAqFonAtZeWGAADPCqXGAADAcoI6dSm&#x2B;gLHnPdLYvAVx&#x2B;4ePo/TmKL1JjZoPj3A66aRk2hrntFpoazxXW0SKKD3RMYmuOTxcbhFj3JTUTEKIr6/CtSIQIYTD4Ywd&#x2B;eFnvTt26zGZEPJyy7rzvx2oVHgRQoRCvipAeet2dP4/9A67wzX6V8gerpgp8xIrvWXJSeml&#x2B;8VKgkQikT3mqU7lhgAAxYJSYwAAYA9KJBK/8UbOvr3ujYzblsBF43C4Af7cAH9Sr34pdu6J/PwUS&#x2B;cNc7222exC4cPpLmGh2pjYRA6HIoRERcd/M/HTls1rE0Ioigzs13nYwHddyeHPI&#x2B;ejoxNjLcnup83JsRFC&#x2B;nz8xpgvPnzQRhFCoqMTNAHleiMwiqIUCoVQKPR0RzyDXc87oGyg1BgAACorcddu3ACVe0vO3t3OjAxP9edZNGpYdceW6Y0aVCWExFqSenw23dVud9C1auoiIuNsNjsh5Mg/l97rOUWplBFC4hNShw9674sh73O5HJp2Llj627DRy2iGJoRUrxr0ervGrjPwhbz53w6aMOZjPi9/3UwmMyuXEMLjl9&#x2B;VNDkcjo&#x2B;PD2tH/wRPAKBsoNQYAAAqh7SJExgn7d5CJySkTRgn6dpV0Lgpx9vbUx0rEk07z5y9vmn1eNcA/eTpq6O&#x2B;WpmekU0ISUpOH/HldzfC7xfsbvrp4A8/H3K9Pnv&#x2B;5shxyxfNHkIISUvPmjx9w6HD511vde7YYvrkz0Wi&#x2B;5tkDR3QzW3o/1D1asE0XU4f/guFQrlczrZJ/wUgAIDHoNQYAAAqHGdGJpObU7AxLTVr4waycQNHLudqtFy1mqvWcDQarlrNVakpDy0vk5qWOfKrFdExCZ/27kgIiU9I/d&#x2B;QBa65/hcv3x0&#x2B;ZmliUjohhM/nGfTqbbvuL&#x2B;e/78C/G376wzV8v3bDOHzMMlfJL4/LfbV1g2GD3nW/ROHRP00zNWvowm&#x2B;ay&#x2B;FOwAzDeHl5eXl5ebojnocAAOXL40qNXc8KUGoMAADlmTMjw5mRYb9182ETRXF9fblqDVej5apVHLWGZwjlyOWl3ROLJfnjz2fGWZIDtX6uFgdNu0b/VasE9uk3y7X7r6&#x2B;PnMfl3L4TI5WKOBxqzIgPNv/yl2v0f&#x2B;LfK5t&#x2B;OmTLs1etEuit9BKLhUFB/oSQvDy7OTq&#x2B;alhQkde9d89WPpcBpShKqVSyedqPOwQAqAAKpwKGYR7MIEKpMQAAlGMMQycl0UlJ5NpVV4Pk3fck775f2peNjk2MsyQTQrweLNlJCOFwqOrVgsNvRrl&#x2B;bN605qUrd10FAN5KrxWLvmjetObmXw8TQgb9r8uRfy7a8uyEEJmXOCYuMTUtixASZ0kaNnpZl04vPS4AuMKDWCL09i5Hq&#x2B;twuVylUokSxHysnv8EFRdFURwOB6XGAAAAT9CoYdW1K8a6XicnpQcF&#x2B;eeP/vv27rh&#x2B;5VjX6L9u7dBN349r3rQmIcTLS7xi0YgRg99zPWn/&#x2B;KPXOVyua/ffO3di3&#x2B;0x&#x2B;Xq46ckX1Wp8RUJBVlZ52TVZJBL5&#x2B;vpiVOAOvxZQeTyu1PjBDCKUGgMAAIt8/NHr40b3dE3TP/Hv1UnT1lviUwghYonw26n93mzfzHVY925tJ43vLeDzCSFnzoXPmNy3bu1QQohIyJ87vX&#x2B;Xt1v16fctIaRmDd2/566npWc/&#x2B;aIcLichMc3hoPMLhT2IYRi5XC6RSDzdkXIHAQAqufxU4N6YP30ofwszlBoDAEBl0rB&#x2B;lWZNahBCGIb5fv3epSu2iUVCQoguRL1i0YiwUK3rsBlT&#x2B;r7fta3r9caf/pi3&#x2B;Netm6e5fly2YIS/n4IQQlGuiUPmWjV1hJB2bRt069L6cdd10k6HgyaEuG814BEURXl7ewsEns8h5RACALDRgwWIHvnvH6XGAADwVN5z59OWOGd8vCMujk6w0nEWOiGB0A5P96sgPp9HCMnKzp0596cdu08QQsQSYYtmtebM6O8lFecf5hr95&#x2B;TYJn6zbv/BM&#x2B;5ncI3&#x2B;CSE8PufW7WhCCIeihg9&#x2B;d1C/LoX/cXQ6GddWYi61aurv3csjnsPn85VKJcvX&#x2B;nwCBACA&#x2B;1BqDAAAT8WRyTjetUmt2g9Xk3E66aRE2mpxWiy0NZ62xNHxFjopmXj6wXJEZNyQUUtcK/9wOFSvj9oP6Pt24bG7yWwdNnppnPX&#x2B;Fr/OQuv32/NoQohCLh0&#x2B;&#x2B;P02reoWvtDR45ev3zAOGdDV9XGDXnMj3KRReWwnYLFYLC/9dZYqNAQAgMeiKMpVbUzIw&#x2B;eYDMMwjGubgvxnBeXuxg8AAJSSjIXzZcOGU2K3aeUcDjdAxQ1QkXoN8tsYu52Oj6etFqfVSlvi6Ph42hLnTE8vs36G34rq2XdGbo4tJFilkEsXzB70csu6hBC7g16xeueIwe&#x2B;5Djvyz8WxX3&#x2B;flZ0rFPClUpG/r5LD5RBCaNqZk2uTed1/VlCzRsiyBcODtP4FruJ0Msu/37Fize7ePdsTQs79d&#x2B;vYyatGk6XMvmYBFEXJZDKxWPz0Q9kNAQDg&#x2B;VAURVFcDgelxgAAbGS/cyd95gz5V&#x2B;M4sifdY6b4fF5QEC/okbUymXv3aEscJXqO4ekL/0sSF5eYm2MjhGhU3hu&#x2B;Hxuo8SOEJCaljxi77M6dmBGD36Np56Jlv6/dtN91vK&#x2B;vPCfHZoqyioT8lNSMkV&#x2B;tGNK/a7MmNRiGea1d44/ee7XIOf2r1u5evnqX6/XGnw7OX/JrzRo6Qoi/n6Lsi4C5XK5CoeB7aNu1igVTowBKgKvUWCAQiERiiUQql8sVCqVCoZTJZBKJRCgU8Xh8LpeLigIAgErAYTJmzJzhTE193g9SIhFPbyBluB5l186tVn83xjX6T0hM69Zj0n8X7xBC0tOzBwxfmD/6f6tDc2t8Slp6FiEk0mR5t8fkM&#x2B;fC&#x2B;XxeVnbukJFLgjS&#x2B;rtF/RmbBLZDTMrIIIRwOlZGRPXvBz67y36pVAjMyc8q4BkAgEPj4&#x2B;GD0/4wQAABKC0VRXC5PIBCKxWIvLy&#x2B;ZTK5QKOVyhZeXTCyWCARCPp9PURw8KAAAqHAcMdHp06c5U5Kf61N0XGz6N1Ntx/8ppV654/H5k8f3mf1N//w798kpGUlJ6YQQuUz6Xs/JJ05dJYRwuZxxo3sunD3YVSrQtnW9r6eus8anEkISk9Le6zn1yD8XBUKBzWb/atLqw0cvFL6Qr498w6qv8mcHCQS8O3djXdsLlBmJROLt7Y2S32eHKUAAZcpVauy&#x2B;Hcmjpcb3pw&#x2B;h1BgAoJyjE&#x2B;LTpk5WfD2Zq1I99WDGbr&#x2B;3Z3f27p3E4eDXLaKOtsS1fbne/UszjPvz5yph2qTkzLS0TEKIj49s8ZyhrtVCCSFD&#x2B;r8zZEC35m0HEULCDJpv52&#x2B;2WFMIIenp2R9&#x2B;8s3NW1EvNa9d4Cp1aho&#x2B;69VRo/Y5d&#x2B;GmVCLy91Pm5d2vi6tbJ7SUv&#x2B;J9CoVCJBI9/Thwg6gE4GGP7moscd/VWCLBrsYAAOWXMyUlffo0R3TUkw&#x2B;z37md9vX47O1bSZkvGhEdmzB&#x2B;6lrXawdN16qpvxsRZ8&#x2B;zE0Lq1w3bsWW6a/RvsSR/t3D4sEHvupbyrFVTF2G0OBxOQkitmvp1P&#x2B;y/eSuKEOIlLTjO7tLpJY3ahxDCOBm&#x2B;gGeKshJChEL&#x2B;nOn9B37eubS/HZfL9fX1xej/BSAAAJRHbkUFIqlU6uUlUyq93VKBSCAQcDgoKgAA8DBnWmrGrBkOk7HId5nc3OyN69O/mUrHxZZxxwghx05eeb/nVNfYnRDC43JvhJtcr3t0f/WndRNUAd6EkNNnrr/38ZRmTWoSQpJT0rVavxvhZtdh3bq0/mXjRNdUVa3G11nUnFWGYdb/sP/U2etpaVmEEJlU/OsPk995u1VpfzuBQODr64sbZC8Gv2oAFQZ2NQYAKIecmZnpM6fLv5rAr1LFvd124UL2pvXOlBSP9Or8xdsDhi1kGEaj8XVvFwr5E8f16ta5NSGEYZi1m/YtWrbVVQBw5WrEsDHLsrJzCSF8HnfogK4fvv&#x2B;q61PVqwVHRMZxKIoQcuOmOSM9q0Xz2oSQnBzb&#x2B;KlrDv55rn7dMEJIm5frzZs5UCGXlupXYxhGJpNJpaV7lcoNAQCgYnvcrsauZUmxqzEAQMniyGR0bsHFcJjc3IxZ0&#x2B;VjxvJr1SaEONPTsjdusJ0764kO3peelum6GVS3liG/MVDrt3T&#x2B;sNo19a4fM7NyFyz53fV6&#x2B;65jC5b8ZnfQUqlIFeC9bP6wenXDXG/5&#x2B;ymOn7zqer1zz4kpMzdO/foTQojRZJk1f7PrLYq6X0Lgvh9waeBwOAqFQiAo6zVGKxkEAIBK6HGlxq5QgFJjAIAXJp/wdcac2bQlrkA7k5eXMX&#x2B;ubMhwJiM96&#x2B;fNTKGQUPY4HGrksPf7fdLJ9aNa5b3t52lKhVeBwyiKGjaw2&#x2B;wFW1w/NqxXdc6M//n6KPIPSEy6v3/ZocPnd&#x2B;075Xr915ELX01eHabXEkLkMsnA/73zysv1S/XrEEJ4PJ5SqSzwJBxeAAIAACvk72rM4z2yq3GhZwXY1RgA4Em4fv6KKdMyF8yz37ld4C0mLy9j0XyP9KowhVK2bsWXLd3W7fFWyoo4TC6dN2tgm1b1lq7cTgipVVM3aXxv99G/i1Qqmju9/6bNh1w/Hjt59cDBM67X1asGLVs4IiQooFS&#x2B;hhuhUKhQKPA0u0SgCBiAvVxFBXw&#x2B;v6hSYwlKjQEAisTx8pKPmyBs3NjTHXmSJg2ruUb/ubm2xx0jEvG3/jy1Tat6hBCxWBBm0NwIN/N4XKeTWbZy&#x2B;83b96uHq4Zqt22e9tqrjQkhQiG/SligOcrqeqt&#x2B;/bBff5hS2qN/16R/pVKJf49KCgIAADziwQJEwgK7Gnt5YVdjAKj88i5dvHf4L/uN687kZPL4BRUooVA2YpSo3WvPdXKKL5B0elvc4c1id/NZnb1wc9joZa7XhbfmFfD5wYH3x&#x2B;5ikTDCaCGEZGblDhyxcPnqXa5vv/GnPz7s3k6vUxNCvKQiuUxyNyKWEMLncb8e2&#x2B;vrL3uJRKU7HZ&#x2B;iKF9fX4lEUqpXYRtMAQKAp0OpMQCwhP3q1dyDB1yvKaGAq1JzVWquVstVqTkaDVet4cgeTKThcLz69uMqvbO3b336eTkcUdu2km7vc3x8Sq3vBW386eC8xb9UrRJECLl6PXLuol9&#x2B;XDuBEGKz2fO3B86XkppJCNGofUaOXW40WQgh9&#x2B;7ljRy34sDBMz&#x2B;sGU8I2brzn1hLkqseQOYl2bRmfKMGVUv7K/B4PGzxWxoQAADgBWFXYwCo3BhbniMqyhH1yD5flETCVat5mkCuWs3RqPmNGnlJxFmbf3rC4wJhs&#x2B;aS7h9yNZrS7/JD/5y4MnvBz67XW3f&#x2B;M/3bH/38FISQuxGx46es/f2nKYU/0qJZrYWzB3XoMpYQolR6fTN7U/jNKEKIw&#x2B;GY9M3633f8U7VKICGkccNq82cN8vcrWCdQ4iQSiZeXF&#x2B;4rlQYEAAAoMfmlxoSg1BgAKicmJ8cRGemIjHyk9TGDVEHtOpIPP&#x2B;KFhr345V50XxeH3e560bBu2MRp612v//jz7Pipa3mFbqjb7Y7PP3lr1LDuXC6HEKLXqRMT05KSMgghUqlo2aodFy/fdR3Zu2f7sSN78Hmluw4PRVEymUwsFpfqVdgMAQAASlf&#x2B;/mV8foFUQLtSQf6zAuxfBgAVVVF/fVF8AaEo2/Hjjju3OWoNV6Ph&#x2B;vqRMlzCUuYlnjNjoJdUtGXr34SQls1rfTF2uavd/bCExLQRXy77ftlo1&#x2B;i/apXA/y7dJYRIJKLgQP&#x2B;MzJzklExCiFgsGNjvnU4dmpd2t7lcrkKhcP8nA0ocAgAAeABFUVwuj8sl7n/Du6YPuSIBdjUGgIqOseflXbtKrl192MTlcQP8JV26Clu3Ke2ra7X&#x2B;WzdP1YWoz56/KRYLvpnYt0pY4NYdxwghYaHa/MPO/Xfri7HLk5PT81vu3I11vdCofK6FG51ORqHwCgkO&#x2B;G7hiGpVgkq723w&#x2B;X6lUYtJ/aUMAAIDywlVq7F5UQB6WGjto2olSYwCo2GgHbbHQiQllcKma1UNcLxiG&#x2B;WXT5OpVg8NvRfF43DCDJiLy/i5mazfuW7x8m8NBF/gsj8sNC9Na4lOcToYQ0qh&#x2B;lQlje8llpb4Oj1Qq9fIquE8ZlAYEAAAo1x5Taux0PSdAqTEAlCyqlGe3l7Fft/69bdex336cQghJSEz185HfuhMj8xLn5tomTlu378FmXlWrBJIHT1uVSi&#x2B;ZzHnrdrS/n5LDoYYO7DaoX5cyuO2iVCqFQmFpXwVcEAAAoIKhKIqiuBwOF6XGAFDiJD0&#x2B;Fr3dmbZanXEWOsFKx8bRCVbaamXyCi6iX87l5dmnztq0fdfxGtVDCCF7/zi9ZPk2a0IqIUQiFn7Y55vbd2NcR9aqqbsRbiYUIYQc/OtcdvY915KgMi/xrGn9Wr9Ut7S7yuPxlEoltwyrIwABAAAqA5QaA0BJ4cjkHJmcVK32sIlhnCkpdLyVtlhoq4W2WmiLlU5MIHTByTPlx/GTV7bvOk4IYRhm1vzNP2w&#x2B;FOCvJIToQtQ5Obmu0b9EIgrwU94INxNCnE7nvEW/rvthv1QqIoTUrBGyeM5QXYiqtPspEAiwxW/ZQwAAgErrMaXGrulDD58VoNQYAJ6Coji&#x2B;vhxfX36t2g8baZpOTqLj4pz3g4HVYbU8ef/gsieWCNu/2vi773e6fqxZUxcebpZKRISQIK1fZlauKcpKCBEJ&#x2B;UNGLbnw323XYV27vDxtwqeFNwsrWQzDyGQyqVRaqleBIiEAAAC7UBSHxyu4vsSD2UPO/OlDTqcTd6QA2MlhjLQdP&#x2B;5MT&#x2B;NqtcLWbbkBAUUfx&#x2B;VyA1TcgEfukTN2Ox1vpa1Wp9VKW&#x2B;Lo&#x2B;HjaEudMTy/6DKVMF6JevnB4Smom&#x2B;X6nUMD/4N22332/y/VWjeoht&#x2B;9Eu2p8VQHeDtrpGv3zedxRw7p//OHrpd03DoejUCgEAkFpXwiKROG&#x2B;FwBAkVwTh9yDAUqNASo926kTmStXPLyLz&#x2B;PJPvlM&#x2B;Gq7/AOYvDzqOYetzL17tCWOjrc64yx0fDy/Tm1h67bP&#x2B;Fkej5&#x2B;dnf1cl3OJjk3wVsq8pOKz52&#x2B;Om7x6ybyhPB6v20eTuFxO/75vr1yz23VYtapBJpM1z&#x2B;4ghAT4K5ctGF6/7otvW/aM&#x2B;Hy&#x2B;QqHApH8PwhMAAICiuYoKUGoMwB5MXl7Whg2PzOFxODLXraG8vQUNGroaUoYMosQirkrNVat5Gg2l0vC0Gq5/AOE9dkxFiUQ8QyjPEFra/XcXHHj/wUVaeta2n6d5K2Xht6J8fRWL5gwO1PqtXLOboqhqVYNu3Y52HdaoYdVl84f5&#x2B;ihKu2MikUgul&#x2B;MRq2chAAAAPKvHlRrnPytAqTFAheYwm5jcnMLtOb9syQ8AhBBnSoozJcUefuPhERTF9ffjqrVctYarVnHUGq5ay/XzJR7d0Mpud3y74Of/Lt3Z&#x2B;dp0QojFmrz952mqAO9YS5KXVOzjK88f/X/aq8Po4R/w&#x2B;aU7LGQYRqFQiMXipx8KpQwBAACgWFz7lxVodD7g/qwAd7wAyr2i/5A6YqKdKckcH9/Hfo5h6IREOiGRXLn8sJHL46pVXLWap9Zw1RqORsMNUHF8fEq6z0VLSckYMmrJxct3a1QPoWnnkhVb9/9x5q99CwghV65FcjgkKiqeECKWCGdN&#x2B;bzjG81Luz8URfn4&#x2B;LjfPQEPQgAAACh5rv3LCjTmPyV4sCwpSo0ByheeTkcJhYzNVvitIhufgnbQsbF0bKz7DgKUUCj9qIeofYcX7&#x2B;WzuXj5zsXLdwkhjNPZb8j8f89cD9T6MQyzev3edZv2ZWTmEkJCQlQrFo6oEhZY2p3h8/lKpbLw34rgKQgAAABlpMhU8GD60CPLknqkewBACQTiTm/nbN9WsF0s4fj5l8glGJvNmZn5HMcXbz5hcKD/xx&#x2B;1nzx9g&#x2B;tUQ0ctPXz0P9cyoK&#x2B;/2nj29P95SUt9Qo5YLJbL5aV9FXguCAAAAJ70oNT4ETRNP0gETpQaA5QlyTtd6eho27mz7o3SDz&#x2B;iKuDcldat6s6fOejWnWhCiI&#x2B;PTCoRHT76HyGEoqhRw7r/77NOpf0EkqIouVwuEolK9SrwAhAAAADKnQelxg9bUGoMUEa4PNnwLwRnTtuO/UPHx3N8fUVvvCFs0szT3XpujRtVf7VtIw6HIoSEGTRx1uR0bjYhRKmQLpwz&#x2B;KXmdUq7AxwOx9vbu3CJFJQH&#x2B;F0BAKgAnlhq/MgWZigqACguihK2aCls0bLIN6UffkhHRzssFjre6kxOLuOuPTulwosQ4nDQfx&#x2B;7GGG0EEJkXpI6tQxL5w/VavxK&#x2B;&#x2B;oCgUCpVOKvo3ILAQAAoKJ6UFTwyN/krkDAMCg1BigVotffyH/N5OW57fsbS1vjaYvFmZnhwe65S05JHzl2hTUh1fXjK60bTPyql0BQ6nOZpFKpl5dXaV8FigMBAACgUkGpMUCZoQQCXnAILzjEvZHJzaEtFtpqcVrjHVYLbbXQFguTm1vGfTNHWXv3&#x2B;zYhMS0kWCXg8yaO6/3Bu6&#x2B;UwXWVSqVQKCyDC0FxIAAAAFR&#x2B;Tyg1dl&#x2B;W1CN9A6hkKLGEFxrGCw1zb3RmZtBxcU5rPG2N44aEPO6zJehuRGxCYhohROYlXrD&#x2B;67p1Sn0fYh6Pp1QqC/9VA&#x2B;UQAgAAAEsVTgUMwzy6eRlKjQEei46NdcRGM2lpFF9IZDKuvx9XraEec/ObI5NzqstJ9Rpl3MkWzWotnD3Ix7vUV&#x2B;EUCoUKhQKzDSsKBAAAALiPoqjCqQClxgAF2G/dzP5xk8NkKvwWx8eHq1Jz1WqeRkOpNDythusfQDyxEg5FUf0&#x2B;7TRy6Ptcbuluv8UwjFwul0gkpXoVKFkUbu0AAMDzepgJnCg1BnaxnT6Vufw78uzDJ4ri&#x2B;vtx1VquWsNVqzhqDc9g4Mie9ZY8l8vLycl5gX7aHTSfV&#x2B;qzcTgcjkKhEAgEpX0hKFkIAAAAUDLyywlQagyVFR0bmzZxPGO3F&#x2B;ckknffk7z7/jMe/MIBoAzw&#x2B;XylUll41QEo/zAFCAAASsbjFiAqsCypR/oGUCJytm0t5ui/0hCLxTKZDM/9KigEAAAAKEVPKDV2TSNCqTFUFIzdnnf5P0/3wvMoipLJZGKx2NMdgReHAAAAAGXqcaXGrqcEKDWGcouOjWFseZ7uhYdxuVyFQsHnl/puYlCqEAAAAMDzOBwOIRwut&#x2B;Cuxg&#x2B;eFTicTgalxuBZzoz0sr9ouXo4JhAIFAoFJv1XAggAAABQTrmKCng8HiEP11Z/UGTscDoZlBpDWaJERU96ocQSYePGlEjsTEulrVY6Pp6xV8IHBVKp1MvLy9O9gJKBAAAAABWJKxUUmIHwoKLA4fp/lBpDaeAolIUbKaFAOfNbbkDAwyaGoZOT6Ph4p8VCW6201UJb4uikJELTZdbVkkVRlFwuF4lEnu4IlBgEAAAAqPAeFBU8TAXupcb5KxGVq9kUUOFwVSqOj48zJcW9kV&#x2B;txiOjf0IIRXH9/Ll&#x2B;/qR2nYeNNE0nJdIWi9Ni4QQFlUl/SwaHw/H29uZ5Yi8zKD347QQAgEqoyFJjhmHyNy/LX5YURQWQj8nNpYRC8vg57qJWL&#x2B;fs2f1IE/VsE&#x2B;K5XK5KzVWpSYOGxetjmRIIBEqlEn9GKh8EAAAAYAuKong8XoF/&#x2B;/IrjfNXH0KpMWvlbP099/CfXJWKq1bz1BquWsPRaLgBKo6Pj&#x2B;sA0Vtv5x45wmRn5X/EfucWk5tDiSUe6nJpYRjGy8sLk/4rKwQAAABgtQelxo805s8ecjho1xKlKDVmC4eDjo2lY2Pdy3gpoZCr1nBVaq5WI6hb13b63/y3mNzcrNXfy4YMI5VokgyHw5HL5UKh8OmHQsVEYUIkAADAU7mKCgosS&#x2B;rpTkEJy/7xh9yDB17gg7zgEHHnLvx69Tklfcucw&#x2B;Hm5uaW7DmfjMfjKZXKAtPnoJKpPGkVAACg9OQXFbgvQMQwTP6mxig1ZjNHdFTmiu8IIRyFkqvRcFUqrlbLUam5ajVXpaYqzrZZIpFILpdjClylhwAAAADwgiiK4nJ5BW6VMozz/qqkThqlxmzjTE9zpqfZb4Y/bKIojq8vT63hqtVctZqj1vAMoRyFwnN9LBrDMHK5XCKpbMUMUCQEAAAAgJJEURwer&#x2B;DKMA9nDzldpQUoNWYNhnEmJeUlJZFrV10Nknffk7z7vmc7VQBFUd7e3gKBwNMdgTKCAAAAAFDqiiw1fhAIHq5BhFJjKHsCgUChUHAev/gpVD4IAAAAAJ7xuP3LUGrsKbywMH6t2rTV6kxJ9nRfyohEIvHy8sLDKLZBAAAAACgvHldqXPhZAUqNS4PwpVbCl1oRQpi8PNpqpeOtTouFtsbR1njaYnFmZni6gyWJoiiZTCYWiz3dEfAABAAAAIBy7cH&#x2B;ZY9wPkTT9P1nBbiPW1IogYAXEsILCXFvZHJzaKuVtsQ5rfEOq4W2WmiLlcnN8VQni4PL5SoUCn7FWZ4IShYCAAAAQMXjKioo0OheaIxS4xJHiSU8QyjPEOre6MzMoK1WZ5yFTrDScXF0vJWOtzK2vMed5HmVRlkIn89XKpWY9M9mCAAAAACVRJGp4P6exjTNME6HA6XGJYwjk3NkclK12sMmhnGmpNDxVqfF6rA&#x2B;CAYJiYQuF&#x2B;UcUqnUq6R3K4MKBzsBAwAAsMuDUmM6Pw&#x2B;g1LjUOZ10UiJttTitVo42UFCn7jN/krLZbCXVC4VCIRKJSupsUHEhAAAAAMD9VEDTtCsYOJ1OlBqXDyUTADgcjre3d&#x2B;FiEmAn/HcAAAAADxcgcm90qzN25i9LiqKCCkcoFCoUCvzGQT4EAAAAACjag6KCR0YLBSoKUGpcnjEMI5PJpFKppzsC5QsCAAAAADyH/FJjgeBho9sCRA6app1OBqXGHsfhcBQKhcD99wmAEIIAAAAAAMXntgCR0NWSX2r8YGFSGqXGZYnP5ysUigJzugBcUAQMAAAAZcSt1NhB0wx2NX4GL1IELBKJ5HI55mXB4yAAAAAAgCc9WmpMu5YlxeD1gecLAAzDKBQKsVhceh2CSgBTgAAAAMCTHldqnL8sKU07aRqlxk9HUZSPjw&#x2B;fz/d0R6C8QwAAAACAcseVCgqsW&#x2B;9eUUDTDpQau&#x2B;Pz&#x2B;UqlsvBW0ACFIQAAAABAxcDhcDmcR6paH5Qa5ycDlpYaSyQSmUzm6V5AhYEaAAAAAKhUGIZ5MHHo/k4FDMNU2AHPU2oAKIqSy&#x2B;UikajMOgSVAJ4AAAAAQKVCURSXyyuwACbDOF1Fxq79yypHqTGXy1UqlQUmSgE8FZ4AAAAAAEu5zR5y7WhMl7dSY4YheXl5Rb4lFArlcjkm/cMLQAAAAAAAeCi/nMDpdHq81PhxAUAqlXp5eZV9f6ByQAAAAAAAeJL8UuP8GURlVmpcZABQKpVCobBsOgCVEgIAAAAAwHNjGCZ/UVKn0&#x2B;Fw0KVRalwgAHC5XG9vb26B&#x2B;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" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>